<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Nanomaterials (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Nanomaterials (Basel)</journal-id><journal-id journal-id-type="pmc-domain-id">3130</journal-id><journal-id journal-id-type="pmc-domain">nanomat</journal-id><journal-id journal-id-type="publisher-id">nanomaterials</journal-id><journal-title-group><journal-title>Nanomaterials</journal-title></journal-title-group><issn pub-type="epub">2079-4991</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC8778544</article-id><article-id pub-id-type="pmcid-ver">PMC8778544.1</article-id><article-id pub-id-type="pmcaid">8778544</article-id><article-id pub-id-type="pmcaiid">8778544</article-id><article-id pub-id-type="pmid">35055257</article-id><article-id pub-id-type="doi">10.3390/nano12020238</article-id><article-id pub-id-type="publisher-id">nanomaterials-12-00238</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Precision and Advanced Nano-Phytopharmaceuticals for Therapeutic Applications</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Lim</surname><given-names initials="CL">Chooi Ling</given-names></name><xref rid="af1-nanomaterials-12-00238" ref-type="aff">1</xref><xref rid="c1-nanomaterials-12-00238" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Raju</surname><given-names initials="CS">Chandramathi S.</given-names></name><xref rid="af2-nanomaterials-12-00238" ref-type="aff">2</xref><xref rid="c1-nanomaterials-12-00238" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mahboob</surname><given-names initials="T">Tooba</given-names></name><xref rid="af2-nanomaterials-12-00238" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kayesth</surname><given-names initials="S">Sunil</given-names></name><xref rid="af3-nanomaterials-12-00238" ref-type="aff">3</xref><xref rid="c1-nanomaterials-12-00238" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gupta</surname><given-names initials="KK">Kamal K.</given-names></name><xref rid="af3-nanomaterials-12-00238" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jain</surname><given-names initials="GK">Gaurav Kumar</given-names></name><xref rid="af4-nanomaterials-12-00238" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dhobi</surname><given-names initials="M">Mahaveer</given-names></name><xref rid="af4-nanomaterials-12-00238" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Nawaz</surname><given-names initials="M">Muhammad</given-names></name><xref rid="af5-nanomaterials-12-00238" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2730-7788</contrib-id><name name-style="western"><surname>Wilairatana</surname><given-names initials="P">Polrat</given-names></name><xref rid="af6-nanomaterials-12-00238" ref-type="aff">6</xref><xref rid="c1-nanomaterials-12-00238" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6703-7869</contrib-id><name name-style="western"><surname>de Lourdes Pereira</surname><given-names initials="M">Maria</given-names></name><xref rid="af7-nanomaterials-12-00238" ref-type="aff">7</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4118-4355</contrib-id><name name-style="western"><surname>Patra</surname><given-names initials="JK">Jayanta Kumar</given-names></name><xref rid="af8-nanomaterials-12-00238" ref-type="aff">8</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6090-2407</contrib-id><name name-style="western"><surname>Paul</surname><given-names initials="AK">Alok K.</given-names></name><xref rid="af9-nanomaterials-12-00238" ref-type="aff">9</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0216-7977</contrib-id><name name-style="western"><surname>Rahmatullah</surname><given-names initials="M">Mohammed</given-names></name><xref rid="af10-nanomaterials-12-00238" ref-type="aff">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Nissapatorn</surname><given-names initials="V">Veeranoot</given-names></name><xref rid="af11-nanomaterials-12-00238" ref-type="aff">11</xref><xref rid="c1-nanomaterials-12-00238" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Cho</surname><given-names initials="EB">Eun-Bum</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name name-style="western"><surname>Park</surname><given-names initials="J">Jongnam</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name name-style="western"><surname>Choi</surname><given-names initials="SS">Shin Sik</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-nanomaterials-12-00238"><label>1</label>Division of Applied Biomedical Science and Biotechnology, School of Health Sciences, International Medical University, Kuala Lumpur 57000, Malaysia</aff><aff id="af2-nanomaterials-12-00238"><label>2</label>Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia; <email>tooba666@hotmail.com</email></aff><aff id="af3-nanomaterials-12-00238"><label>3</label>Department of Zoology, Deshbandhu College, University of Delhi, New Delhi 110019, India; <email>kgupta@db.du.ac.in</email></aff><aff id="af4-nanomaterials-12-00238"><label>4</label>Department of Pharmacognosy and Phytochemistry, Delhi Pharmaceutical Sciences and Research University (DPSRU), New Delhi 110017, India; <email>gkjain@dpsru.edu.in</email> (G.K.J.); <email>mahaveer@dpsru.edu.in</email> (M.D.)</aff><aff id="af5-nanomaterials-12-00238"><label>5</label>Department of Nano-Medicine, Institute for Research and Medical Consultations ((IRMC), Imam Abdulrahman Bin Faisal University, Dammam 34212, Saudi Arabia; <email>mnnmuhammad@uod.edu.sa</email></aff><aff id="af6-nanomaterials-12-00238"><label>6</label>Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand</aff><aff id="af7-nanomaterials-12-00238"><label>7</label>CICECO-Aveiro Institute of Materials &amp; Department of Medical Sciences, University of Aveiro, 3810-193 Aveiro, Portugal; <email>mlourdespereira@ua.pt</email></aff><aff id="af8-nanomaterials-12-00238"><label>8</label>Research Institute of Biotechnology &amp; Medical Converged Science, Dongguk University-Seoul, Goyang-si 10326, Korea; <email>jkpatra@dongguk.edu</email></aff><aff id="af9-nanomaterials-12-00238"><label>9</label>School of Pharmacy and Pharmacology, University of Tasmania, Private Bag 26, Hobart, TAS 7001, Australia; <email>alok.paul@utas.edu.au</email></aff><aff id="af10-nanomaterials-12-00238"><label>10</label>Department of Biotechnology &amp; Genetic Engineering, University of Development Alternative, Lalmatia, Dhaka 1207, Bangladesh; <email>rahamatm@hotmail.com</email></aff><aff id="af11-nanomaterials-12-00238"><label>11</label>School of Allied Health Sciences and World Union for Herbal Drug Discovery (WUHeDD), Walailak University, Nakhon Si Thammarat 80160, Thailand</aff><author-notes><corresp id="c1-nanomaterials-12-00238"><label>*</label>Correspondence: <email>chooi_linglim@imu.edu.my</email> (C.L.L.); <email>chandramathi@um.edu.my</email> (C.S.R.); <email>skayesth@db.du.ac.in</email> (S.K.); <email>polrat.wil@mahidol.ac.th</email> (P.W.); <email>veeranoot.ni@wu.ac.th</email> (V.N.)</corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>1</month><year>2022</year></pub-date><pub-date pub-type="collection"><month>1</month><year>2022</year></pub-date><volume>12</volume><issue>2</issue><issue-id pub-id-type="pmc-issue-id">399079</issue-id><elocation-id>238</elocation-id><history><date date-type="received"><day>21</day><month>12</month><year>2021</year></date><date date-type="accepted"><day>08</day><month>1</month><year>2022</year></date></history><pub-history><event event-type="pmc-release"><date><day>12</day><month>01</month><year>2022</year></date></event><event event-type="pmc-live"><date><day>22</day><month>01</month><year>2022</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-04-04 12:25:14.050"><day>04</day><month>04</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2022 by the authors.</copyright-statement><copyright-year>2022</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nanomaterials-12-00238.pdf"/><abstract><p>Phytopharmaceuticals have been widely used globally since ancient times and acknowledged by healthcare professionals and patients for their superior therapeutic value and fewer side-effects compared to modern medicines. However, phytopharmaceuticals need a scientific and methodical approach to deliver their components and thereby improve patient compliance and treatment adherence. Dose reduction, improved bioavailability, receptor selective binding, and targeted delivery of phytopharmaceuticals can be likely achieved by molding them into specific nano-formulations. In recent decades, nanotechnology-based phytopharmaceuticals have emerged as potential therapeutic candidates for the treatment of various communicable and non-communicable diseases. Nanotechnology combined with phytopharmaceuticals broadens the therapeutic perspective and overcomes problems associated with plant medicine. The current review highlights the therapeutic application of various nano-phytopharmaceuticals in neurological, cardiovascular, pulmonary, and gastro-intestinal disorders. We conclude that nano-phytopharmaceuticals emerge as promising therapeutics for many pathological conditions with good compliance and higher acceptance.</p></abstract><kwd-group><kwd>nano-formulations</kwd><kwd>phytopharmaceuticals</kwd><kwd>herbal medications</kwd><kwd>therapeutics</kwd><kwd>precision</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-nanomaterials-12-00238"><title>1. Introduction</title><p>Nanotechnology is the application of nanoparticles for various purposes, including disease diagnostics, cosmetics, and therapeutics. From a small beginning in the 1950s by the physicist Richard Feynman and in 1974 by Norio Taniguchi, the applications of nanotechnology have changed to an enormous dimension today, and are encompassing many branches of chemistry, physics, biochemistry, biotechnology, information technology, environmental science, and pharmacy, to name only a few [<xref rid="B1-nanomaterials-12-00238" ref-type="bibr">1</xref>]. Nanotechnology is a vital tool for medical sciences. The introduction of nanomedicine, using nanotechnology combined with drugs or diagnostic molecules, has improved the ability to target specific cells or tissues that require treatment and repair. These nanomaterials have been proven to be produced at a nanoscale level and are safe to introduce into the body. It is possible to modify a variety of nanocarriers&#8217; characteristics that include their constituents, size, shape, bioavailability, surface properties, and target specificity to achieve or enhance desirable pharmacological targets [<xref rid="B1-nanomaterials-12-00238" ref-type="bibr">1</xref>,<xref rid="B2-nanomaterials-12-00238" ref-type="bibr">2</xref>] Several strategies have been implemented to increase the drug-target specificity. Recently, several studies have reported improved efficacy of therapy when combined with nanomaterials [<xref rid="B3-nanomaterials-12-00238" ref-type="bibr">3</xref>]. Pure herbal medicines are often considered less effective compared to pure constituents that are mainly demonstrated to have reduced intestinal absorption when administered orally [<xref rid="B4-nanomaterials-12-00238" ref-type="bibr">4</xref>]. This is the reason behind the pharmacological activity/loss associated with pure constituents and such problems can be overcome using new drug delivery systems, such as nanotechnology.</p><p>Nanoparticulate delivery of drugs can generally improve drugs&#8217; solubility, bioavailability, stability, pharmacological activity, increase target specificity, promote transport across membrane, prolong circulation times, and reduce systemic and organ toxicity [<xref rid="B5-nanomaterials-12-00238" ref-type="bibr">5</xref>,<xref rid="B6-nanomaterials-12-00238" ref-type="bibr">6</xref>]. Various treatments are being investigated with the use of nanoparticle drug delivery systems for diseases, such as infectious diseases, autoimmune diseases, cardiovascular diseases, neurodegenerative diseases, ocular diseases, fungal infections, iron deficiency, and pulmonary diseases [<xref rid="B7-nanomaterials-12-00238" ref-type="bibr">7</xref>,<xref rid="B8-nanomaterials-12-00238" ref-type="bibr">8</xref>]. However, the greatest advances were seen in the treatment of cancer with several nano strategies being used clinically after approval by the FDA in the United States of America [<xref rid="B9-nanomaterials-12-00238" ref-type="bibr">9</xref>]. Recently, more attention has shifted towards novel drug delivery systems using nanoparticles for herbal and plant-based drugs [<xref rid="B10-nanomaterials-12-00238" ref-type="bibr">10</xref>]. The use of plants for medicinal purposes can be documented from as far back as 6000 years ago with many important plant compounds being developed into conventional or allopathic medicine used today [<xref rid="B11-nanomaterials-12-00238" ref-type="bibr">11</xref>]. Although conventional medicine is widely used compared to herbal medicine in developed countries, there is a considerably large segment of society that continues to use medicines derived from plants for their healthcare [<xref rid="B12-nanomaterials-12-00238" ref-type="bibr">12</xref>].</p><p>According to the World Health Organization, nine million Malaysians out of an estimated population of 30 million would have used or are using traditional and complementary medicines (which includes plants, parts of plants, or plant materials) for the prevention and treatment of medical ailments. Additionally, 88% of WHO member states (170 of the 194 member states) have acknowledged their use of traditional and complementary medicine amongst their population [<xref rid="B13-nanomaterials-12-00238" ref-type="bibr">13</xref>].</p><p>Despite these numbers, plant-based medicine has some limitations which hinder its use and production in the mainstream disease treatment and therapy. There are several chemical constituents in a plant&#8217;s extract that lead to its medicinal properties. The active constituents of plant extracts like tannins, flavonoids, alkaloids, phenylpropanoids, and terpenoids are water-soluble but show poor absorption from their inability to cross lipid membranes and have large molecular sizes, which then results in low bioavailability and efficacy [<xref rid="B5-nanomaterials-12-00238" ref-type="bibr">5</xref>,<xref rid="B12-nanomaterials-12-00238" ref-type="bibr">12</xref>,<xref rid="B14-nanomaterials-12-00238" ref-type="bibr">14</xref>]. There are also concerns of safety due to the incompatibility of some plant extracts with other components in a drug formulation which can lead to undesirable effects [<xref rid="B12-nanomaterials-12-00238" ref-type="bibr">12</xref>]. High systemic clearance of these compounds also leads to low therapeutic levels in the blood resulting in no therapeutic effect [<xref rid="B15-nanomaterials-12-00238" ref-type="bibr">15</xref>]. Furthermore, poor reproducibility of in vitro effects in vivo prevents many plant-based medicines from clearing clinical trial phases [<xref rid="B16-nanomaterials-12-00238" ref-type="bibr">16</xref>]. Nanomedicine aims to overcome these limitations and to improve the delivery of plant-based medicines to treat various diseases. Nanoparticle drug delivery systems can potentially improve the stability, solubility, and bioavailability of encapsulated plant extracts, promote its movement across lipid membranes, and prolong its circulation, all while delivering the active constituent to a specific target site [<xref rid="B5-nanomaterials-12-00238" ref-type="bibr">5</xref>,<xref rid="B6-nanomaterials-12-00238" ref-type="bibr">6</xref>,<xref rid="B12-nanomaterials-12-00238" ref-type="bibr">12</xref>] (<xref rid="nanomaterials-12-00238-f001" ref-type="fig">Figure 1</xref>). Liposomes, dendrimers, polymeric NCs, polymeric micelles, metallic NPs (magnetic, gold), SLNs, nanocapsules, nanospheres, and nanogels are some of the examples of nano-based drug delivery systems that are presently under investigation [<xref rid="B10-nanomaterials-12-00238" ref-type="bibr">10</xref>]. This review aims to show the potential of plant-based drugs to prevent and treat some of the communicable and non-communicable diseases. Although not exhaustive, this review highlights several examples where the application of nanotechnology proves to be effective.</p></sec><sec id="sec2-nanomaterials-12-00238"><title>2. Materials and Methods</title><p>Databases including PubMed, Medline, Scielo, Thomson Reuters ISI Web of Knowledge, and Science Direct were searched, combining the following keywords: &#8220;Nanotechnology&#8221;, &#8220;plant-based medicine&#8221;, &#8220;herbal nanoformulations&#8221;, &#8220;phytochemical-based nanoformulations&#8221;, and &#8220;nano-phytopharmaceuticals&#8221;. The available scientific literature within the last decade (2011&#8211;2021) was considered in this review.</p></sec><sec id="sec3-nanomaterials-12-00238"><title>3. Therapeutic Applications of Nano-Phytopharmaceuticals</title><sec id="sec3dot1-nanomaterials-12-00238"><title>3.1. Nano-Phytopharmaceuticals in Neurological (CNS) Disorders</title><p>The central nervous system is a complex environment&#8212;a vast network of neurons, astrocytes, microglia, and other supportive tissues buoyed in lubricating cerebrospinal fluid. The delicate balance between nerve connections, spinal cord, and the control center, the brain, is easily perturbed by exogenous insults and endogenous degenerative conditions. Debilitating disorders of the central nervous system (CNS) include Alzheimer&#8217;s disease (AD) [<xref rid="B17-nanomaterials-12-00238" ref-type="bibr">17</xref>] and variants of dementia such as Lewy body dementia (LBD), tumors such as neuroblastoma and glioblastoma [<xref rid="B18-nanomaterials-12-00238" ref-type="bibr">18</xref>], as well as dyskinesia-related conditions such as Parkinson&#8217;s disease (PD), Huntington&#8217;s disease (HD), and amyotrophic lateral sclerosis (ALS) [<xref rid="B19-nanomaterials-12-00238" ref-type="bibr">19</xref>]. Alzheimer&#8217;s disease is a type of neurodegenerative disease that is described by the formation of plaques with tangled neurofibers composed of amyloid and tau proteins. It is recognized as the most common type of dementia and the main risk factor is associated with age [<xref rid="B20-nanomaterials-12-00238" ref-type="bibr">20</xref>]. Parkinson&#8217;s disease is described by the deficiency of dopamine neurons in the substantia nigra. It has been associated with the aggregation of ubiquitinated synuclein in the dopaminergic neurons [<xref rid="B20-nanomaterials-12-00238" ref-type="bibr">20</xref>]. It is estimated that 1% of individuals over 60 years of age are affected by Parkinson&#8217;s disease, which is the main source of the movement disorder known as Parkinsonism [<xref rid="B20-nanomaterials-12-00238" ref-type="bibr">20</xref>]. Parkinsonism comprises tremors, bradykinesia, and akinesia in severe cases [<xref rid="B21-nanomaterials-12-00238" ref-type="bibr">21</xref>]. Huntington&#8217;s disease is described by the accumulation of a mutant Huntingtin protein in the neurons, prompting inaccurate neuronal actions and eventually results in neuronal demise [<xref rid="B22-nanomaterials-12-00238" ref-type="bibr">22</xref>]. This prompts unusual movements in the patient, adduced as chorea [<xref rid="B23-nanomaterials-12-00238" ref-type="bibr">23</xref>]. The cause of Huntington&#8217;s disease is the autosomal dominant mutation [<xref rid="B20-nanomaterials-12-00238" ref-type="bibr">20</xref>]. The pathophysiology underlying CNS diseases involve neuroinflammation, accumulation of distorted protein aggregates [<xref rid="B24-nanomaterials-12-00238" ref-type="bibr">24</xref>], and neuronal death [<xref rid="B25-nanomaterials-12-00238" ref-type="bibr">25</xref>].</p><p>The CNS and related diseases represent a serious health burden globally [<xref rid="B26-nanomaterials-12-00238" ref-type="bibr">26</xref>]. The therapy to treat CNS disorders is mainly hampered by the blood-brain barrier (BBB). BBB is a highly organized arrangement of the vasculature that has evolved naturally to restrict the entrance of molecules into the brain and to prevent the brain from potentially harmful microbes, to prevent microbials entering the bloodstream. Following these restrictions, most known therapies face the same hindrance from the BBB in entering the CNS and targeting the site of infection [<xref rid="B27-nanomaterials-12-00238" ref-type="bibr">27</xref>], whereas the BBB slowly allows the passage of nutrients and other related molecules with a smaller size which are a necessary function of the CNS [<xref rid="B28-nanomaterials-12-00238" ref-type="bibr">28</xref>].</p><p>Despite enduring efforts to deliver medicinal drugs to the brain tissue, these treatment regimens are compromised by low bioavailability due to the blood-brain barrier (BBB), a natural protective layer consisting of capillary endothelial cells, pericytes, and tight junctions [<xref rid="B29-nanomaterials-12-00238" ref-type="bibr">29</xref>]. This near-impermeable barrier impedes the entry of most macromolecules and allows only the minutest particles (&lt;400 Da) to cross into the nerve tissue. Indeed, less than 5% of conventional therapeutic molecules in various stages of pharmaceutical development may penetrate this physiological barrier [<xref rid="B30-nanomaterials-12-00238" ref-type="bibr">30</xref>]. Therefore, CNS-targeted natural product formulations in nanocarriers hold infinite promise. Evidence suggests that nutraceuticals and phytochemicals exert therapeutic effects in neurological diseases, owing to their antioxidant, anti-inflammatory, and neuroprotective mechanisms [<xref rid="B31-nanomaterials-12-00238" ref-type="bibr">31</xref>,<xref rid="B32-nanomaterials-12-00238" ref-type="bibr">32</xref>]. Coupled with nanoscale delivery systems which improve solubility, enhance retention rates [<xref rid="B33-nanomaterials-12-00238" ref-type="bibr">33</xref>], and with the ability to permeate through the BBB (<xref rid="nanomaterials-12-00238-f001" ref-type="fig">Figure 1</xref>), there is hope yet for effective treatment of neurological disorders. The following topic discusses two herbal compounds, curcumin and ginseng, and their significant potential for use in neurotherapeutics through nano-encapsulation.</p><p>A derivative of the South Asian turmeric plant rhizome, <italic toggle="yes">Curcuma longa</italic> (turmeric), the polyphenol curcumin has amassed quite a reputation in nutraceutical development for various diseases, including cancer and inflammatory conditions [<xref rid="B34-nanomaterials-12-00238" ref-type="bibr">34</xref>]. The healing properties of this yellow spice date back to ancient civilizations, featuring strongly in Ayurvedic therapy. Nevertheless, the relatively poor bioavailability due to dismal water solubility and rapid intestinal clearance impedes the therapeutic effects of conventional drug delivery, paving the way for the advent of nano-formulations.</p><p>The role of nanoparticulate systems to treat glioblastoma was recently highlighted using different strategies, such as improving their diffusion through the BBB [<xref rid="B35-nanomaterials-12-00238" ref-type="bibr">35</xref>]. In a glioblastoma study, Schmitt et al. demonstrated that curcumin encased in liposomal carriers (LipoCur) proved to be superior in reducing the proliferation and reactivity of human microglia and astrocytes (human fetal astrocyte cell line, SVGA) compared to the free compound. Immunostaining of murine organotypic brain segments challenged with lipopolysaccharide (LPS) for eight days, revealed that LipoCur was equally effective in reducing glial scarring [<xref rid="B34-nanomaterials-12-00238" ref-type="bibr">34</xref>].</p><p>Research on neuroblastoma models also corroborated that the anticancer properties of curcumin were significantly enhanced through nanocarrier delivery [<xref rid="B36-nanomaterials-12-00238" ref-type="bibr">36</xref>]. Curcumin nanosuspensions, consisting of stable nanoscale droplets of the compound with surfactants and biopolymers, improved solubilization and increased intravenous plasma distribution to vital organs compared with standard curcumin. Higher levels of curcumin in male Wistar rat brains were discovered when delivered via Tween 80-coated nanoparticles (NPs) in comparison to curcumin solution [<xref rid="B37-nanomaterials-12-00238" ref-type="bibr">37</xref>]. The mechanism of action exerted by curcumin in neuroblastoma cells involved the regulation of PTEN&#8211;Akt (phosphatase and tensin homolog-protein kinase B), NF-&#954;B (nuclear factor kappa-light-chain-enhancer of activated B cells), and p53 (tumor protein P53), signaling, activation of the apoptosis cascade, and mitochondrial dysfunction [<xref rid="B36-nanomaterials-12-00238" ref-type="bibr">36</xref>].</p><p>In another study, dextran-coated cerium oxide nanoparticles (CNP-Cur), containing curcumin, induced significant cell death in an in vitro model of neuroblastoma. The formulation enhanced oxidative stress and triggered caspase-dependent apoptosis targeted to MYCN-amplified tumor cells and sparing non-MYCN augmented populations [<xref rid="B38-nanomaterials-12-00238" ref-type="bibr">38</xref>]. The synthesis of nanoparticle shells themselves could use natural compounds, such as silk fibroin of the <italic toggle="yes">Bombyx mori</italic> silkworm. The biocompatible and biodegradable properties add to the allure of the curcumin-loaded silk fibroin NP formulation, which conferred enhanced and tumor-specific cytotoxicity in neuroblastoma cells [<xref rid="B39-nanomaterials-12-00238" ref-type="bibr">39</xref>].</p><p>Aside from pure curcumin, combinations of herbal compounds that exhibit synergistic effects were also a subject of interest. A 10&#8211;25 &#181;g/mL curcumin&#8211;piperine combination loaded into zein-chitosan nanoparticles (CPZChN) successfully reduced SH-SY5Y neuroblastoma cell viability by half, with encapsulation efficiencies of 89% (curcumin) and 87% (piperine) respectively [<xref rid="B40-nanomaterials-12-00238" ref-type="bibr">40</xref>]. Multi-compound bioactive complexes like curcumin&#8211;piperine are challenging to create, due to their distinct polarities. To overcome this, the two components were encased in core-shell NPs through antisolvent precipitation and progressive layering of zein-hyaluronic acid, followed by chitosan coating [<xref rid="B41-nanomaterials-12-00238" ref-type="bibr">41</xref>].</p><p>Aside from the CNS cancers, chronic degenerative conditions such as Alzheimer&#8217;s disease (AD) fall under intense scrutiny from researchers. Characterized by neurofibrillary tangles of tau proteins and &#8220;senile&#8221;amyloid-&#946; (A&#946;) plaques in the brain, the condition is notoriously challenging to diagnose and treat due to the late onset of symptoms, usually decades after the onset of pathological changes [<xref rid="B42-nanomaterials-12-00238" ref-type="bibr">42</xref>]. Neuro-inflammation is recognized as one of the primary mechanisms underlying neuronal degeneration, and thus is a target for natural product (NP) research. Malvajerd and colleagues encapsulated curcumin in solid lipid nanoparticles (SLNs) (entrapment efficiency 82 &#177; 0.49%) and nanostructured lipid carriers (NLCs) (94 &#177; 0.74%), and found that NLCs resulted in the highest bioaccumulation of curcumin in rat brains compared to free compound and SLNs [<xref rid="B43-nanomaterials-12-00238" ref-type="bibr">43</xref>].</p><p>A variant of lipid NPs, lipid-core nanocapsules (LNC), were used as curcumin carriers in an AD model of aged mice injected with &#946;-amyloid 1&#8211;42 peptide. Significant behavioral changes indicating reversal of degeneration and reduced inflammatory cytokine levels were observed in the mice which received the loaded LNCs [<xref rid="B44-nanomaterials-12-00238" ref-type="bibr">44</xref>]. Recently, Nakama and colleagues proposed an analytical method to quantify curcumin and meloxicam in an LNC co-nanoencapsulation trial. They validated the encapsulation using a HPLC-DAD technique, which has been proven non-toxic to male Swiss mice [<xref rid="B45-nanomaterials-12-00238" ref-type="bibr">45</xref>].</p><p>Similar models, using curcumin-loaded SLNs (SCLNs) of about 86 nm in diameter, reduced LPS-induced neuroinflammation in BV-2 microglial cells by hindering nitric oxide (NO) production. Proinflammatory cytokines, including TNF (tumor necrosis factor)-&#945;, IL (interleukin)-1&#946;, and IL-6, were also more strongly inhibited compared to free curcumin [<xref rid="B46-nanomaterials-12-00238" ref-type="bibr">46</xref>]. Both in vitro and in vivo year-old 5xFAD mice models for SCLN delivery were evaluated by Maiti and colleagues, who reported enhanced curcumin penetration and neuroprotection. The assessment of A&#946; plaque load and pre-frontal cortex (PFC) and hippocampus neuronal morphology revealed a down-regulation of pyknotic neurons and anti-inflammatory effect conferred by the curcumin NPs [<xref rid="B47-nanomaterials-12-00238" ref-type="bibr">47</xref>].</p><p>Poly (<sc>d,l</sc>-lactic acid-co-glycolic acid, PLGA) and polymer NPs are known to be biocompatible and thus show great potential in disarming neuroinflammation in another 5xFAD mice Alzheimer&#8217;s disease model [<xref rid="B48-nanomaterials-12-00238" ref-type="bibr">48</xref>]. Huang and team also achieved positive outcomes using novel PLGA NPs added with a BBB-penetrating (cyclic CRTIGPSVC) peptide, and co-administering curcumin with A&#946; generation inhibitor. Transgenic AD mice responded well to treatment, with improved spatial memory scores and enhanced &#8217;new-object recognition&#8217; ability [<xref rid="B49-nanomaterials-12-00238" ref-type="bibr">49</xref>]. Co-administration with phytol and selenium in PLGA NPs have also been proven to inhibit &#946; amyloid aggregation in various AD models [<xref rid="B50-nanomaterials-12-00238" ref-type="bibr">50</xref>,<xref rid="B51-nanomaterials-12-00238" ref-type="bibr">51</xref>].</p><p>Venturing into intranasal delivery, Zhang et al. compared two different formulations, namely CUR-encapsulated chitosan-coated poly (lactic-co-glycolic acid) nanoparticles (CUR-CS-PLGA-NPs) and hydroxypropyl-&#946;-cyclodextrin-encapsulated CUR (CUR/HP&#946;-CD inclusion) complexes. Both showed anti-inflammatory potential in BV-2 cells and higher bioavailability in vivo, although the latter was evidently more effective by 1.12 fold (plasma)and 2.57 fold (brain) [<xref rid="B52-nanomaterials-12-00238" ref-type="bibr">52</xref>]. Other NP formulations include curcumin-conjugated superparamagnetic iron oxide (SPIO) particles &lt; 100 nm in diameter, resulting in biocompatible curcumin magnetic nanoparticles (Cur-MNPs). Administration of Cur-MNPs to Tg2576 mouse brains revealed co-localization of the particles with amyloid plaques, enabling less invasive diagnosis of AD using MRI (magnetic resonance imaging) [<xref rid="B53-nanomaterials-12-00238" ref-type="bibr">53</xref>]. Clearly, curcumin-encapsulated NPs have captivated the pharmaceutical drug development sector for neurotheranostics and advancing to the next stage of clinical trials would be warranted.</p><p>Another &#8217;superherb&#8217;, with its medicinal use dating back to ancient Chinese and Korean civilizations, the ginseng plant (<italic toggle="yes">Panax ginseng</italic> C. A. Meyer) is traditionally consumed to enhance alertness, cognition, memory, and overall well-being. Its purported effects on the CNS form the basis of neurotherapeutic drug development from numerous ginseng-derived bioactive compounds such as ginsenoside, gintonin and Compound K. These phytochemicals have been evaluated for curative and preventive properties in neurodegenerative diseases, including AD, PD, HD, and even depression [<xref rid="B54-nanomaterials-12-00238" ref-type="bibr">54</xref>,<xref rid="B55-nanomaterials-12-00238" ref-type="bibr">55</xref>]. Mechanistic studies suggest anti--apoptotic, antioxidant, neurogenesis, and inhibition of amyloid beta aggregation [<xref rid="B56-nanomaterials-12-00238" ref-type="bibr">56</xref>] in AD studies. A detailed review of bioactive components of <italic toggle="yes">P</italic>. <italic toggle="yes">ginseng</italic> and their effects on AD pathogenesis was recently reported by Razgonova and colleagues [<xref rid="B57-nanomaterials-12-00238" ref-type="bibr">57</xref>].</p><p>Aalinkeel and team investigated the neuroprotective effect of Ginsenoside Rg3 combined with Thioflavin T, an A&#946; diagnostic, encased in biodegradable PLGA NPs. An in vitro model was used to evaluate the efficiency of BBB penetration and underlying mechanistic pathways of bioactivity. They concluded that PLGA-Rg3 NPs may prove to be a potent nanodelivery tool for the treatment of neurological disease [<xref rid="B58-nanomaterials-12-00238" ref-type="bibr">58</xref>]. Ginsenoside was also evaluated for anti-PD therapy through its antioxidant effect, modulation of glutathione level, ROS-mediated NF-&#954;B signaling, iron transport, and subsequently reduced iron accumulation in the substantia nigra [<xref rid="B31-nanomaterials-12-00238" ref-type="bibr">31</xref>].</p><p>Other groups evaluated the bioactivity of Compound K (CK), a metabolite from the biotransformation of ginsenosides Rb1, Rb2, and Rc. Other well-studied ginsenosides include Rd, Re, and Rg131. As the most bioavailable component of ginsenoside metabolism, its neuroprotective and cognition-enhancing effects have been characterized in animal models of AD [<xref rid="B59-nanomaterials-12-00238" ref-type="bibr">59</xref>]. Although CK is regarded as safe and well-tolerated, findings from clinical trials are marginal and based on CK-rich fermented red ginseng. Delivery of CK through nanocarriers was reported to override its limitations of efflux, poor water solubility, and membrane permeability, which impeded the research progress into clinical trials [<xref rid="B60-nanomaterials-12-00238" ref-type="bibr">60</xref>,<xref rid="B61-nanomaterials-12-00238" ref-type="bibr">61</xref>].</p><p>Kim et al. established a formulation of red ginseng water extract with gold nanoparticles (WERGGN) and established its antioxidant activity through DPPH, ORAC and ABTS assays. WERGGN treatment on neuron-like PC-12 cells revealed cytoprotective effects, mainly due to the decreased intracellular oxidative stress. In addition, levels of neurotransmitter degradation enzymes such as acetylcholinesterase and butyrylcholinesterase were also inhibited, suggesting that WERGGN promoted synaptic impulse transmission [<xref rid="B62-nanomaterials-12-00238" ref-type="bibr">62</xref>]. Nonetheless, the dosage of ginseng extract, when co-administered with a synthetic drug (e.g. selegiline), determines the pharmacokinetics in the body: lower doses result in poorer bioavailability due to CYP1A2 induction, while higher concentrations cause inhibition of CYP3A4 and thus enhanced systemic exposure [<xref rid="B63-nanomaterials-12-00238" ref-type="bibr">63</xref>].</p><p>Although the root of <italic toggle="yes">Panax ginseng</italic> is generally the primary source of extracted bioactive compounds, its leaves may be equally valuable. Singh et al. characterized and validated gold- and silver-NPs with fresh ginseng leaf extract, demonstrating significant antioxidant and anti-inflammatory activity, and anti-carcinogenic effects or biocompatibility in several tumorigenic or normal human cell lines, respectively [<xref rid="B64-nanomaterials-12-00238" ref-type="bibr">64</xref>]. Studies on the anti-carcinogenic effects of polymer&#8211;ginsenoside nanoconjugates revealed improved bioavailability into the tumor sites, efficient drug release, and oncogene-targeting mechanisms [<xref rid="B65-nanomaterials-12-00238" ref-type="bibr">65</xref>]. In a glioma spheroid model, Zhu et al. developed a multifunctional ginsenoside Rg3-based liposomal system (Rg3-LPs) which demonstrated a superior anti-proliferation effect on C6 glioma cells compared to cholesterol liposomes (C-LPs) when embedded with paclitaxel (PTX). In C6-bearing mice//rats, Rg3-PTX-LPs triggered expansion of CD8+T-cell populations, thus enhancing cancer-ridding immune surveillance. The researchers surmised that ginsenoside Rg3 shows a synergistic effect with synthetic chemotherapy drugs and provides an effective delivery tool for neurological tumors [<xref rid="B66-nanomaterials-12-00238" ref-type="bibr">66</xref>]. In another study, a nano-ginseng formulation, &#8217;ginsenoside Rb1/protopanaxadiol nanoparticles&#8217; (Rb//PPD NPs) of ~110 nm in size, showed increased drug-loading efficiency (~96.8%) and capacity ((~27.9 wt%), although this was targeted on the Lewis lung cancer (LLC) cell line and xenograft [<xref rid="B67-nanomaterials-12-00238" ref-type="bibr">67</xref>].</p><p>In a nutshell, derivatives of <italic toggle="yes">Panax ginseng</italic> display great potential in the treatment of neurodegenerative conditions as well as various cancers, including gliomas, and should be explored further (<xref rid="nanomaterials-12-00238-f002" ref-type="fig">Figure 2</xref>). Nano-formulations of active compounds or extracts from curcumin and ginseng for neurological disorders described in this topic are briefly listed in <xref rid="nanomaterials-12-00238-t001" ref-type="table">Table 1</xref>.</p><p>It is essential to note that nanomaterials have potential limitations and the adverse effects on CNS were described previously [<xref rid="B69-nanomaterials-12-00238" ref-type="bibr">69</xref>,<xref rid="B70-nanomaterials-12-00238" ref-type="bibr">70</xref>]. For example, one study showed that female mice that were intranasally treated with titanium dioxide nanoparticles (TiO<sub>2</sub> NPs) (0.5 mg daily for 1 month) produced apoptosis, affected brain development, and oxidative stress (caused increased lipid peroxidation, protein oxidation, catalase expressions, and release of glutamic acid and nitric oxide) [<xref rid="B70-nanomaterials-12-00238" ref-type="bibr">70</xref>]. These authors also concluded that an intranasal spray of TiO<sub>2</sub> NPs could be translocated into the CNS and cause potential lesions of the brain [<xref rid="B70-nanomaterials-12-00238" ref-type="bibr">70</xref>]. Similarly, Fe<sub>2</sub>O<sub>3</sub> magnetic NPs (0.15&#8211;15 mM) also showed toxicity and c viability in a neuronal cell line in vitro [<xref rid="B71-nanomaterials-12-00238" ref-type="bibr">71</xref>]. Whereas another study showed that toxicity of zinc and silicon NPs is relatively low, but the neuronal toxicity of NPs depends on the materials used [<xref rid="B69-nanomaterials-12-00238" ref-type="bibr">69</xref>,<xref rid="B72-nanomaterials-12-00238" ref-type="bibr">72</xref>,<xref rid="B73-nanomaterials-12-00238" ref-type="bibr">73</xref>]. Therefore, the toxicity of NPs is present, and depends on the formulation, particle size and concentration or treatment protocols of specific NPs.</p></sec><sec id="sec3dot2-nanomaterials-12-00238"><title>3.2. Nano-Phytopharmaceuticals in Cardiovascular Disorders</title><p>Cardiovascular disorders are linked to the heart and blood vessels, implicating coronary heart diseases (e.g., heart attack), cerebrovascular disease (e.g., stroke), elevated blood pressure (e.g., hypertension), peripheral artery disorders, rheumatic heart disease, congenital heart disease, and heart failure [<xref rid="B74-nanomaterials-12-00238" ref-type="bibr">74</xref>]. A large number of individuals die of cardiovascular diseases yearly compared to other diseases around the globe [<xref rid="B74-nanomaterials-12-00238" ref-type="bibr">74</xref>]. The risk factors associated with cardiovascular disorders mainly include tobacco use, unhealthy diet and obesity, lack of physical activity, inappropriate use of alcohol, hypertension, diabetes, and hyperlipidaemia [<xref rid="B75-nanomaterials-12-00238" ref-type="bibr">75</xref>]. Cardiovascular disorder refers to a condition that affects the heart or blood vessels mostly associated with deposits of fats in the arteries, a condition specifically known as atherosclerosis that can lead to blood clots. Most often, CVD is associated with damage to the arteries, not only of the heart, but also of other major organs, such as kidneys, brain, and eyes [<xref rid="B76-nanomaterials-12-00238" ref-type="bibr">76</xref>]. It is one of the leading causes of death worldwide. Noticeably, some pressing concerns are related to rising heart disease mortality rates among younger adults [<xref rid="B77-nanomaterials-12-00238" ref-type="bibr">77</xref>] A wide range of complications may emerge within cardiovascular systems, such as rheumatic heart disease, endocarditis, and abnormal conduction system [<xref rid="B78-nanomaterials-12-00238" ref-type="bibr">78</xref>]. There are many different types of CVD, but the main four are (i) Coronary heart disease (CHD) which occurs when the flow of oxygenated blood to the heart muscle is reduced or totally blocked. This condition leads to angina, heart attack, and heart failure; (ii) Stroke and transient ischemic attack (TIA), both conditions block the blood supply to the brain, but the former can cause brain damage and possibly death, while the latter brings about temporary interruption of blood flow to the brain, hence it is called a &#8217;mini-stroke&#8217;; (iii) Peripheral arterial disease happens when the blockage of arteries involves the limbs, often the legs; (iv) Aortic disease involves the biggest artery, the aorta. This artery weakens and bulges outwards, and may be life-threatening due to its possible bursting that could lead to profuse bleeding [<xref rid="B77-nanomaterials-12-00238" ref-type="bibr">77</xref>,<xref rid="B79-nanomaterials-12-00238" ref-type="bibr">79</xref>].</p><p>Cardiovascular disorders, associated with many factors, involve various congenital and acquired ailments. Cardiovascular disorders include atherosclerosis with its subtypes, such as coronary, cerebral, and peripheral artery disease, along with two main complexities, myocardial infarction and ischemic stroke, heart failure, cardiac valvulopathies and arrhythmias, rheumatic heart disease, congenital heart disease, deep vein thrombosis with its specific complexities, and pulmonary embolism [<xref rid="B80-nanomaterials-12-00238" ref-type="bibr">80</xref>]. It comprises the main noncommunicable reason for death in Europe specifically, and also globally [<xref rid="B80-nanomaterials-12-00238" ref-type="bibr">80</xref>].</p><p>CVD requires immediate attention and treatment to prevent further damage to avoid harmful clots from forming in blood vessels and plaque build-up [<xref rid="B81-nanomaterials-12-00238" ref-type="bibr">81</xref>]. Medications are any one or combinations of the following: anti-coagulants, anti-platelet agents, dual anti-platelet therapy, angiotensin-converting enzyme (ACE) Inhibitors, angiotensin II receptor blockers, angiotensin receptor-neprilysin inhibitors, beta blockers, calcium channel blockers, cholesterol--lowering medications, digitalis preparations, diuretics, and vasodilators [<xref rid="B81-nanomaterials-12-00238" ref-type="bibr">81</xref>,<xref rid="B82-nanomaterials-12-00238" ref-type="bibr">82</xref>]. Each type of medication has a specific action to prevent the formation of a blood clot that could cause a blockage in the blood vessel. In worst conditions, patients may undergo medical procedures such as coronary angioplasty and stent implantation, thrombolytic therapy, coronary artery bypass graft surgery (CABG), artificial pacemaker surgery, defibrillation, and heart valve surgery [<xref rid="B82-nanomaterials-12-00238" ref-type="bibr">82</xref>] </p><p>Since CVD require most often long-term medication, treatment regimens become complex and create a burden for the patient especially when multiple medicines are prescribed and must be taken for life [<xref rid="B83-nanomaterials-12-00238" ref-type="bibr">83</xref>,<xref rid="B84-nanomaterials-12-00238" ref-type="bibr">84</xref>] Although these therapeutic drugs have been successful in halting the progression of the disease, thereby improving the quality of life of patients, most of these cure only the symptoms and may not repair or regenerate the damaged tissues. In addition, CVD medication has different side effects, such as antiplatelet drugs may cause diarrhea, rash, or itching [<xref rid="B83-nanomaterials-12-00238" ref-type="bibr">83</xref>]. Others can cause abdominal pain, headache, chest pain, muscle aches, and dizziness. In the case of anticoagulants, their side effects can lead to bleeding and necrotic or gangrenous skin. Given the excessive side effects of current therapies, alternative therapeutic approaches like medicinal plants and natural products are preferred. Against this premise, a better treatment for CVD that would not burden the patients is necessary. Hence, it is important to explore new technologies and drugs to lessen the use of conventional treatments. The lower toxicity, chemical diversity, cost-effectiveness, and therapeutic potentials of natural products make them the popular choice of medicine compared to other products [<xref rid="B85-nanomaterials-12-00238" ref-type="bibr">85</xref>]. With the combination of nanoformulation methods to deliver phytomedicines, it becomes more effective with improved solubility, bioavailability, circulation time, surface area-to-volume ratio, nil systemic adverse side effects, and drug delivery efficiency of these medications. The introduction of nanomedicine using a combined nanotechnology with drugs or diagnostic molecules has improved the ability to target specific cells or tissues that require treatment and repair. These nanomaterials are produced on a nanoscale level and are safe to introduce into the body. Hence, applications for nanotechnology in medicine include imaging, diagnosis, or the delivery of drugs that will help medical professionals treat various diseases including cardiovascular diseases [<xref rid="B86-nanomaterials-12-00238" ref-type="bibr">86</xref>,<xref rid="B87-nanomaterials-12-00238" ref-type="bibr">87</xref>]. The functionality of the most recent nano-formulated medicinal plants and/or natural products against various cardiovascular conditions such as hypertension, atherosclerosis, thrombosis, and myocardial infarction is expected to be maximized.</p><p>Some plant extracts/compounds used for treatment of CVD that are nano-formulated for efficient delivery to their target are listed in <xref rid="nanomaterials-12-00238-t002" ref-type="table">Table 2</xref>. Among the extracts used for CVD, curcumin, quercetin, and resveratrol were the most applied natural products, respectively. However, curcumin, despite its curative potential, has poor aqueous solubility and consequently, minimal systemic bioavailability along with rapid degradation [<xref rid="B88-nanomaterials-12-00238" ref-type="bibr">88</xref>]. These characteristics restrict the utilization of curcumin at medical perspective. Liposomes have found uses in drug delivery of poorly water-soluble drugs. Such drug-loaded liposomes can be fabricated by a wide variety of nanotechnology methods such as ethanol injection, thin-film hydration, sonication, high-pressure extrusion, reverse-phase evaporation, calcium-induced fusion, and supercritical fluid methods, among others [<xref rid="B88-nanomaterials-12-00238" ref-type="bibr">88</xref>].</p><p>Quercetin acts as an antioxidant on cells but is hindered by its high metabolism rate. In order to control this, quercetin is encapsulated in poly [lactic-co-glycolic] acid (PLGA) nanoparticles [<xref rid="B89-nanomaterials-12-00238" ref-type="bibr">89</xref>]. This guarantees secure and controlled release of the quercetin, and permits cell enlistment, attachment, expansion, and articulation of heart proteins in local myocardium.</p><p>Resveratrol&#8217;s capacity for protective action makes it one of the commonly used compounds against CVD. However, its poor pharmacokinetic properties, such as low aqueous solubility, low photostability and extensive first-pass metabolism, result in poor bioavailability and hinder its clinical potential [<xref rid="B90-nanomaterials-12-00238" ref-type="bibr">90</xref>,<xref rid="B91-nanomaterials-12-00238" ref-type="bibr">91</xref>]. To resolve this issue, the use of lipid nanoparticles offer the possibility to develop new therapeutics. Further, solid lipid nanoparticles hold great promise for reaching the goal of controlled and site-specific drug delivery [<xref rid="B85-nanomaterials-12-00238" ref-type="bibr">85</xref>].</p><p>Other compounds used for CVDs are Magnolols, Berberine, Tilianin and Baicalin. These compounds require nanoformulation to maximize their use. Magnolols as a phenolic polyhydroxy compound have poor aqueous solubility and low oral bioavailability which limit their clinical use. Therefore, various formulations such as liposomes [<xref rid="B92-nanomaterials-12-00238" ref-type="bibr">92</xref>], solid dispersions [<xref rid="B93-nanomaterials-12-00238" ref-type="bibr">93</xref>], emulsions [<xref rid="B94-nanomaterials-12-00238" ref-type="bibr">94</xref>], and nanoparticles [<xref rid="B95-nanomaterials-12-00238" ref-type="bibr">95</xref>] have been developed to ameliorate the water solubility and bioavailability of it (<xref rid="nanomaterials-12-00238-f003" ref-type="fig">Figure 3</xref>). On the other hand, Berberine (BBR) has low bioavailability and also shows poor absorption through the gut wall (&lt;5%) and bowel glycoprotein appears to contribute to its poor absorption, actively expelling the alkaloid from the lumen mucosal cells, hence the use of liposomes as nanoformulation works best for BBR [<xref rid="B85-nanomaterials-12-00238" ref-type="bibr">85</xref>,<xref rid="B96-nanomaterials-12-00238" ref-type="bibr">96</xref>]. Studies have shown that Tilianin eases ischemia-reperfusion-induced cardiomyocyte injury. However, its full effectiveness is prevented because of its insolubility in water. The use of nanoformulation based on Tilianin nano-micelles overcomes this obstacle, as does the polyethylene glycol compound, covalently attached to propylene sulfide-formed amphiphilic diblock polymers [<xref rid="B97-nanomaterials-12-00238" ref-type="bibr">97</xref>]. In the aqueous solution, Tilianin is encapsulated in a hydrophobic shell to form nano-micelles [<xref rid="B85-nanomaterials-12-00238" ref-type="bibr">85</xref>,<xref rid="B97-nanomaterials-12-00238" ref-type="bibr">97</xref>]. The Ph-PPS-PEG self-assembles into nanoscale micelles with a size of approximately 70 nm, termed &#8220;Tilianin-loaded micelles&#8221; (TLMs).</p><p>NPs have shown some adverse effects on cardiovascular systems previously. Mice exposed to zinc NPs in the stomach (5 mg/kg body weight) experienced cardiac impairment, increased lactate dehydrogenase, creatinine kinase and aspartate aminotransferase, which was lower in zinc microparticles at the same dose [<xref rid="B98-nanomaterials-12-00238" ref-type="bibr">98</xref>,<xref rid="B99-nanomaterials-12-00238" ref-type="bibr">99</xref>]. Therefore, cardiac toxicity of zinc nanomaterials may be associated with particle sizes as per Wang and colleagues [<xref rid="B99-nanomaterials-12-00238" ref-type="bibr">99</xref>].</p><p>The rapid elimination half-life in plasma and poor water solubility of Baicalin (BN) limits its clinical efficacy. Aside from its short half-life and low water solubility, its bioavailability is low [<xref rid="B100-nanomaterials-12-00238" ref-type="bibr">100</xref>]. In order to enhance its clinical efficacy, the Novel Baicalin-loaded PEGylated nanostructured lipid carriers (BN-PEG-NLC) have been used to improve the bioavailability of BN, to prolong retention time in vivo and to enhance its protective effect [<xref rid="B85-nanomaterials-12-00238" ref-type="bibr">85</xref>,<xref rid="B101-nanomaterials-12-00238" ref-type="bibr">101</xref>,<xref rid="B102-nanomaterials-12-00238" ref-type="bibr">102</xref>]. These nanotech applications aim to elude problems related to conventional drug delivery and possible negative systemic side effects. Once the nano-drug carriers have migrated locally, they provide the therapeutic payload delivery. This process eventually achieves therapeutic efficacy for a variety of cardiac disease indications [<xref rid="B89-nanomaterials-12-00238" ref-type="bibr">89</xref>].</p></sec><sec id="sec3dot3-nanomaterials-12-00238"><title>3.3. Nano-Phytopharmaceuticals in Pulmonary Disorders</title><p>Globally, at least two billion people get infections of the respiratory system, which causes disability, death and imposes an enormous health burden [<xref rid="B108-nanomaterials-12-00238" ref-type="bibr">108</xref>]. An estimated 65 million people have moderate to severe Chronic Obstructive Pulmonary Disease (COPD), which cause three million deaths every year [<xref rid="B109-nanomaterials-12-00238" ref-type="bibr">109</xref>]. About 334 million people suffer from asthma [<xref rid="B110-nanomaterials-12-00238" ref-type="bibr">110</xref>,<xref rid="B111-nanomaterials-12-00238" ref-type="bibr">111</xref>]. Acute lower respiratory tract infections are among the top three causes of death and disability. Influenza alone kills approximately 650,000 people annually [<xref rid="B112-nanomaterials-12-00238" ref-type="bibr">112</xref>]. Pulmonary disorders are characterized as progressive and incurable diseases, that comprise one of the five leading reasons for death around the world. The risk factors involved in the disease are smoking, permanent bronchoconstriction, alveolar destruction, and airway and pulmonary vascular remodeling [<xref rid="B113-nanomaterials-12-00238" ref-type="bibr">113</xref>].</p><p>Obstructive Lung Disease is characterized as airflow disturbances with consistent respiratory ailments. Patients having obstructive lung diseases present breathlessness, sputum production, and intolerance to exercise. Dyspnea may be considered a symptom of the early stages of the disease, whereas heart failure can be the symptom of severe and chronic disease [<xref rid="B114-nanomaterials-12-00238" ref-type="bibr">114</xref>]. In addition to chronic bronchitis and lung emphysema, it also affects various systems in the human body [<xref rid="B115-nanomaterials-12-00238" ref-type="bibr">115</xref>].</p><p>Tuberculosis, another respiratory disease, is one of the 10 leading causes of death from a single infectious agent. In 2019, around 1.4 million people died from tuberculosis (TB), and an estimated 10 million people became ill. Multidrug-resistant TB (MDR-TB) remains a public health crisis and a threat to security health [<xref rid="B116-nanomaterials-12-00238" ref-type="bibr">116</xref>]. In addition, more than 100 million people suffer from sleep-disordered breathing and millions live with pulmonary hypertension. More than 50 million people struggle with occupational lung diseases. The reason for pulmonary infections is the potential widespread pathogens in our environment and infections acquired from other infected individuals [<xref rid="B117-nanomaterials-12-00238" ref-type="bibr">117</xref>]. Nosocomial transmission primarily contributes to the pulmonary infections of multidrug-resistant (MDR) bacteria like cystic fibrosis [<xref rid="B118-nanomaterials-12-00238" ref-type="bibr">118</xref>] and bronchiectasis [<xref rid="B119-nanomaterials-12-00238" ref-type="bibr">119</xref>]. Intensive care units [<xref rid="B120-nanomaterials-12-00238" ref-type="bibr">120</xref>] are frequent sources of recurrent cross infection. The common nosocomial pneumonia with pathogens are <italic toggle="yes">Legionella</italic>, [<xref rid="B121-nanomaterials-12-00238" ref-type="bibr">121</xref>], <italic toggle="yes">Aspergillus</italic> [<xref rid="B122-nanomaterials-12-00238" ref-type="bibr">122</xref>] and mucormycosis [<xref rid="B123-nanomaterials-12-00238" ref-type="bibr">123</xref>].</p><p>Pathogens causing respiratory infections are either well adapted to the human body or cause little or no disease in animals. In addition, some pathogens, such as <italic toggle="yes">Mycobacterium tuberculosis</italic> and viruses producing IL-10, change their genetic system to evade the host immune system [<xref rid="B124-nanomaterials-12-00238" ref-type="bibr">124</xref>]. Another challenge of the respiratory infections is the development of drug-resistant pathogens, for example, pan-resistant <italic toggle="yes">Pseudomonas aeruginosa</italic> [<xref rid="B125-nanomaterials-12-00238" ref-type="bibr">125</xref>] and extensively drug-resistant <italic toggle="yes">M</italic>. <italic toggle="yes">tuberculosis</italic> [<xref rid="B126-nanomaterials-12-00238" ref-type="bibr">126</xref>]. Some new developments in drug-resistant pathogens, such as methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic>, are new threats in some regions [<xref rid="B127-nanomaterials-12-00238" ref-type="bibr">127</xref>]. Viruses are also developing resistance against many antiviral agents, for example, the neuraminidase inhibitor-resistant influenza virus [<xref rid="B128-nanomaterials-12-00238" ref-type="bibr">128</xref>]. The constant modification of viral genomes results in the antigenic drift and antigenic shift responsible for the development of resistant strains. New pathogens, like SARS, MERS and SARS-CoV-2, are serious threats to the world population [<xref rid="B129-nanomaterials-12-00238" ref-type="bibr">129</xref>]. The continuous use of antibiotics is creating a new niche for other pathogens, for example, bronchiectasis and cystic fibrosis, and non-tuberculous mycobacteria [<xref rid="B130-nanomaterials-12-00238" ref-type="bibr">130</xref>].</p><p>To curb the increasing threat of respiratory diseases, there is an immediate need to explore some alternatives to the use of antibiotics, and an ecofriendly, cost effective, efficacious and durable strategy to combat these global respiratory problems. Thus, the field of nanotechnology provides a promising technology against respiratory diseases. In the past, various studies have shown very effective and interesting results. In addition to their antiviral properties, the application of nanoparticles (NPs) provides a potential strategy to manage infections caused by multidrug-resistant organisms (MDROs) [<xref rid="B131-nanomaterials-12-00238" ref-type="bibr">131</xref>,<xref rid="B132-nanomaterials-12-00238" ref-type="bibr">132</xref>,<xref rid="B133-nanomaterials-12-00238" ref-type="bibr">133</xref>]. NPs exhibiting antibacterial activities can target multiple biomolecules and have the potential to reduce or eliminate the evolution of MDROs [<xref rid="B134-nanomaterials-12-00238" ref-type="bibr">134</xref>]. Plant extracts are complex mixtures that provide a rich arsenal of molecules, such as flavanones, flavones, flavonols and chalcones, fatty acids, amino acids, terpenoids, aldehydes, and alcohols [<xref rid="B135-nanomaterials-12-00238" ref-type="bibr">135</xref>], with high redox potential [<xref rid="B136-nanomaterials-12-00238" ref-type="bibr">136</xref>]. Furthermore, biogenic synthesis produces potential, stable, and better-defined materials [<xref rid="B137-nanomaterials-12-00238" ref-type="bibr">137</xref>,<xref rid="B138-nanomaterials-12-00238" ref-type="bibr">138</xref>].</p><p>Silver nanoparticles (AgNPs) have shown broad applications in the medical system, such as anti-inflammatory, anti-angiogenesis, antiplatelet, antifungal, anticancer, and antibacterial activities [<xref rid="B139-nanomaterials-12-00238" ref-type="bibr">139</xref>,<xref rid="B140-nanomaterials-12-00238" ref-type="bibr">140</xref>,<xref rid="B141-nanomaterials-12-00238" ref-type="bibr">141</xref>,<xref rid="B142-nanomaterials-12-00238" ref-type="bibr">142</xref>]. Nowadays, AgNPs have been reported as biomedical therapeutic agents, such as wound dressings and long-term burn care products and antibacterial lotions [<xref rid="B143-nanomaterials-12-00238" ref-type="bibr">143</xref>]; They also exhibit antiviral activities against influenza A virus, hepatitis B virus, human parainfluenza virus, herpes simplex virus, and human immunodeficiency virus [<xref rid="B144-nanomaterials-12-00238" ref-type="bibr">144</xref>,<xref rid="B145-nanomaterials-12-00238" ref-type="bibr">145</xref>]. They prevent the anchoring and binding of the virus to the host and cell receptor, respectively, and hence they deactivate the virus by denaturing the surface.</p><p>AgNPs inhibit the binding of the virus by interacting with the glycoprotein (gp120) of the sulphur-bearing groups distributed in the lipid membrane of the virus [<xref rid="B146-nanomaterials-12-00238" ref-type="bibr">146</xref>]. In another study, the virus inactivation was observed when the nano-silver was combined with the nucleic acid of the virus and modified the structure of capsid and affected the replication [<xref rid="B147-nanomaterials-12-00238" ref-type="bibr">147</xref>]. Along with such surface modification, AgNPs also show synergistic antiviral activity. In one study, it was reported that curcumin, when used as both a reducing and stabilizing agent prevented viral replication, and blocked the budding of viruses [<xref rid="B148-nanomaterials-12-00238" ref-type="bibr">148</xref>]. Similarly, the AgNP surface, when modified through chemical methods with drugs like zanamivir, amantadine and oseltamivir, was able to interact with virus particles directly, which destroyed the virus and blocked its entry [<xref rid="B149-nanomaterials-12-00238" ref-type="bibr">149</xref>].</p><p>Du et al. showed the Ag2S NCs has excellent antiviral and immunomodulating activities against the porcine epidemic diarrhea virus (PEDV) [<xref rid="B150-nanomaterials-12-00238" ref-type="bibr">150</xref>]. Ag2S NCs also showed a comparable inhibitory effect of the virus on other RNA viruses, such as porcine reproductive and respiratory syndrome virus (PRRSV). Various reports on the use of natural products as reducing and capping agents for nanomaterial synthesis has been well documented [<xref rid="B151-nanomaterials-12-00238" ref-type="bibr">151</xref>,<xref rid="B152-nanomaterials-12-00238" ref-type="bibr">152</xref>]. Leaves of plants like <italic toggle="yes">Azadirachta indica</italic> [<xref rid="B153-nanomaterials-12-00238" ref-type="bibr">153</xref>], <italic toggle="yes">Ocimum tenuiforum</italic> [<xref rid="B154-nanomaterials-12-00238" ref-type="bibr">154</xref>], and <italic toggle="yes">Ficus benghalensis</italic> [<xref rid="B155-nanomaterials-12-00238" ref-type="bibr">155</xref>] have been used for the synthesis of AgNPs (<xref rid="nanomaterials-12-00238-f004" ref-type="fig">Figure 4</xref>). The medicinal properties and broad-spectrum antimicrobial activities of Tulsi leaves were known for over a thousand years [<xref rid="B156-nanomaterials-12-00238" ref-type="bibr">156</xref>].</p><p>Gold nanoparticles (AuNPs) provide superior properties [<xref rid="B157-nanomaterials-12-00238" ref-type="bibr">157</xref>], and various methods for the preparation of gold nanoparticles have been well reported [<xref rid="B139-nanomaterials-12-00238" ref-type="bibr">139</xref>]. Compared to silver nanoparticles, AuNPs display better results in in vivo studies. AuNPs can interact with the haemagglutinin (HA) glycoprotein and can oxidize the disulfide bond, resulting in the inactivation of the virus [<xref rid="B158-nanomaterials-12-00238" ref-type="bibr">158</xref>]. Surface properties are useful in targeting the virus. The sulphonates are organic sulphates that were used to interact with the capsid proteins of the virus cell and prevent the HA activity [<xref rid="B159-nanomaterials-12-00238" ref-type="bibr">159</xref>]. In one study, it is reported that Brazilian Red Propolis (BRP), a product of bees, exhibits anti-inflammatory, anti-tumor, antioxidant, and antimicrobial activities [<xref rid="B160-nanomaterials-12-00238" ref-type="bibr">160</xref>]. It described the biosynthesis of AuNPs using BRP extract (AuNPextract) and its fractions (AuNPhexane, AuNPdichloromethane, AuNPethyl acetate) and evaluated their structural properties and their potential against micro-organisms and cancer cells.</p><p>Many drugs failed to treat viral infections, mainly due to drug release efficiency. To resolve this issue, mesoporous silicon nanoparticles are used as antiviral drug delivery carriers [<xref rid="B161-nanomaterials-12-00238" ref-type="bibr">161</xref>]. Compared to silver and gold nanoparticles, silicon nanomaterials are less cytotoxic and more biocompatible. The glycosaminoglycan (GAGs) mimetic-functionalized solid and mesoporous silica nanoparticles have shown antiviral activities that inhibit the entry of herpes simplex virus (HSV) type 1 and type 2 viruses into host cells [<xref rid="B162-nanomaterials-12-00238" ref-type="bibr">162</xref>].</p><p>In nanoscience, the carbon dots (CDs) also play an important role due to their unique properties. CDs prevent the viral infection as they have hydroxyl and carboxyl groups on their surfaces that interact with viral membranes [<xref rid="B163-nanomaterials-12-00238" ref-type="bibr">163</xref>]. To improve the activities of CDs, antiviral agents like plant extracts are grafted on the surface that involves a two-step reaction. The functionalized antiviral agent shows the inhibition of the virus into the cell that has a broad-spectrum action for the enveloped and the non-enveloped viruses [<xref rid="B164-nanomaterials-12-00238" ref-type="bibr">164</xref>].</p><p>Another important nanotechnology-based materials are based on graphene, (GO), which also have biomedical applications [<xref rid="B165-nanomaterials-12-00238" ref-type="bibr">165</xref>]. To prevent viral infection in the host cell, GO has been used with organic and metallic nanoparticles that show antiviral activities [<xref rid="B166-nanomaterials-12-00238" ref-type="bibr">166</xref>].</p><p>In one study, different nanocomposites of graphene oxide (GO) with Ag and iron oxide (IO) NPs were shown to exhibit both antimicrobial and magnetic properties. In another study, Ocsoy et al (2017) [<xref rid="B167-nanomaterials-12-00238" ref-type="bibr">167</xref>] reported that silver nanoparticles (Ag NPs)-decorated magnetic graphene oxide nanocomposites showed antimicrobial activities against <italic toggle="yes">Staphylococcus aureus</italic> (Gram+), <italic toggle="yes">Escherichia coli</italic> (Gram&#8722;) bacteria, and <italic toggle="yes">Candida albicans</italic> fungus.</p><p>Another material suitable for nanotechnology is selenium. In the in vivo study, selenium nanoparticles (SeNPs) showed antiviral efficiency [<xref rid="B168-nanomaterials-12-00238" ref-type="bibr">168</xref>]. Mainly, these nanoparticles depend on the quenching of free radicals in the host, and the prevention of the mitochondrial depolarization and apoptosis [<xref rid="B168-nanomaterials-12-00238" ref-type="bibr">168</xref>]. Zinc is another material that can be used in nanotechnology. In one study, ZnO-NPs, when inoculated with the virus, prevented cell adhesion from displaying the viral antigens to the T cells. The in vivo study showed that it has 90% antiviral activity and it mimics the couple cells [<xref rid="B169-nanomaterials-12-00238" ref-type="bibr">169</xref>]. In another study, ZnO-NPs and graphene carbon material showed antibacterial activities against Gram negative bacteria <italic toggle="yes">Escherichia coli [E</italic>. <italic toggle="yes">coli</italic><italic toggle="yes">]</italic> and Gram-positive bacteria <italic toggle="yes">Staphylococcus aureus</italic> [<xref rid="B170-nanomaterials-12-00238" ref-type="bibr">170</xref>]. Graphene oxide-Ag nanoparticles formed from the extract of <italic toggle="yes">Pistacia atlantica</italic> leaves showed antimicrobial activities against <italic toggle="yes">S</italic>. <italic toggle="yes">aureus, S</italic>. <italic toggle="yes">saprophyticus, S</italic>. <italic toggle="yes">pyrogenes</italic> and <italic toggle="yes">B</italic>. <italic toggle="yes">Subtilis</italic> [<xref rid="B171-nanomaterials-12-00238" ref-type="bibr">171</xref>]. Calcium as a nanomaterial also has some unique features, and it can be used in nanotechnology. In one study, calcium phosphate nanoparticles (CaPNPs) showed antiviral activities [<xref rid="B172-nanomaterials-12-00238" ref-type="bibr">172</xref>]. The CaPNPs covalently modified with the alum and the two peptides generated efficient antibodies to block the cell from infection by the virus [<xref rid="B173-nanomaterials-12-00238" ref-type="bibr">173</xref>].</p><p>Self-assembling polypeptide nanoparticles that repetitively display a SARS B-cell epitope from the C-terminal heptad repeat of the virus&#8217; spike protein represent a promising platform for vaccine design [<xref rid="B174-nanomaterials-12-00238" ref-type="bibr">174</xref>]. It has also been reported that novel nanoparticle vaccine containing full spike protein of MERS CoV and SARS-CoV resulted in higher-titer neutralizing antibody in vaccinated mice [<xref rid="B175-nanomaterials-12-00238" ref-type="bibr">175</xref>]. The vaccination in combination with an adjuvant, matrix M1, boosted the neutralizing antibody titer [<xref rid="B176-nanomaterials-12-00238" ref-type="bibr">176</xref>].</p><p>Nanoparticles also have shown toxicity in lungs and other parts of the respiratory system, as observed in several preclinical and in vitro studies. Carbon black NPs showed increased release of pro-inflammatory cytokines in the alveoli that could potentially induce migration of macrophages in a lung cell line (type II alveolar epithelial cells) (in vitro) [<xref rid="B177-nanomaterials-12-00238" ref-type="bibr">177</xref>]. Another study showed TiO<sub>2</sub> NPs showed increased oxidative damage (increased nitric oxide and H<sub>2</sub>O<sub>2</sub> levels), lipid peroxidation, and micronuclei formation in a human bronchial epithelial cell line [<xref rid="B178-nanomaterials-12-00238" ref-type="bibr">178</xref>]. Another study also reported that a daily dose of 40 mg/kg body weight of TiO<sub>2</sub> NPs over a period of three days increased serum albumin, alkaline phosphatase (ALP), acid phosphatase (ACP) levels, and pulmonary toxicity in mice [<xref rid="B179-nanomaterials-12-00238" ref-type="bibr">179</xref>]. Importantly, pH of the formulation, particle size, surface area, and aggregation of particles may play an important role in the pulmonary toxicity of TiO<sub>2</sub> NPs [<xref rid="B179-nanomaterials-12-00238" ref-type="bibr">179</xref>].</p></sec><sec id="sec3dot4-nanomaterials-12-00238"><title>3.4. Nano-Phytopharmaceuticals in Gastro-Intestinal Disorders</title><p>Gastrointestinal disorders are recognized as an important health issue because of increasing number of individuals diagnosed with colorectal cancer, coeliac disease, and inflammatory bowel disease. Early diagnosis plays a vital role in survival, especially in colon cancer, which can be achieved with endoscopy or colonoscopy [<xref rid="B180-nanomaterials-12-00238" ref-type="bibr">180</xref>]. The gastrointestinal tract consists of a dynamic linkage where several layers frame a coordinated functional unit as a semipermeable ecosystem with multiple layers [<xref rid="B181-nanomaterials-12-00238" ref-type="bibr">181</xref>]. The association between host and gut microbiota is regulated by a mutual and complex symbiosis [<xref rid="B182-nanomaterials-12-00238" ref-type="bibr">182</xref>]. This association is continuously being tested with various factors, which may result in the destruction of the microbial community [<xref rid="B182-nanomaterials-12-00238" ref-type="bibr">182</xref>]. Dysbiosis, a disturbance in the composition of microbiota, has been related with severe complications of the gut, for example, in the pathogenesis of inflammatory bowel disease, irritable bowel syndrome and other GI disorders [<xref rid="B183-nanomaterials-12-00238" ref-type="bibr">183</xref>,<xref rid="B184-nanomaterials-12-00238" ref-type="bibr">184</xref>]. A dysregulated immune response to environmental factors leads to inflammatory disorders of the digestive system, such as inflammatory bowel syndrome, including ulcerative colitis or Crohn&#8217;s disease [<xref rid="B185-nanomaterials-12-00238" ref-type="bibr">185</xref>]. Irritable bowel syndrome comprises the most recognized condition. In addition to other contributing factors, dysbiosis contributes as a major factor [<xref rid="B186-nanomaterials-12-00238" ref-type="bibr">186</xref>]. Similarly, diverticular disease is responsible for a significant burden in Western and developed nations, socially and economically. The pathophysiology of diverticular disease is not exactly known, though less intense inflammation and diversification of gut microbiota are considered to be the main factors associated with the disease. Gut microbiota specifically play a role in diverticula progression and in basic diverticular disease, which is defined as a disease with mild symptoms, for example pain in the abdomen or variations in bowel habits [<xref rid="B182-nanomaterials-12-00238" ref-type="bibr">182</xref>,<xref rid="B183-nanomaterials-12-00238" ref-type="bibr">183</xref>].</p><p>There are numerous gastrointestinal diseases that can occur in different areas of the gastrointestinal tract [(GIT)], from the mouth to the anus [<xref rid="B187-nanomaterials-12-00238" ref-type="bibr">187</xref>]. Although the mouth is part of the GIT, mouth-related diseases are rarely considered as part of gastrointestinal diseases. The most common types of GIT-related diseases are Crohn&#8217;s disease, ulcerative colitis, irritable bowel syndrome, and colorectal cancer. Their common symptoms include diarrhea, abdominal pain, stomach bloating, and gastrointestinal bleeding [<xref rid="B188-nanomaterials-12-00238" ref-type="bibr">188</xref>]. Apart from lifestyle and genetic factors, infectious agents such as parasites, virus, and bacteria are also known as the etiological agents for most of the gastrointestinal disorders. Interestingly, most gastrointestinal disorders can be cured with traditional or modern medicine. Phytotherapy based on herbal medicines has been one of the important resources to treat gastrointestinal disorders for many years. Their efficacies could be improved by using nanotechnology with lesser side effects.</p><p><italic toggle="yes">Berberis vulgaris</italic> and <italic toggle="yes">Curcuma longa</italic> extracts encapsulated in cationic polymer EPO (<xref rid="nanomaterials-12-00238-f005" ref-type="fig">Figure 5</xref>), demonstrated significant anti-parasitic activity against <italic toggle="yes">Entamoeba histolytica</italic>. Furthermore, <italic toggle="yes">B</italic>. <italic toggle="yes">vulgaris</italic> encapsulated within EPO showed IC<sub>50</sub> of 26 ppm in comparison with the free extract having IC<sub>50</sub> of 34 &#181;g/mL. The IC<sub>50</sub> of <italic toggle="yes">Curcuma longa</italic> loaded within EPO was found to be 19 ppm in comparison with the free extract having IC<sub>50</sub> of 38 &#181;g/mL [<xref rid="B187-nanomaterials-12-00238" ref-type="bibr">187</xref>]. Another group of researchers used cerium oxide nanoparticles encapsulated with <italic toggle="yes">Nelumbo nucifera</italic> flower extract against the human colon cancer cell line (HCT 116), exhibited IC<sub>50</sub> of 4.16 mg/mL [<xref rid="B187-nanomaterials-12-00238" ref-type="bibr">187</xref>]. <italic toggle="yes">Garcinia mangostana</italic> has been widely used for medical applications. <italic toggle="yes">G</italic>. <italic toggle="yes">mangostana</italic> extract loaded within ethylcellulose and methylcellulose nanoparticles proved a highly protective agent for stomach ulcers with a MIC value of 6.25 ug/mL against <italic toggle="yes">Helicobacter pylori</italic>, which is almost the same as metronidazole. A study done by Saravanakumar and team found that silver nanoparticles encapsulated with <italic toggle="yes">Toxicodendron vernicifluum</italic> extract were effective against enteropathogenic bacteria, <italic toggle="yes">E</italic>. <italic toggle="yes">coli</italic> and <italic toggle="yes">H</italic>. <italic toggle="yes">Pylori,</italic> with MIC 8.12 &#181;g/mL and 18.14 &#181;g/mL. <italic toggle="yes">Acorus calamus</italic> Lim extract loaded within silver nanoparticles has shown significant inhibition in the formation of <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> at a concentration of 350 &#181;g/mL. Metallic nanoparticles demonstrated promising results in inhibition of enteropathogenic bacteria in various studies. Gold nanoparticles loaded with extracts of <italic toggle="yes">Tribulus terrestris</italic> showed effective activity against <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> in a size-dependent manner, with MIC of 16.75 &#181;g/mL at 55 nm and MIC of 18 &#181;g/mL at 7 nm size of gold nanoparticles, respectively [<xref rid="B187-nanomaterials-12-00238" ref-type="bibr">187</xref>](<xref rid="nanomaterials-12-00238-f005" ref-type="fig">Figure 5</xref>; <xref rid="nanomaterials-12-00238-t003" ref-type="table">Table 3</xref>).</p><p>Apart from benefits, NPs showed adverse events, such as selenium and selenite nanoparticles in mice (2 or 4 mg/kg body weight daily) treated over a period of 15 days which showed more toxicity (growth suppression, increased liver toxicity, and reduced superoxide dismutase activity) in selenite NPs [<xref rid="B189-nanomaterials-12-00238" ref-type="bibr">189</xref>].</p><p>Nanotechnology is a vital tool for its applications in medical science, given that it is possible to obtain a variety of nanocarrier characteristics that include their constituents, size, shape, bioavailability, surface properties, and target specificity to achieve or enhance desirable pharmacological targets [<xref rid="B187-nanomaterials-12-00238" ref-type="bibr">187</xref>]. A number of strategies have been implemented to increase the drug-target specificity. Recently, several studies have reported the improved efficacy of herbal extracts for gastrointestinal disorders when associated with nanomaterials mainly due to oral absorption, greater stability, and simulated intestinal fluid [<xref rid="B3-nanomaterials-12-00238" ref-type="bibr">3</xref>,<xref rid="B4-nanomaterials-12-00238" ref-type="bibr">4</xref>]. Pure herbal medicines are often considered less effective in comparison due to their size and reduced intestinal absorption when administered orally. However, plant extracts loaded on nanoparticles are more stable in high protein environments and help to increase target specificity [<xref rid="B4-nanomaterials-12-00238" ref-type="bibr">4</xref>]. Solubility is always considered a major concern associated with plant extracts, which can be successfully upgraded using nanosystems [<xref rid="B189-nanomaterials-12-00238" ref-type="bibr">189</xref>]. These are the reasons behind a pharmacological loss associated with plant extracts and such problems can be overcome using novel drug delivery systems such as nanotechnology. The advantages of using these novel delivery systems include better absorption by smoothing diffusion through the epithelium, modification of pharmacokinetics, enhancement of intracellular penetration, and distribution with reduced toxicity, overcoming resistance and lowering cost. Nanoparticles are extremely stable in harsh conditions like sterilization temperatures [<xref rid="B189-nanomaterials-12-00238" ref-type="bibr">189</xref>].</p></sec></sec><sec sec-type="conclusions" id="sec4-nanomaterials-12-00238"><title>4. Conclusions</title><p>The role of nanotechnology has been evident in the field of public health. This review article highlights the role of nanotechnology applied to the treatment of various diseases. The use of nanomedicines can play a significant and promising role in the successful application of plant-based medicine to treat various diseases and thus improve patient health outcomes. Nanoparticles and their use in novel drug delivery systems may provide solutions to the problems faced by conventional or allopathic medicine, as well as the limitations of plant-based medicine delivery. Despite the great advent of nanotechnology, as explained in this review, there are some limitations mentioned below that should be developed and clarified in future research. For example, the unbalanced distribution of the inorganic parts of nanostructures in the brain may induce adverse effects. Additionally, the concentration of these nanomaterials in the brain may cause neurotoxicity, given their interference with mitochondrial activity, autophagy, apoptosis, and neuronal inflammation. Thus, in vitro and preclinical studies have shown that, by combining nanomaterials with plant-based drugs, a more adequate delivery to target cells or tissues is possible, increasing their effectiveness. However, the low reproducibility of in vitro and in vivo effects of many herbal medicines prevents these medications from reaching the clinical trial phases, so it will be necessary to develop concerted actions through in vitro and in vivo protocols that can be comparable. Therefore, preclinical pharmacodynamic and pharmacokinetic studies of the phytoconstituents involved are also important in view of their efficacy and safety. In addition, studies focused on systemic toxicity are still required to know its adverse effects in order to promote its future application. Future research studies must address describing critical process parameters, techniques, challenges, and solutions for the development of nano-phytopharmaceuticals.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, V.N., M.R., P.W.; methodology, A.K.P., G.K.J., V.N.; validation, C.L.L., C.S.R., T.M., S.K., K.K.G., M.R., M.D., P.W., M.d.L.P.; investigation, T.M., M.N., J.K.P., P.W.; writing&#8212;original draft preparation, C.L.L., C.S.R., S.K., T.M., S.K., K.K.G.; writing&#8212;review and editing, V.N., M.d.L.P., A.K.P., M.D., M.N., M.R., J.K.P.; supervision, V.N., M.R., G.K.J. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>M.d.L.P. thanks Project CICECO-Aveiro Institute of Materials, UIDB/50011/2020 and UIDP/50011/2020, national funds by FCT/MCTES. J.K.P. is grateful to the National Research Foundation of Korea [NRF] grant funded by the Korea government (MSIT) (No. 2020R1G1A1004667), the Republic of Korea for support.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Not applicable.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-nanomaterials-12-00238"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mobasser</surname><given-names>S.</given-names></name><name name-style="western"><surname>Firoozi</surname><given-names>A.A.</given-names></name></person-group><article-title>Review of nanotechnology applications in science and engineering</article-title><source>J. Civil. Eng. Urban.</source><year>2017</year><volume>64</volume><fpage>84</fpage><lpage>93</lpage></element-citation></ref><ref id="B2-nanomaterials-12-00238"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>G.</given-names></name><name name-style="western"><surname>Roy</surname><given-names>I.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Prasad</surname><given-names>P.N.</given-names></name></person-group><article-title>Nanochemistry and nanomedicine for nanoparticle-based diagnostics and therapy</article-title><source>Chem. Rev.</source><year>2016</year><volume>116</volume><fpage>2826</fpage><lpage>2885</lpage><pub-id pub-id-type="doi">10.1021/acs.chemrev.5b00148</pub-id><pub-id pub-id-type="pmid">26799741</pub-id></element-citation></ref><ref id="B3-nanomaterials-12-00238"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morelli</surname><given-names>L.</given-names></name><name name-style="western"><surname>Gimondi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sevieri</surname><given-names>M.</given-names></name><name name-style="western"><surname>Salvioni</surname><given-names>L.</given-names></name><name name-style="western"><surname>Guizzetti</surname><given-names>M.</given-names></name><name name-style="western"><surname>Colzani</surname><given-names>B.</given-names></name><name name-style="western"><surname>Palugan</surname><given-names>L.</given-names></name><name name-style="western"><surname>Foppoli</surname><given-names>A.</given-names></name><name name-style="western"><surname>Talamini</surname><given-names>L.</given-names></name><name name-style="western"><surname>Morosi</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Monitoring the fate of orally administered PLGA nanoformulation for local delivery of therapeutic drugs</article-title><source>Pharmaceutics</source><year>2019</year><volume>11</volume><elocation-id>658</elocation-id><pub-id pub-id-type="doi">10.3390/pharmaceutics11120658</pub-id><pub-id pub-id-type="pmcid">PMC6955864</pub-id><pub-id pub-id-type="pmid">31817781</pub-id></element-citation></ref><ref id="B4-nanomaterials-12-00238"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Luan</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tian</surname><given-names>X.-H.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W.-D.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>B.-L.</given-names></name></person-group><article-title>Synergistic mechanisms of constituents in herbal extracts during intestinal absorption: Focus on natural occurring nanoparticles</article-title><source>Pharmaceutics</source><year>2020</year><volume>12</volume><elocation-id>128</elocation-id><pub-id pub-id-type="doi">10.3390/pharmaceutics12020128</pub-id><pub-id pub-id-type="pmid">32028739</pub-id><pub-id pub-id-type="pmcid">PMC7076514</pub-id></element-citation></ref><ref id="B5-nanomaterials-12-00238"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumari</surname><given-names>P.</given-names></name><name name-style="western"><surname>Luqman</surname><given-names>S.</given-names></name><name name-style="western"><surname>Meena</surname><given-names>A.</given-names></name></person-group><article-title>Application of the combinatorial approaches of medicinal and aromatic plants with nanotechnology and its impacts on healthcare</article-title><source>DARU J. Pharm. Sci.</source><year>2019</year><volume>27</volume><fpage>475</fpage><lpage>489</lpage><pub-id pub-id-type="doi">10.1007/s40199-019-00271-6</pub-id><pub-id pub-id-type="pmid">31129806</pub-id><pub-id pub-id-type="pmcid">PMC6592997</pub-id></element-citation></ref><ref id="B6-nanomaterials-12-00238"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mitchell</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Billingsley</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Haley</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Wechsler</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Peppas</surname><given-names>N.A.</given-names></name><name name-style="western"><surname>Langer</surname><given-names>R.</given-names></name></person-group><article-title>Engineering precision nanoparticles for drug delivery</article-title><source>Nat. Rev. Drug Discov.</source><year>2021</year><volume>20</volume><fpage>101</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1038/s41573-020-0090-8</pub-id><pub-id pub-id-type="pmid">33277608</pub-id><pub-id pub-id-type="pmcid">PMC7717100</pub-id></element-citation></ref><ref id="B7-nanomaterials-12-00238"><label>7.</label><element-citation publication-type="book"><person-group person-group-type="editor"><name name-style="western"><surname>Mishra</surname><given-names>V.</given-names></name><name name-style="western"><surname>Kesharwani</surname><given-names>P.</given-names></name><name name-style="western"><surname>Amin</surname><given-names>M.C.M.</given-names></name><name name-style="western"><surname>Iyer</surname><given-names>A.</given-names></name></person-group><source>Nanotechnology-Based Approaches for Targeting and Delivery of Drugs and Genes</source><edition>1st ed.</edition><year>2021</year><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.elsevier.com/books/nanotechnology-based-approaches-for-targeting-and-delivery-of-drugs-and-genes/mishra/978-0-12-809717-5" ext-link-type="uri">https://www.elsevier.com/books/nanotechnology-based-approaches-for-targeting-and-delivery-of-drugs-and-genes/mishra/978-0-12-809717-5</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2021-08-20">(accessed on 20 August 2021)</date-in-citation></element-citation></ref><ref id="B8-nanomaterials-12-00238"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yetisgin</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Cetinel</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zuvin</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kosar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kutlu</surname><given-names>O.</given-names></name></person-group><article-title>Therapeutic nanoparticles and their targeted delivery applications</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>2193</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25092193</pub-id><pub-id pub-id-type="pmcid">PMC7248934</pub-id><pub-id pub-id-type="pmid">32397080</pub-id></element-citation></ref><ref id="B9-nanomaterials-12-00238"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pelaz</surname><given-names>B.</given-names></name><name name-style="western"><surname>Alexiou</surname><given-names>C.</given-names></name><name name-style="western"><surname>Alvarez-Puebla</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Alves</surname><given-names>F.</given-names></name><name name-style="western"><surname>Andrews</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Ashraf</surname><given-names>S.</given-names></name><name name-style="western"><surname>Balogh</surname><given-names>L.P.</given-names></name><name name-style="western"><surname>Ballerini</surname><given-names>L.</given-names></name><name name-style="western"><surname>Bestetti</surname><given-names>A.</given-names></name><name name-style="western"><surname>Brendel</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Diverse applications of nanomedicine</article-title><source>ACS Nano</source><year>2017</year><volume>11</volume><fpage>2313</fpage><lpage>2381</lpage><pub-id pub-id-type="doi">10.1021/acsnano.6b06040</pub-id><pub-id pub-id-type="pmid">28290206</pub-id><pub-id pub-id-type="pmcid">PMC5371978</pub-id></element-citation></ref><ref id="B10-nanomaterials-12-00238"><label>10.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Prairna</surname></name><name name-style="western"><surname>Paramanya</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bagdat</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>Ali</surname><given-names>A.</given-names></name></person-group><article-title>Recent practices of medicinal and aromatic plants in nanotechnology</article-title><source>Nanomaterials for Agriculture and Forestry Applications</source><publisher-name>Elsevier</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2020</year><fpage>435</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1016/b978-0-12-817852-2.00018-4</pub-id></element-citation></ref><ref id="B11-nanomaterials-12-00238"><label>11.</label><element-citation publication-type="webpage"><person-group person-group-type="author"><name name-style="western"><surname>Bernhoft</surname><given-names>A.</given-names></name></person-group><article-title>Bioactive compounds in plants -benefits and risks for man and snimals. The Norwegian Academy of Science and Letters, Oslo</article-title><year>2010</year><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.scirp.org/(S(351jmbntvnsjt1aadkposzje))/reference/ReferencesPapers.aspx?ReferenceID=717353" ext-link-type="uri">https://www.scirp.org/(S(351jmbntvnsjt1aadkposzje))/reference/ReferencesPapers.aspx?ReferenceID=717353</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2021-08-20">(accessed on 20 August 2021)</date-in-citation></element-citation></ref><ref id="B12-nanomaterials-12-00238"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bonif&#225;cio</surname><given-names>B.V.</given-names></name><name name-style="western"><surname>Silva</surname><given-names>P.B.</given-names></name><name name-style="western"><surname>Ramos</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Negri</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Bauab</surname><given-names>T.M.</given-names></name><name name-style="western"><surname>Chorilli</surname><given-names>M.</given-names></name></person-group><article-title>Nanotechnology-based drug delivery systems and herbal medicines: A review</article-title><source>Int. J. Nanomed.</source><year>2013</year><volume>9</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.2147/IJN.S52634</pub-id><pub-id pub-id-type="pmcid">PMC3862741</pub-id><pub-id pub-id-type="pmid">24363556</pub-id></element-citation></ref><ref id="B13-nanomaterials-12-00238"><label>13.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><source>WHO Global Report on Traditional and Complementary Medicine 2019 (Internet)</source><publisher-name>World Health Organization</publisher-name><publisher-loc>Geneva, Switzerland</publisher-loc><year>2019</year><fpage>1</fpage><lpage>228</lpage></element-citation></ref><ref id="B14-nanomaterials-12-00238"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yuan</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Ye</surname><given-names>L.</given-names></name><name name-style="western"><surname>Piao</surname><given-names>G.</given-names></name></person-group><article-title>The traditional medicine and modern medicine from natural products</article-title><source>Molecules</source><year>2016</year><volume>21</volume><elocation-id>559</elocation-id><pub-id pub-id-type="doi">10.3390/molecules21050559</pub-id><pub-id pub-id-type="pmcid">PMC6273146</pub-id><pub-id pub-id-type="pmid">27136524</pub-id></element-citation></ref><ref id="B15-nanomaterials-12-00238"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Namdari</surname><given-names>M.</given-names></name><name name-style="western"><surname>Eatemadi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Soleimaninejad</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hammed</surname><given-names>A.T.</given-names></name></person-group><article-title>A brief review on the application of nanoparticle enclosed herbal medicine for the treatment of infective endocarditis</article-title><source>Biomed. Pharmacother.</source><year>2017</year><volume>87</volume><fpage>321</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2016.12.099</pub-id><pub-id pub-id-type="pmid">28064105</pub-id></element-citation></ref><ref id="B16-nanomaterials-12-00238"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patra</surname><given-names>J.K.</given-names></name><name name-style="western"><surname>Das</surname><given-names>G.</given-names></name><name name-style="western"><surname>Fraceto</surname><given-names>L.F.</given-names></name><name name-style="western"><surname>Campos</surname><given-names>E.V.R.</given-names></name><name name-style="western"><surname>del Pilar Rodriguez-Torres</surname><given-names>M.</given-names></name><name name-style="western"><surname>Acosta-Torres</surname><given-names>L.S.</given-names></name><name name-style="western"><surname>Diaz-Torres</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Grillo</surname><given-names>R.</given-names></name><name name-style="western"><surname>Swamy</surname><given-names>M.K.</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Nano based drug delivery systems: Recent developments and future prospects</article-title><source>J. Nanobiotechnol.</source><year>2018</year><volume>16</volume><fpage>71</fpage><pub-id pub-id-type="doi">10.1186/s12951-018-0392-8</pub-id><pub-id pub-id-type="pmid">30231877</pub-id><pub-id pub-id-type="pmcid">PMC6145203</pub-id></element-citation></ref><ref id="B17-nanomaterials-12-00238"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abbas</surname><given-names>M.</given-names></name></person-group><article-title>Potential role of nanoparticles in treating the accumulation of amyloid-beta peptide in Alzheimer&#8217;s patients</article-title><source>Polymers</source><year>2021</year><volume>13</volume><elocation-id>1051</elocation-id><pub-id pub-id-type="doi">10.3390/polym13071051</pub-id><pub-id pub-id-type="pmid">33801619</pub-id><pub-id pub-id-type="pmcid">PMC8036916</pub-id></element-citation></ref><ref id="B18-nanomaterials-12-00238"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhai</surname><given-names>K.</given-names></name><name name-style="western"><surname>Siddiqui</surname><given-names>M.</given-names></name><name name-style="western"><surname>Abdellatif</surname><given-names>B.</given-names></name><name name-style="western"><surname>Liskova</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kubatka</surname><given-names>P.</given-names></name><name name-style="western"><surname>B&#252;sselberg</surname><given-names>D.</given-names></name></person-group><article-title>Natural compounds in glioblastoma therapy: Preclinical insights, mechanistic pathways, and outlook</article-title><source>Cancers</source><year>2021</year><volume>13</volume><elocation-id>2317</elocation-id><pub-id pub-id-type="doi">10.3390/cancers13102317</pub-id><pub-id pub-id-type="pmid">34065960</pub-id><pub-id pub-id-type="pmcid">PMC8150927</pub-id></element-citation></ref><ref id="B19-nanomaterials-12-00238"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khadka</surname><given-names>B.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.-Y.</given-names></name><name name-style="western"><surname>Park</surname><given-names>D.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>K.-T.</given-names></name><name name-style="western"><surname>Bae</surname><given-names>J.-S.</given-names></name></person-group><article-title>The role of natural compounds and their nanocarriers in the treatment of CNS inflammation</article-title><source>Biomolecules</source><year>2020</year><volume>10</volume><elocation-id>1401</elocation-id><pub-id pub-id-type="doi">10.3390/biom10101401</pub-id><pub-id pub-id-type="pmid">33019651</pub-id><pub-id pub-id-type="pmcid">PMC7601486</pub-id></element-citation></ref><ref id="B20-nanomaterials-12-00238"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barchet</surname><given-names>T.M.</given-names></name><name name-style="western"><surname>Amiji</surname><given-names>M.M.</given-names></name></person-group><article-title>Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases</article-title><source>Expert Opin. Drug Deliv.</source><year>2009</year><volume>6</volume><fpage>211</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1517/17425240902758188</pub-id><pub-id pub-id-type="pmid">19290842</pub-id></element-citation></ref><ref id="B21-nanomaterials-12-00238"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weintraub</surname><given-names>D.</given-names></name><name name-style="western"><surname>Comella</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Horn</surname><given-names>S.</given-names></name></person-group><article-title>Parkinson&#8217;s disease&#8212;Part 1: Pathophysiology, symptoms, burden, diagnosis, and assessment</article-title><source>Am. J. Manag. Care</source><year>2008</year><volume>14</volume><fpage>40</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">18402507</pub-id></element-citation></ref><ref id="B22-nanomaterials-12-00238"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walker</surname><given-names>F.O.</given-names></name></person-group><article-title>Huntington&#8217;s disease</article-title><source>Lancet</source><year>2007</year><volume>369</volume><fpage>218</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(07)60111-1</pub-id><pub-id pub-id-type="pmid">17240289</pub-id></element-citation></ref><ref id="B23-nanomaterials-12-00238"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Imarisio</surname><given-names>S.</given-names></name><name name-style="western"><surname>Carmichael</surname><given-names>J.</given-names></name><name name-style="western"><surname>Korolchuk</surname><given-names>V.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C.-W.</given-names></name><name name-style="western"><surname>Saiki</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rose</surname><given-names>C.</given-names></name><name name-style="western"><surname>Krishna</surname><given-names>G.</given-names></name><name name-style="western"><surname>Davies</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Ttofi</surname><given-names>E.</given-names></name><name name-style="western"><surname>Underwood</surname><given-names>B.R.</given-names></name><etal/></person-group><article-title>Huntington&#8217;s disease: From pathology and genetics to potential therapies</article-title><source>Biochem. J.</source><year>2008</year><volume>412</volume><fpage>191</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1042/BJ20071619</pub-id><pub-id pub-id-type="pmid">18466116</pub-id></element-citation></ref><ref id="B24-nanomaterials-12-00238"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vaquer-Alicea</surname><given-names>J.</given-names></name><name name-style="western"><surname>Diamond</surname><given-names>M.I.</given-names></name></person-group><article-title>Propagation of protein aggregation in neurodegenerative diseases</article-title><source>Annu. Rev. Biochem.</source><year>2019</year><volume>88</volume><fpage>785</fpage><lpage>810</lpage><pub-id pub-id-type="doi">10.1146/annurev-biochem-061516-045049</pub-id><pub-id pub-id-type="pmid">30917002</pub-id></element-citation></ref><ref id="B25-nanomaterials-12-00238"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dugger</surname><given-names>B.N.</given-names></name><name name-style="western"><surname>Dickson</surname><given-names>D.W.</given-names></name></person-group><article-title>Pathology of neurodegenerative diseases</article-title><source>Cold Spring Harb. Perspect. Biol.</source><year>2017</year><volume>9</volume><fpage>a028035</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a028035</pub-id><pub-id pub-id-type="pmid">28062563</pub-id><pub-id pub-id-type="pmcid">PMC5495060</pub-id></element-citation></ref><ref id="B26-nanomaterials-12-00238"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gooch</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Pracht</surname><given-names>E.</given-names></name><name name-style="western"><surname>Borenstein</surname><given-names>A.R.</given-names></name></person-group><article-title>The burden of neurological disease in the United States: A summary report and call to action</article-title><source>Ann. Neurol.</source><year>2017</year><volume>81</volume><fpage>479</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.1002/ana.24897</pub-id><pub-id pub-id-type="pmid">28198092</pub-id></element-citation></ref><ref id="B27-nanomaterials-12-00238"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abbott</surname><given-names>N.J.</given-names></name><name name-style="western"><surname>R&#246;nnb&#228;ck</surname><given-names>L.</given-names></name><name name-style="western"><surname>Hansson</surname><given-names>E.</given-names></name></person-group><article-title>Astrocyte-endothelial interactions at the blood -Brain barrier</article-title><source>Nat. Rev. Neurosci.</source><year>2006</year><volume>7</volume><fpage>41</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1038/nrn1824</pub-id><pub-id pub-id-type="pmid">16371949</pub-id></element-citation></ref><ref id="B28-nanomaterials-12-00238"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bergmann</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lawler</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Qu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Fadzen</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Wolfe</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Regan</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Pentelute</surname><given-names>B.L.</given-names></name><name name-style="western"><surname>Agar</surname><given-names>N.Y.R.</given-names></name><name name-style="western"><surname>Cho</surname><given-names>C.-F.</given-names></name></person-group><article-title>Blood&#8212;Brain barrier organoids for investigating the permeability of CNS therapeutics</article-title><source>Nat. Protoc.</source><year>2018</year><volume>13</volume><fpage>2827</fpage><lpage>2843</lpage><pub-id pub-id-type="doi">10.1038/s41596-018-0066-x</pub-id><pub-id pub-id-type="pmid">30382243</pub-id><pub-id pub-id-type="pmcid">PMC6673652</pub-id></element-citation></ref><ref id="B29-nanomaterials-12-00238"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guerra</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bl&#225;zquez</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Rodr&#237;guez</surname><given-names>E.M.</given-names></name></person-group><article-title>Blood&#8211;brain barrier and foetal-onset hydrocephalus, with a view on potential novel treatments beyond managing CSF flow</article-title><source>Fluids Barriers CNS</source><year>2017</year><volume>14</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1186/s12987-017-0067-0</pub-id><pub-id pub-id-type="pmid">28701191</pub-id><pub-id pub-id-type="pmcid">PMC5508761</pub-id></element-citation></ref><ref id="B30-nanomaterials-12-00238"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>X.</given-names></name></person-group><article-title>Current strategies for brain drug delivery</article-title><source>Theranostics</source><year>2018</year><volume>8</volume><fpage>1481</fpage><lpage>1493</lpage><pub-id pub-id-type="doi">10.7150/thno.21254</pub-id><pub-id pub-id-type="pmid">29556336</pub-id><pub-id pub-id-type="pmcid">PMC5858162</pub-id></element-citation></ref><ref id="B31-nanomaterials-12-00238"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Makkar</surname><given-names>R.</given-names></name><name name-style="western"><surname>Behl</surname><given-names>T.</given-names></name><name name-style="western"><surname>Bungau</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zengin</surname><given-names>G.</given-names></name><name name-style="western"><surname>Mehta</surname><given-names>V.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Uddin</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ashraf</surname><given-names>G.M.</given-names></name><name name-style="western"><surname>Abdel-Daim</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Arora</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Nutraceuticals in neurological disorders</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>4424</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21124424</pub-id><pub-id pub-id-type="pmcid">PMC7352709</pub-id><pub-id pub-id-type="pmid">32580329</pub-id></element-citation></ref><ref id="B32-nanomaterials-12-00238"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uddin</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hossain</surname><given-names>F.</given-names></name><name name-style="western"><surname>Al Mamun</surname><given-names>A.</given-names></name><name name-style="western"><surname>Shah</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Hasana</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bulbul</surname><given-names>I.J.</given-names></name><name name-style="western"><surname>Sarwar</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mansouri</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Ashraf</surname><given-names>G.M.</given-names></name><name name-style="western"><surname>Rauf</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Exploring the multimodal role of phytochemicals in the modulation of cellular signaling pathways to combat age-related neurodegeneration</article-title><source>Sci. Total Environ.</source><year>2020</year><volume>725</volume><fpage>138313</fpage><pub-id pub-id-type="doi">10.1016/j.scitotenv.2020.138313</pub-id><pub-id pub-id-type="pmid">32464743</pub-id></element-citation></ref><ref id="B33-nanomaterials-12-00238"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>F.-D.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y.-J.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X.-G.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J.-M.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Qin</surname><given-names>D.-L.</given-names></name><name name-style="western"><surname>Fan</surname><given-names>Q.-Z.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>A.-G.</given-names></name></person-group><article-title>Nanoparticles: A hope for the treatment of inflammation in CNS</article-title><source>Front. Pharmacol.</source><year>2021</year><volume>12</volume><fpage>683935</fpage><pub-id pub-id-type="doi">10.3389/fphar.2021.683935</pub-id><pub-id pub-id-type="pmid">34122112</pub-id><pub-id pub-id-type="pmcid">PMC8187807</pub-id></element-citation></ref><ref id="B34-nanomaterials-12-00238"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmitt</surname><given-names>C.</given-names></name><name name-style="western"><surname>Lechanteur</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cossais</surname><given-names>F.</given-names></name><name name-style="western"><surname>Bellefroid</surname><given-names>C.</given-names></name><name name-style="western"><surname>Arnold</surname><given-names>P.</given-names></name><name name-style="western"><surname>Lucius</surname><given-names>R.</given-names></name><name name-style="western"><surname>Held-Feindt</surname><given-names>J.</given-names></name><name name-style="western"><surname>Piel</surname><given-names>G.</given-names></name><name name-style="western"><surname>Hattermann</surname><given-names>K.</given-names></name></person-group><article-title>Liposomal encapsulated curcumin effectively attenuates neuroinflammatory and reactive astrogliosis reactions in glia cvells and organotypic brain slices</article-title><source>Int. J. Nanomed.</source><year>2020</year><volume>ume 15</volume><fpage>3649</fpage><lpage>3667</lpage><pub-id pub-id-type="doi">10.2147/IJN.S245300</pub-id><pub-id pub-id-type="pmcid">PMC7259452</pub-id><pub-id pub-id-type="pmid">32547020</pub-id></element-citation></ref><ref id="B35-nanomaterials-12-00238"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alphand&#233;ry</surname><given-names>E.</given-names></name></person-group><article-title>Nano-therapies for glioblastoma treatment</article-title><source>Cancers</source><year>2020</year><volume>12</volume><elocation-id>242</elocation-id><pub-id pub-id-type="doi">10.3390/cancers12010242</pub-id><pub-id pub-id-type="pmid">31963825</pub-id><pub-id pub-id-type="pmcid">PMC7017259</pub-id></element-citation></ref><ref id="B36-nanomaterials-12-00238"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhai</surname><given-names>K.</given-names></name><name name-style="western"><surname>Brockm&#252;ller</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kubatka</surname><given-names>P.</given-names></name><name name-style="western"><surname>Shakibaei</surname><given-names>M.</given-names></name><name name-style="western"><surname>B&#252;sselberg</surname><given-names>D.</given-names></name></person-group><article-title>Curcumin&#8217;s beneficial effects on neuroblastoma: Mechanisms, challenges, and potential solutions</article-title><source>Biomolecules</source><year>2020</year><volume>10</volume><elocation-id>1469</elocation-id><pub-id pub-id-type="doi">10.3390/biom10111469</pub-id><pub-id pub-id-type="pmcid">PMC7690450</pub-id><pub-id pub-id-type="pmid">33105719</pub-id></element-citation></ref><ref id="B37-nanomaterials-12-00238"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dibaei</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rouini</surname><given-names>M.-R.</given-names></name><name name-style="western"><surname>Sheikholeslami</surname><given-names>B.</given-names></name><name name-style="western"><surname>Gholami</surname><given-names>M.</given-names></name><name name-style="western"><surname>Dinarvand</surname><given-names>R.</given-names></name></person-group><article-title>The effect of surface treatment on the brain delivery of curcumin nanosuspension: In vitro and in vivo studies</article-title><source>Int. J. Nanomed.</source><year>2019</year><volume>ume 14</volume><fpage>5477</fpage><lpage>5490</lpage><pub-id pub-id-type="doi">10.2147/IJN.S199624</pub-id><pub-id pub-id-type="pmcid">PMC6649305</pub-id><pub-id pub-id-type="pmid">31409999</pub-id></element-citation></ref><ref id="B38-nanomaterials-12-00238"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kalashnikova</surname><given-names>I.</given-names></name><name name-style="western"><surname>Mazar</surname><given-names>J.</given-names></name><name name-style="western"><surname>Neal</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Rosado</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Das</surname><given-names>S.</given-names></name><name name-style="western"><surname>Westmoreland</surname><given-names>T.J.</given-names></name><name name-style="western"><surname>Seal</surname><given-names>S.</given-names></name></person-group><article-title>Nanoparticle delivery of curcumin induces cellular hypoxia and ROS-mediated apoptosis: Via modulation of Bcl-2/Bax in human neuroblastoma</article-title><source>Nanoscale</source><year>2017</year><volume>9</volume><fpage>10375</fpage><lpage>10387</lpage><pub-id pub-id-type="doi">10.1039/C7NR02770B</pub-id><pub-id pub-id-type="pmid">28702620</pub-id></element-citation></ref><ref id="B39-nanomaterials-12-00238"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Montalb&#225;n</surname><given-names>M.G.</given-names></name><name name-style="western"><surname>Coburn</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Lozano-P&#233;rez</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Cenis</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>V&#237;llora</surname><given-names>G.</given-names></name><name name-style="western"><surname>Kaplan</surname><given-names>D.L.</given-names></name></person-group><article-title>Production of curcumin-loaded silk fibroin nanoparticles for cancer therapy</article-title><source>Nanomaterials</source><year>2018</year><volume>8</volume><elocation-id>126</elocation-id><pub-id pub-id-type="doi">10.3390/nano8020126</pub-id><pub-id pub-id-type="pmid">29495296</pub-id><pub-id pub-id-type="pmcid">PMC5853757</pub-id></element-citation></ref><ref id="B40-nanomaterials-12-00238"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baspinar</surname><given-names>Y.</given-names></name><name name-style="western"><surname>&#220;st&#252;ndas</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bayraktar</surname><given-names>O.</given-names></name><name name-style="western"><surname>Sezgin</surname><given-names>C.</given-names></name></person-group><article-title>Curcumin and piperine loaded zein-chitosan nanoparticles: Development and in-vitro characterisation</article-title><source>Saudi Pharm. J.</source><year>2018</year><volume>26</volume><fpage>323</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1016/j.jsps.2018.01.010</pub-id><pub-id pub-id-type="pmid">29556123</pub-id><pub-id pub-id-type="pmcid">PMC5856953</pub-id></element-citation></ref><ref id="B41-nanomaterials-12-00238"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>S.</given-names></name><name name-style="western"><surname>McClements</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Jian</surname><given-names>L.</given-names></name><name name-style="western"><surname>Han</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Dai</surname><given-names>L.</given-names></name><name name-style="western"><surname>Mao</surname><given-names>L.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Y.</given-names></name></person-group><article-title>Core&#8211;shell biopolymer nanoparticles for co-delivery of curcumin and piperine: Sequential electrostatic deposition of hyaluronic acid and chitosan shells on the zein core</article-title><source>ACS Appl. Mater. Interfaces</source><year>2019</year><volume>11</volume><fpage>38103</fpage><lpage>38115</lpage><pub-id pub-id-type="doi">10.1021/acsami.9b11782</pub-id><pub-id pub-id-type="pmid">31509373</pub-id></element-citation></ref><ref id="B42-nanomaterials-12-00238"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ege</surname><given-names>D.</given-names></name></person-group><article-title>Action mechanisms of curcumin in Alzheimer&#8217;s disease and its brain targeted delivery</article-title><source>Materials</source><year>2021</year><volume>14</volume><elocation-id>3332</elocation-id><pub-id pub-id-type="doi">10.3390/ma14123332</pub-id><pub-id pub-id-type="pmid">34208692</pub-id><pub-id pub-id-type="pmcid">PMC8234049</pub-id></element-citation></ref><ref id="B43-nanomaterials-12-00238"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sadegh Malvajerd</surname><given-names>S.</given-names></name><name name-style="western"><surname>Azadi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Izadi</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Kurd</surname><given-names>M.</given-names></name><name name-style="western"><surname>Dara</surname><given-names>T.</given-names></name><name name-style="western"><surname>Dibaei</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zadeh</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Javar</surname><given-names>H.A.</given-names></name><name name-style="western"><surname>Hamidi</surname><given-names>M.</given-names></name></person-group><article-title>Brain delivery of curcumin using solid lipid nanoparticles and nanostructured lipid carriers: Preparation, optimization, and pharmacokinetic evaluation</article-title><source>ACS Chem. Neurosci.</source><year>2019</year><volume>10</volume><fpage>728</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1021/acschemneuro.8b00510</pub-id><pub-id pub-id-type="pmid">30335941</pub-id></element-citation></ref><ref id="B44-nanomaterials-12-00238"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Giacomeli</surname><given-names>R.</given-names></name><name name-style="western"><surname>Izoton</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>dos Santos</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>Boeira</surname><given-names>S.P.</given-names></name><name name-style="western"><surname>Jesse</surname><given-names>C.R.</given-names></name><name name-style="western"><surname>Haas</surname><given-names>S.E.</given-names></name></person-group><article-title>Neuroprotective effects of curcumin lipid-core nanocapsules in a model Alzheimer&#8217;s disease induced by &#946;-amyloid 1-42 peptide in aged female mice</article-title><source>Brain Res.</source><year>2019</year><volume>1721</volume><fpage>146325</fpage><pub-id pub-id-type="doi">10.1016/j.brainres.2019.146325</pub-id><pub-id pub-id-type="pmid">31325424</pub-id></element-citation></ref><ref id="B45-nanomaterials-12-00238"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakama</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>dos Santos</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>Silva</surname><given-names>C.E.D.R.</given-names></name><name name-style="western"><surname>Izoton</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Savall</surname><given-names>A.S.P.</given-names></name><name name-style="western"><surname>Gutirrez</surname><given-names>M.E.Z.</given-names></name><name name-style="western"><surname>Roman</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Luchese</surname><given-names>C.</given-names></name><name name-style="western"><surname>Pinton</surname><given-names>S.</given-names></name><name name-style="western"><surname>Haas</surname><given-names>S.E.</given-names></name></person-group><article-title>Establishment of analytical method for quantification of anti-inflammatory agents co-nanoencapsulated and its application to physicochemical development and characterization of lipid-core nanocapsules</article-title><source>Arab. J. Chem.</source><year>2020</year><volume>13</volume><fpage>2456</fpage><lpage>2469</lpage><pub-id pub-id-type="doi">10.1016/j.arabjc.2018.05.011</pub-id></element-citation></ref><ref id="B46-nanomaterials-12-00238"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ganesan</surname><given-names>P.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>B.</given-names></name><name name-style="western"><surname>Ramalingam</surname><given-names>P.</given-names></name><name name-style="western"><surname>Karthivashan</surname><given-names>G.</given-names></name><name name-style="western"><surname>Revuri</surname><given-names>V.</given-names></name><name name-style="western"><surname>Park</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Ko</surname><given-names>Y.T.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>D.-K.</given-names></name><name name-style="western"><surname>Ramalaingam</surname><given-names>P.</given-names></name></person-group><article-title>Antineuroinflammatory activities and neurotoxicological assessment of curcumin loaded solid lipid nanoparticles on LPS-stimulated BV-2 microglia cell models</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>1170</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24061170</pub-id><pub-id pub-id-type="pmcid">PMC6470586</pub-id><pub-id pub-id-type="pmid">30934561</pub-id></element-citation></ref><ref id="B47-nanomaterials-12-00238"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maiti</surname><given-names>P.</given-names></name><name name-style="western"><surname>Paladugu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Dunbar</surname><given-names>G.L.</given-names></name></person-group><article-title>Solid lipid curcumin particles provide greater anti-amyloid, anti-inflammatory and neuroprotective effects than curcumin in the 5xFAD mouse model of Alzheimer&#8217;s disease</article-title><source>BMC Neurosci.</source><year>2018</year><volume>19</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1186/s12868-018-0406-3</pub-id><pub-id pub-id-type="pmid">29471781</pub-id><pub-id pub-id-type="pmcid">PMC5824468</pub-id><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="retraction-forward" ext-link-type="pmc" xlink:href="PMC9951464"/></element-citation></ref><ref id="B48-nanomaterials-12-00238"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jeon</surname><given-names>S.G.</given-names></name><name name-style="western"><surname>Cha</surname><given-names>M.-Y.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J.-I.</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>T.W.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>T.H.</given-names></name><name name-style="western"><surname>Song</surname><given-names>K.C.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J.-J.</given-names></name><name name-style="western"><surname>Moon</surname><given-names>M.</given-names></name></person-group><article-title>Vitamin D-binding protein-loaded PLGA nanoparticles suppress Alzheimer&#8217;s disease-related pathology in 5XFAD mice</article-title><source>Nanomed. Nanotechnol. Biol. Med.</source><year>2019</year><volume>17</volume><fpage>297</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1016/j.nano.2019.02.004</pub-id><pub-id pub-id-type="pmid">30794963</pub-id></element-citation></ref><ref id="B49-nanomaterials-12-00238"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>N.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X.-G.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.-J.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>R.-T.</given-names></name></person-group><article-title>PLGA nanoparticles modified with a BBB-penetrating peptide co-delivering A&#946; generation inhibitor and curcumin attenuate memory deficits and neuropathology in Alzheimer&#8217;s disease mice</article-title><source>Oncotarget</source><year>2017</year><volume>8</volume><fpage>81001</fpage><lpage>81013</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.20944</pub-id><pub-id pub-id-type="pmid">29113362</pub-id><pub-id pub-id-type="pmcid">PMC5655257</pub-id></element-citation></ref><ref id="B50-nanomaterials-12-00238"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huo</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>X.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name></person-group><article-title>A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid &#946; aggregation in Alzheimer&#8217;s disease</article-title><source>J. Photochem. Photobiol. B Biol.</source><year>2019</year><volume>190</volume><fpage>98</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1016/j.jphotobiol.2018.11.008</pub-id><pub-id pub-id-type="pmid">30504054</pub-id></element-citation></ref><ref id="B51-nanomaterials-12-00238"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sathya</surname><given-names>S.</given-names></name><name name-style="western"><surname>Shanmuganathan</surname><given-names>B.</given-names></name><name name-style="western"><surname>Balasubramaniam</surname><given-names>B.</given-names></name><name name-style="western"><surname>Balamurugan</surname><given-names>K.</given-names></name><name name-style="western"><surname>Devi</surname><given-names>K.P.</given-names></name></person-group><article-title>Phytol loaded PLGA nanoparticles regulate the expression of Alzheimer&#8217;s related genes and neuronal apoptosis against amyloid-&#946; induced toxicity in Neuro-2a cells and transgenic Caenorhabditis elegans</article-title><source>Food Chem. Toxicol.</source><year>2019</year><volume>136</volume><fpage>110962</fpage><pub-id pub-id-type="doi">10.1016/j.fct.2019.110962</pub-id><pub-id pub-id-type="pmid">31734340</pub-id></element-citation></ref><ref id="B52-nanomaterials-12-00238"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>L.R.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>P.C.L.</given-names></name></person-group><article-title>In vitro and in vivo comparison of curcumin-encapsulated chitosan-coated poly (lactic- co-glycolic acid) nanoparticles and curcumin/Hydroxypropyl-&#946;-Cyclodextrin inclusion complexes administered intranasally as therapeutic strategies for Alzheimer&#8217;s diseas</article-title><source>Mol. Pharm.</source><year>2020</year><volume>17</volume><fpage>4256</fpage><lpage>4269</lpage><pub-id pub-id-type="doi">10.1021/acs.molpharmaceut.0c00675</pub-id><pub-id pub-id-type="pmid">33084343</pub-id></element-citation></ref><ref id="B53-nanomaterials-12-00238"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>K.K.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>P.S.</given-names></name><name name-style="western"><surname>Fan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kwan</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Yeung</surname><given-names>K.L.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.-X.</given-names></name><name name-style="western"><surname>Chow</surname><given-names>A.H.L.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>E.X.</given-names></name><name name-style="western"><surname>Baum</surname><given-names>L.</given-names></name></person-group><article-title>Curcumin-conjugated magnetic nanoparticles for detecting amyloid plaques in Alzheimer&#8217;s disease mice using magnetic resonance imaging (MRI)</article-title><source>Biomaterials</source><year>2015</year><volume>44</volume><fpage>155</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2014.12.005</pub-id><pub-id pub-id-type="pmid">25617135</pub-id></element-citation></ref><ref id="B54-nanomaterials-12-00238"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Li</surname><given-names>N.</given-names></name><name name-style="western"><surname>Pu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>B.</given-names></name></person-group><article-title>Neuroprotective effects of Ginseng phytochemicals: Recent perspectives</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>2939</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24162939</pub-id><pub-id pub-id-type="pmcid">PMC6720911</pub-id><pub-id pub-id-type="pmid">31416121</pub-id></element-citation></ref><ref id="B55-nanomaterials-12-00238"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sairazi</surname><given-names>N.S.M.</given-names></name><name name-style="western"><surname>Sirajudeen</surname><given-names>K.N.S.</given-names></name></person-group><article-title>Natural products and their bioactive compounds: Neuroprotective potentials against neurodegenerative diseases</article-title><source>Evid. Based Complement. Altern. Med.</source><year>2020</year><volume>2020</volume><fpage>1</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1155/2020/6565396</pub-id><pub-id pub-id-type="pmid">32148547</pub-id><pub-id pub-id-type="pmcid">PMC7042511</pub-id></element-citation></ref><ref id="B56-nanomaterials-12-00238"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rajabian</surname><given-names>A.</given-names></name><name name-style="western"><surname>Rameshrad</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hosseinzadeh</surname><given-names>H.</given-names></name></person-group><article-title>Therapeutic potential of <italic toggle="yes">Panax ginseng</italic> and its constituents, ginsenosides and gintonin, in neurological and neurodegenerative disorders: A patent review</article-title><source>Expert Opin. Ther. Patents</source><year>2019</year><volume>29</volume><fpage>55</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1080/13543776.2019.1556258</pub-id><pub-id pub-id-type="pmid">30513224</pub-id></element-citation></ref><ref id="B57-nanomaterials-12-00238"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Razgonova</surname><given-names>M.</given-names></name><name name-style="western"><surname>Veselov</surname><given-names>V.</given-names></name><name name-style="western"><surname>Zakharenko</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Golokhvast</surname><given-names>K.</given-names></name><name name-style="western"><surname>Nosyrev</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Cravotto</surname><given-names>G.</given-names></name><name name-style="western"><surname>Tsatsakis</surname><given-names>A.</given-names></name><name name-style="western"><surname>Spandidos</surname><given-names>D.</given-names></name></person-group><article-title><italic toggle="yes">Panax ginseng</italic> components and the pathogenesis of Alzheimer&#8217;s disease (Review)</article-title><source>Mol. Med. Rep.</source><year>2019</year><volume>19</volume><fpage>2975</fpage><lpage>2998</lpage><pub-id pub-id-type="doi">10.3892/mmr.2019.9972</pub-id><pub-id pub-id-type="pmid">30816465</pub-id><pub-id pub-id-type="pmcid">PMC6423617</pub-id></element-citation></ref><ref id="B58-nanomaterials-12-00238"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aalinkeel</surname><given-names>R.</given-names></name><name name-style="western"><surname>Kutscher</surname><given-names>H.L.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cwiklinski</surname><given-names>K.</given-names></name><name name-style="western"><surname>Khechen</surname><given-names>N.</given-names></name><name name-style="western"><surname>Schwartz</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Prasad</surname><given-names>P.N.</given-names></name><name name-style="western"><surname>Mahajan</surname><given-names>S.D.</given-names></name></person-group><article-title>Neuroprotective effects of a biodegradable poly(lactic-co-glycolic acid)-ginsenoside Rg3 nanoformulation: A potential nanotherapy for Alzheimer&#8217;s disease?</article-title><source>J. Drug Target.</source><year>2017</year><volume>26</volume><fpage>182</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1080/1061186X.2017.1354002</pub-id><pub-id pub-id-type="pmid">28697660</pub-id></element-citation></ref><ref id="B59-nanomaterials-12-00238"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oh</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J.-S.</given-names></name></person-group><article-title>Compound K derived from Ginseng: Neuroprotection and cognitive improvement</article-title><source>Food Funct.</source><year>2016</year><volume>7</volume><fpage>4506</fpage><lpage>4515</lpage><pub-id pub-id-type="doi">10.1039/C6FO01077F</pub-id><pub-id pub-id-type="pmid">27801453</pub-id></element-citation></ref><ref id="B60-nanomaterials-12-00238"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharma</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>H.-J.</given-names></name></person-group><article-title>Ginsenoside Compound K: Insights into recent studies on pharmacokinetics and health-promoting activities</article-title><source>Biomolecules</source><year>2020</year><volume>10</volume><elocation-id>1028</elocation-id><pub-id pub-id-type="doi">10.3390/biom10071028</pub-id><pub-id pub-id-type="pmid">32664389</pub-id><pub-id pub-id-type="pmcid">PMC7407392</pub-id></element-citation></ref><ref id="B61-nanomaterials-12-00238"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Qi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>D.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name></person-group><article-title>Neuroprotective potentials of <italic toggle="yes">Panax ginseng</italic> against Alzheimer&#8217;s disease: A review of preclinical and clinical evidences</article-title><source>Front. Pharmacol.</source><year>2021</year><volume>12</volume><fpage>688490</fpage><pub-id pub-id-type="doi">10.3389/fphar.2021.688490</pub-id><pub-id pub-id-type="pmid">34149431</pub-id><pub-id pub-id-type="pmcid">PMC8206566</pub-id></element-citation></ref><ref id="B62-nanomaterials-12-00238"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Cho</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>Y.-G.</given-names></name><name name-style="western"><surname>Park</surname><given-names>W.J.</given-names></name><name name-style="western"><surname>Kang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>D.-O.</given-names></name></person-group><article-title>Protective effects of red ginseng treated with gold nanoparticles against H<sub>2</sub>O<sub>2</sub> -induced oxidative stress in neuronal PC-12 cells</article-title><source>Korean J. Food Sci. Technol.</source><year>2017</year><volume>49</volume><fpage>222</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.9721/KJFST.2017.49.2.222</pub-id></element-citation></ref><ref id="B63-nanomaterials-12-00238"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Li</surname><given-names>C.-L.</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>T.-H.</given-names></name></person-group><article-title>Preclinical herb-drug pharmacokinetic interaction of <italic toggle="yes">Panax ginseng</italic> extract and selegiline in freely moving rats</article-title><source>ACS Omega</source><year>2020</year><volume>5</volume><fpage>4682</fpage><lpage>4688</lpage><pub-id pub-id-type="doi">10.1021/acsomega.0c00123</pub-id><pub-id pub-id-type="pmid">32175515</pub-id><pub-id pub-id-type="pmcid">PMC7066651</pub-id></element-citation></ref><ref id="B64-nanomaterials-12-00238"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>P.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ahn</surname><given-names>S.</given-names></name><name name-style="western"><surname>Castro-Aceituno</surname><given-names>V.</given-names></name><name name-style="western"><surname>Jim&#233;nez</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Simu</surname><given-names>S.Y.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>Y.J.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>D.C.</given-names></name></person-group><article-title>Pharmacological importance, characterization and applications of gold and silver nanoparticles synthesized by <italic toggle="yes">Panax ginseng</italic> fresh leaves</article-title><source>Artif. Cells, Nanomed. Biotechnol.</source><year>2017</year><volume>45</volume><fpage>1415</fpage><lpage>1424</lpage><pub-id pub-id-type="doi">10.1080/21691401.2016.1243547</pub-id><pub-id pub-id-type="pmid">27855495</pub-id></element-citation></ref><ref id="B65-nanomaterials-12-00238"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mathiyalagan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>D.C.</given-names></name></person-group><article-title>Ginseng nanoparticles: A budding tool for cancer treatment</article-title><source>Nanomedicine</source><year>2017</year><volume>12</volume><fpage>1091</fpage><lpage>1094</lpage><pub-id pub-id-type="doi">10.2217/nnm-2017-0070</pub-id><pub-id pub-id-type="pmid">28447867</pub-id></element-citation></ref><ref id="B66-nanomaterials-12-00238"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>A.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hong</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zuo</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ren</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Multifunctional ginsenoside Rg3-based liposomes for glioma targeting therapy</article-title><source>J. Control. Release</source><year>2021</year><volume>330</volume><fpage>641</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1016/j.jconrel.2020.12.036</pub-id><pub-id pub-id-type="pmid">33359582</pub-id></element-citation></ref><ref id="B67-nanomaterials-12-00238"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dai</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Si</surname><given-names>C.</given-names></name><name name-style="western"><surname>Lei</surname><given-names>J.</given-names></name></person-group><article-title>Nano-ginseng&#8221; for enhanced cytotoxicity against cancer cells</article-title><source>Int. J. Mol. Sci.</source><year>2018</year><volume>19</volume><elocation-id>627</elocation-id><pub-id pub-id-type="doi">10.3390/ijms19020627</pub-id><pub-id pub-id-type="pmcid">PMC5855849</pub-id><pub-id pub-id-type="pmid">29473838</pub-id></element-citation></ref><ref id="B68-nanomaterials-12-00238"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Du</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>J.</given-names></name></person-group><article-title>Curcumin inhibits LPS-induced neuroinflammation by promoting microglial M2 polarization via TREM2/ TLR4/ NF-&#954;B pathways in BV2 cells</article-title><source>Mol Immunol.</source><year>2019</year><volume>116</volume><fpage>29</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.molimm.2019.09.020</pub-id><pub-id pub-id-type="pmid">31590042</pub-id></element-citation></ref><ref id="B69-nanomaterials-12-00238"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pattan</surname><given-names>G.</given-names></name><name name-style="western"><surname>Kaul</surname><given-names>G.</given-names></name></person-group><article-title>Health hazards associated with nanomaterials</article-title><source>Toxicol. Ind. Heal.</source><year>2012</year><volume>30</volume><fpage>499</fpage><lpage>519</lpage><pub-id pub-id-type="doi">10.1177/0748233712459900</pub-id><pub-id pub-id-type="pmid">23012342</pub-id></element-citation></ref><ref id="B70-nanomaterials-12-00238"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Jiao</surname><given-names>F.</given-names></name><name name-style="western"><surname>Li</surname><given-names>W.</given-names></name><name name-style="western"><surname>Lao</surname><given-names>F.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.-F.</given-names></name><name name-style="western"><surname>Li</surname><given-names>B.</given-names></name><name name-style="western"><surname>Ge</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>G.</given-names></name></person-group><article-title>Potential neurological lesion after nasal instillation of TiO<sub>2</sub> nanoparticles in the anatase and rutile crystal phases</article-title><source>Toxicol. Lett.</source><year>2008</year><volume>183</volume><fpage>72</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.toxlet.2008.10.001</pub-id><pub-id pub-id-type="pmid">18992307</pub-id></element-citation></ref><ref id="B71-nanomaterials-12-00238"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pisanic</surname><given-names>T.R.</given-names></name><name name-style="western"><surname>Blackwell</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Shubayev</surname><given-names>V.I.</given-names></name><name name-style="western"><surname>Fi&#241;ones</surname><given-names>R.R.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>S.</given-names></name></person-group><article-title>Nanotoxicity of iron oxide nanoparticle internalization in growing neurons</article-title><source>Biomaterials</source><year>2007</year><volume>28</volume><fpage>2572</fpage><lpage>2581</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2007.01.043</pub-id><pub-id pub-id-type="pmid">17320946</pub-id></element-citation></ref><ref id="B72-nanomaterials-12-00238"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ren</surname><given-names>G.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Z.</given-names></name></person-group><article-title>Influences of nanoparticle zinc oxide on acutely isolated rat hippocampal CA3 pyramidal neurons</article-title><source>NeuroToxicology</source><year>2009</year><volume>30</volume><fpage>220</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1016/j.neuro.2008.12.005</pub-id><pub-id pub-id-type="pmid">19146874</pub-id></element-citation></ref><ref id="B73-nanomaterials-12-00238"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cha</surname><given-names>K.E.</given-names></name><name name-style="western"><surname>Myung</surname><given-names>H.</given-names></name></person-group><article-title>Cytotoxic effects of nanoparticles assessed in vitro and in vivo</article-title><source>J. Microbiol. Biotechnol.</source><year>2007</year><volume>17</volume><fpage>1573</fpage><lpage>1578</lpage><pub-id pub-id-type="pmid">18062241</pub-id></element-citation></ref><ref id="B74-nanomaterials-12-00238"><label>74.</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>WHO</collab></person-group><article-title>Cardiovascular diseases (CVDs)</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)" ext-link-type="uri">https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2021-05-16">(accessed on 16 May 2021)</date-in-citation></element-citation></ref><ref id="B75-nanomaterials-12-00238"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rastogi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Pandey</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Rawat</surname><given-names>A.</given-names></name></person-group><article-title>Traditional herbs: A remedy for cardiovascular disorders</article-title><source>Phytomedicine</source><year>2016</year><volume>23</volume><fpage>1082</fpage><lpage>1089</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2015.10.012</pub-id><pub-id pub-id-type="pmid">26656228</pub-id></element-citation></ref><ref id="B76-nanomaterials-12-00238"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deb</surname><given-names>S.</given-names></name><name name-style="western"><surname>Dasgupta</surname><given-names>A.</given-names></name></person-group><article-title>A study on risk factors of cardiovascular diseases in an urban health center of Kolkata</article-title><source>Indian J. Community Med.</source><year>2008</year><volume>33</volume><fpage>271</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.4103/0970-0218.43239</pub-id><pub-id pub-id-type="pmid">19876506</pub-id><pub-id pub-id-type="pmcid">PMC2763703</pub-id></element-citation></ref><ref id="B77-nanomaterials-12-00238"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ritchey</surname><given-names>M.D.</given-names></name><name name-style="western"><surname>Wall</surname><given-names>H.K.</given-names></name><name name-style="western"><surname>George</surname><given-names>M.G.</given-names></name><name name-style="western"><surname>Wright</surname><given-names>J.S.</given-names></name></person-group><article-title>US trends in premature heart disease mortality over the past 50 years: Where do we go from here?</article-title><source>Trends Cardiovasc. Med.</source><year>2020</year><volume>30</volume><fpage>364</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1016/j.tcm.2019.09.005</pub-id><pub-id pub-id-type="pmid">31607635</pub-id><pub-id pub-id-type="pmcid">PMC7098848</pub-id></element-citation></ref><ref id="B78-nanomaterials-12-00238"><label>78.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Olvera</surname><given-names>L.E.</given-names></name><name name-style="western"><surname>Ballard</surname><given-names>B.D.</given-names></name><name name-style="western"><surname>Jan</surname><given-names>A.</given-names></name></person-group><article-title>Cardiovascular disease</article-title><source>StatPearls</source><publisher-name>StatPearls Publishing</publisher-name><publisher-loc>Treasure Island, FL, USA</publisher-loc><year>2021</year><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK535419/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/books/NBK535419/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2022-01-06">(accessed on 6 January 2022)</date-in-citation></element-citation></ref><ref id="B79-nanomaterials-12-00238"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krishnamoorthy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Greiner</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Bertoni</surname><given-names>A.</given-names></name><name name-style="western"><surname>Eapen</surname><given-names>Z.J.</given-names></name><name name-style="western"><surname>O&#8217;Brien</surname><given-names>E.C.</given-names></name><name name-style="western"><surname>Curtis</surname><given-names>L.H.</given-names></name><name name-style="western"><surname>Hernandez</surname><given-names>A.F.</given-names></name><name name-style="western"><surname>Mentz</surname><given-names>R.J.</given-names></name></person-group><article-title>The obesity and heart failure epidemics among African Americans: Insights from the Jackson heart study</article-title><source>J. Card. Fail.</source><year>2016</year><volume>22</volume><fpage>589</fpage><lpage>597</lpage><pub-id pub-id-type="doi">10.1016/j.cardfail.2016.03.004</pub-id><pub-id pub-id-type="pmid">26975941</pub-id><pub-id pub-id-type="pmcid">PMC4967003</pub-id></element-citation></ref><ref id="B80-nanomaterials-12-00238"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thiriet</surname><given-names>M.</given-names></name></person-group><article-title>Cardiovascular disease: An introduction</article-title><source>Vasculopathies</source><year>2018</year><volume>8</volume><fpage>1</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1007/978-3-319-89315-0_1</pub-id></element-citation></ref><ref id="B81-nanomaterials-12-00238"><label>81.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>American Heart Association</collab></person-group><source>Cardiac Medications</source><publisher-name>AHA</publisher-name><publisher-loc>Dallas, TX, USA</publisher-loc><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.heart.org/en/health-topics/heart-attack/treatment-of-a-heart-attack/cardiac-medications" ext-link-type="uri">https://www.heart.org/en/health-topics/heart-attack/treatment-of-a-heart-attack/cardiac-medications</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-07-02">(accessed on 2 July 2020)</date-in-citation></element-citation></ref><ref id="B82-nanomaterials-12-00238"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rossello</surname><given-names>X.</given-names></name><name name-style="western"><surname>Pocock</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Julian</surname><given-names>D.G.</given-names></name></person-group><article-title>Long-term use of cardiovascular drugs challenges for research and for patient care</article-title><source>J Am Coll Cardiol.</source><year>2015</year><volume>66</volume><fpage>1273</fpage><lpage>1285</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2015.07.018</pub-id><pub-id pub-id-type="pmid">26361160</pub-id></element-citation></ref><ref id="B83-nanomaterials-12-00238"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van Der Laan</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Elders</surname><given-names>P.J.M.</given-names></name><name name-style="western"><surname>Boons</surname><given-names>C.C.L.M.</given-names></name><name name-style="western"><surname>Nijpels</surname><given-names>G.</given-names></name><name name-style="western"><surname>Krska</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hugtenburg</surname><given-names>J.G.</given-names></name></person-group><article-title>The impact of cardiovascular medication use on patients&#8217; daily lives: A cross-sectional study</article-title><source>Int. J. Clin. Pharm.</source><year>2018</year><volume>40</volume><fpage>412</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1007/s11096-018-0601-4</pub-id><pub-id pub-id-type="pmid">29435910</pub-id><pub-id pub-id-type="pmcid">PMC5918518</pub-id></element-citation></ref><ref id="B84-nanomaterials-12-00238"><label>84.</label><element-citation publication-type="gov"><article-title>Chronic kidney disease in the United States</article-title><year>2021</year><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cdc.gov/kidneydisease/publications-resources/ckd-national-facts.html" ext-link-type="uri">https://www.cdc.gov/kidneydisease/publications-resources/ckd-national-facts.html</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2021-06-02">(accessed on 2 June 2021)</date-in-citation></element-citation></ref><ref id="B85-nanomaterials-12-00238"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hesari</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mohammadi</surname><given-names>P.</given-names></name><name name-style="western"><surname>Khademi</surname><given-names>F.</given-names></name><name name-style="western"><surname>Shackebaei</surname><given-names>D.</given-names></name><name name-style="western"><surname>Momtaz</surname><given-names>S.</given-names></name><name name-style="western"><surname>Moasefi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Farzaei</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Abdollahi</surname><given-names>M.</given-names></name></person-group><article-title>Current Advances in the use of nanophytomedicine therapies for human cardiovascular diseases</article-title><source>Int. J. Nanomed.</source><year>2021</year><volume>16</volume><fpage>3293</fpage><lpage>3315</lpage><pub-id pub-id-type="doi">10.2147/IJN.S295508</pub-id><pub-id pub-id-type="pmcid">PMC8123960</pub-id><pub-id pub-id-type="pmid">34007178</pub-id></element-citation></ref><ref id="B86-nanomaterials-12-00238"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Owen</surname><given-names>A.</given-names></name><name name-style="western"><surname>Duf&#232;s</surname><given-names>C.</given-names></name><name name-style="western"><surname>Moscatelli</surname><given-names>D.</given-names></name><name name-style="western"><surname>Mayes</surname><given-names>E.</given-names></name><name name-style="western"><surname>Lovell</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Katti</surname><given-names>K.V.</given-names></name><name name-style="western"><surname>Sokolov</surname><given-names>K.</given-names></name><name name-style="western"><surname>Mazza</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fontaine</surname><given-names>O.</given-names></name><name name-style="western"><surname>Rannard</surname><given-names>S.</given-names></name><etal/></person-group><article-title>The application of nanotechnology in medicine: Treatment and diagnostics</article-title><source>Nanomedicine</source><year>2014</year><volume>9</volume><fpage>1291</fpage><lpage>1294</lpage><pub-id pub-id-type="doi">10.2217/nnm.14.93</pub-id><pub-id pub-id-type="pmid">25204820</pub-id></element-citation></ref><ref id="B87-nanomaterials-12-00238"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>D.K.</given-names></name><name name-style="western"><surname>Rahimi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Filgueira</surname><given-names>C.S.</given-names></name></person-group><article-title>Nanotechnology applications for cardiovascular disease treatment: Current and future perspectives</article-title><source>Nanomed. Nanotechnol. Biol. Med.</source><year>2021</year><volume>34</volume><fpage>102387</fpage><pub-id pub-id-type="doi">10.1016/j.nano.2021.102387</pub-id><pub-id pub-id-type="pmid">33753283</pub-id></element-citation></ref><ref id="B88-nanomaterials-12-00238"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gera</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>N.</given-names></name><name name-style="western"><surname>Ghosh</surname><given-names>M.</given-names></name><name name-style="western"><surname>Huynh</surname><given-names>D.L.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Min</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>T.</given-names></name><name name-style="western"><surname>Jeong</surname><given-names>D.K.</given-names></name></person-group><article-title>Nanoformulations of curcumin: An emerging paradigm for improved remedial application</article-title><source>Oncotarget</source><year>2017</year><volume>8</volume><fpage>66680</fpage><lpage>66698</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.19164</pub-id><pub-id pub-id-type="pmid">29029547</pub-id><pub-id pub-id-type="pmcid">PMC5630447</pub-id></element-citation></ref><ref id="B89-nanomaterials-12-00238"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lozano</surname><given-names>O.</given-names></name><name name-style="western"><surname>L&#225;zaro-Alfaro</surname><given-names>A.</given-names></name><name name-style="western"><surname>Silva-Platas</surname><given-names>C.</given-names></name><name name-style="western"><surname>Oropeza-Almaz&#225;n</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Torres-Quintanilla</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bernal-Ramirez</surname><given-names>J.</given-names></name><name name-style="western"><surname>Figueiredo</surname><given-names>H.</given-names></name><name name-style="western"><surname>Garc&#237;a-Rivas</surname><given-names>G.</given-names></name></person-group><article-title>Nanoencapsulated quercetin improves cardioprotection during hypoxia-reoxygenation injury through preservation of mitochondrial function</article-title><source>Oxidative Med. Cell. Longev.</source><year>2019</year><volume>2019</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1155/2019/7683051</pub-id><pub-id pub-id-type="pmid">31341535</pub-id><pub-id pub-id-type="pmcid">PMC6612997</pub-id></element-citation></ref><ref id="B90-nanomaterials-12-00238"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Summerlin</surname><given-names>N.</given-names></name><name name-style="western"><surname>Soo</surname><given-names>E.</given-names></name><name name-style="western"><surname>Thakur</surname><given-names>S.</given-names></name><name name-style="western"><surname>Qu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Jambhrunkar</surname><given-names>S.</given-names></name><name name-style="western"><surname>Popat</surname><given-names>A.</given-names></name></person-group><article-title>Resveratrol nanoformulations: Challenges and opportunities</article-title><source>Int. J. Pharm.</source><year>2015</year><volume>479</volume><fpage>282</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2015.01.003</pub-id><pub-id pub-id-type="pmid">25572692</pub-id></element-citation></ref><ref id="B91-nanomaterials-12-00238"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shahraki</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bahadorikhalili</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hashemzaei</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hajinezhad</surname><given-names>M.</given-names></name><name name-style="western"><surname>Afsharimoghaddam</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sarani</surname><given-names>F.</given-names></name><name name-style="western"><surname>Tajrobekar</surname><given-names>O.</given-names></name></person-group><article-title>Resveratrol nano-capsule as an efficient tool for blood pressure regulation: A study on metabolic syndrome induced mice</article-title><source>Biosci Biotechnol. Res Commun.</source><year>2017</year><volume>10</volume><fpage>623</fpage><lpage>630</lpage><pub-id pub-id-type="doi">10.21786/bbrc/10.4/4</pub-id></element-citation></ref><ref id="B92-nanomaterials-12-00238"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shen</surname><given-names>P.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>He</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Gu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>K.</given-names></name><name name-style="western"><surname>Li</surname><given-names>S.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Magnolol treatment attenuates dextran sulphate sodium-induced murine experimental colitis by regulating inflammation and mucosal damage</article-title><source>Life Sci.</source><year>2018</year><volume>196</volume><fpage>69</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2018.01.016</pub-id><pub-id pub-id-type="pmid">29355546</pub-id></element-citation></ref><ref id="B93-nanomaterials-12-00238"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stefanache</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ignat</surname><given-names>M.</given-names></name><name name-style="western"><surname>Peptu</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Diaconu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Stoleriu</surname><given-names>I.</given-names></name><name name-style="western"><surname>Ochiuz</surname><given-names>L.</given-names></name></person-group><article-title>Development of a prolonged-release drug delivery system with magnolol loaded in amino-functionalized mesoporous silica</article-title><source>Appl. Sci.</source><year>2017</year><volume>7</volume><elocation-id>237</elocation-id><pub-id pub-id-type="doi">10.3390/app7030237</pub-id></element-citation></ref><ref id="B94-nanomaterials-12-00238"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sheng</surname><given-names>Y.-L.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>J.-H.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>C.-H.</given-names></name><name name-style="western"><surname>Li</surname><given-names>W.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>H.-Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>N.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y.-Q.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.-R.</given-names></name></person-group><article-title>UPLC-MS/MS-ESI assay for simultaneous determination of magnolol and honokiol in rat plasma: Application to pharmacokinetic study after administration emulsion of the isomer</article-title><source>J. Ethnopharmacol.</source><year>2014</year><volume>155</volume><fpage>1568</fpage><lpage>1574</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2014.07.052</pub-id><pub-id pub-id-type="pmid">25102243</pub-id></element-citation></ref><ref id="B95-nanomaterials-12-00238"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y.-J.</given-names></name><name name-style="western"><surname>Chien</surname><given-names>Y.-C.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>C.-H.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>D.-M.</given-names></name></person-group><article-title>Magnolol-loaded core&#8211;shell hydrogel nanoparticles: Drug release, intracellular uptake, and controlled cytotoxicity for the inhibition of migration of vascular Ssooth muscle cells</article-title><source>Mol. Pharm.</source><year>2011</year><volume>8</volume><fpage>2339</fpage><lpage>2349</lpage><pub-id pub-id-type="doi">10.1021/mp200257y</pub-id><pub-id pub-id-type="pmid">21942740</pub-id></element-citation></ref><ref id="B96-nanomaterials-12-00238"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xia</surname><given-names>L.-M.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>M.-H.</given-names></name></person-group><article-title>Study progress of berberine for treating cardiovascular disease</article-title><source>Chronic Dis. Transl. Med.</source><year>2015</year><volume>1</volume><fpage>231</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1016/j.cdtm.2015.11.006</pub-id><pub-id pub-id-type="pmid">29063012</pub-id><pub-id pub-id-type="pmcid">PMC5643735</pub-id></element-citation></ref><ref id="B97-nanomaterials-12-00238"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>P.</given-names></name></person-group><article-title>Tilianin-loaded reactive oxygen species-scavenging nano-micelles protect H9c2 cardiomyocyte against hypoxia/reoxygenation-induced injury</article-title><source>J. Cardiovasc. Pharmacol.</source><year>2018</year><volume>72</volume><fpage>32</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1097/FJC.0000000000000587</pub-id><pub-id pub-id-type="pmid">29688912</pub-id></element-citation></ref><ref id="B98-nanomaterials-12-00238"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>B.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>W.-Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>T.-C.</given-names></name><name name-style="western"><surname>Jia</surname><given-names>G.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>J.-W.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y.-L.</given-names></name><name name-style="western"><surname>Chai</surname><given-names>Z.-F.</given-names></name></person-group><article-title>Acute toxicity of nano- and micro-scale zinc powder in healthy adult mice</article-title><source>Toxicol. Lett.</source><year>2006</year><volume>161</volume><fpage>115</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1016/j.toxlet.2005.08.007</pub-id><pub-id pub-id-type="pmid">16165331</pub-id></element-citation></ref><ref id="B99-nanomaterials-12-00238"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yan</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name></person-group><article-title>Comparison of short-term toxicity between Nano-Se and selenite in mice</article-title><source>Life Sci.</source><year>2005</year><volume>76</volume><fpage>1099</fpage><lpage>1109</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2004.08.015</pub-id><pub-id pub-id-type="pmid">15620574</pub-id></element-citation></ref><ref id="B100-nanomaterials-12-00238"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Pan</surname><given-names>J.</given-names></name></person-group><article-title>Baicalin-loaded PEGylated lipid nanoparticles: Characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats</article-title><source>Drug Deliv.</source><year>2016</year><volume>23</volume><fpage>3696</fpage><lpage>3703</lpage><pub-id pub-id-type="doi">10.1080/10717544.2016.1223218</pub-id><pub-id pub-id-type="pmid">27749105</pub-id></element-citation></ref><ref id="B101-nanomaterials-12-00238"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xin</surname><given-names>L.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>H.</given-names></name><name name-style="western"><surname>Qu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Shang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Cui</surname><given-names>X.</given-names></name></person-group><article-title>Regulatory mechanisms of baicalin in cardiovascular diseases: A review</article-title><source>Front. Pharmacol.</source><year>2020</year><volume>11</volume><fpage>583200</fpage><pub-id pub-id-type="doi">10.3389/fphar.2020.583200</pub-id><pub-id pub-id-type="pmid">33224035</pub-id><pub-id pub-id-type="pmcid">PMC7667240</pub-id></element-citation></ref><ref id="B102-nanomaterials-12-00238"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salehi</surname><given-names>B.</given-names></name><name name-style="western"><surname>Prado-Audelo</surname><given-names>D.</given-names></name><name name-style="western"><surname>Mar&#237;a</surname><given-names>L.</given-names></name><name name-style="western"><surname>Cort&#233;s</surname><given-names>H.</given-names></name><name name-style="western"><surname>Leyva-G&#243;mez</surname><given-names>G.</given-names></name><name name-style="western"><surname>Stojanovi&#263;-Radi&#263;</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>Y.D.</given-names></name><name name-style="western"><surname>Patra</surname><given-names>J.K.</given-names></name><name name-style="western"><surname>Das</surname><given-names>G.</given-names></name><name name-style="western"><surname>Martins</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Therapeutic applications of curcumin nanomedicine formulations in cardiovascular diseases</article-title><source>J. Clin. Med.</source><year>2020</year><volume>9</volume><elocation-id>746</elocation-id><pub-id pub-id-type="doi">10.3390/jcm9030746</pub-id><pub-id pub-id-type="pmcid">PMC7141226</pub-id><pub-id pub-id-type="pmid">32164244</pub-id></element-citation></ref><ref id="B103-nanomaterials-12-00238"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bonnefont-Rousselot</surname><given-names>D.</given-names></name></person-group><article-title>Resveratrol and Cardiovascular Diseases</article-title><source>Nutrients</source><year>2016</year><volume>8</volume><elocation-id>250</elocation-id><pub-id pub-id-type="doi">10.3390/nu8050250</pub-id><pub-id pub-id-type="pmcid">PMC4882663</pub-id><pub-id pub-id-type="pmid">27144581</pub-id></element-citation></ref><ref id="B104-nanomaterials-12-00238"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duan</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Dhar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Patel</surname><given-names>C.</given-names></name><name name-style="western"><surname>Khimani</surname><given-names>M.</given-names></name><name name-style="western"><surname>Neogi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>P.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>N.S.</given-names></name><name name-style="western"><surname>Vekariya</surname><given-names>R.L.</given-names></name></person-group><article-title>A brief review on solid lipid nanoparticles: Part and parcel of contemporary drug delivery systems</article-title><source>RSC Adv.</source><year>2020</year><volume>10</volume><fpage>26777</fpage><lpage>26791</lpage><pub-id pub-id-type="doi">10.1039/D0RA03491F</pub-id><pub-id pub-id-type="pmcid">PMC9055574</pub-id><pub-id pub-id-type="pmid">35515778</pub-id></element-citation></ref><ref id="B105-nanomaterials-12-00238"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Tian</surname><given-names>B.</given-names></name><name name-style="western"><surname>Qu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Song</surname><given-names>Y.</given-names></name></person-group><article-title>Pharmacology, toxicity, bioavailability, and formulation of magnolol: An update</article-title><source>Front. Pharmacol.</source><year>2021</year><volume>12</volume><fpage>632767</fpage><pub-id pub-id-type="doi">10.3389/fphar.2021.632767</pub-id><pub-id pub-id-type="pmid">33815113</pub-id><pub-id pub-id-type="pmcid">PMC8010308</pub-id></element-citation></ref><ref id="B106-nanomaterials-12-00238"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>C.Y.-C.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>C.-H.</given-names></name></person-group><article-title>Magnolol encapsulated by liposome in inhibiting smooth muscle cell proliferation</article-title><source>J. Chin. Chem. Soc.</source><year>2008</year><volume>55</volume><fpage>517</fpage><lpage>521</lpage><pub-id pub-id-type="doi">10.1002/jccs.200800076</pub-id></element-citation></ref><ref id="B107-nanomaterials-12-00238"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duong</surname><given-names>T.</given-names></name><name name-style="western"><surname>Isom&#228;ki</surname><given-names>A.</given-names></name><name name-style="western"><surname>Paaver</surname><given-names>U.</given-names></name><name name-style="western"><surname>Laidm&#228;e</surname><given-names>I.</given-names></name><name name-style="western"><surname>T&#245;nisoo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Yen</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kogermann</surname><given-names>K.</given-names></name><name name-style="western"><surname>Raal</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hein&#228;m&#228;ki</surname><given-names>J.</given-names></name><name name-style="western"><surname>Pham</surname><given-names>T.-M.-H.</given-names></name></person-group><article-title>Nanoformulation and evaluation of oral berberine-loaded liposomes</article-title><source>Molecules</source><year>2021</year><volume>26</volume><elocation-id>2591</elocation-id><pub-id pub-id-type="doi">10.3390/molecules26092591</pub-id><pub-id pub-id-type="pmid">33946815</pub-id><pub-id pub-id-type="pmcid">PMC8125214</pub-id></element-citation></ref><ref id="B108-nanomaterials-12-00238"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>GBD 2015 Mortality and causes of death collaborators</collab></person-group><article-title>Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980&#8211;2015: A systematic analysis for the Global Burden of Disease Study 2015</article-title><source>Lancet</source><year>2016</year><volume>388</volume><fpage>1459</fpage><lpage>1544</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(16)31012-1</pub-id><pub-id pub-id-type="pmid">27733281</pub-id><pub-id pub-id-type="pmcid">PMC5388903</pub-id></element-citation></ref><ref id="B109-nanomaterials-12-00238"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burney</surname><given-names>P.G.</given-names></name><name name-style="western"><surname>Patel</surname><given-names>J.</given-names></name><name name-style="western"><surname>Newson</surname><given-names>R.</given-names></name><name name-style="western"><surname>Minelli</surname><given-names>C.</given-names></name><name name-style="western"><surname>Naghavi</surname><given-names>M.</given-names></name></person-group><article-title>Global and regional trends in COPD mortality, 1990&#8211;2010</article-title><source>Eur. Respir. J.</source><year>2015</year><volume>45</volume><fpage>1239</fpage><lpage>1247</lpage><pub-id pub-id-type="doi">10.1183/09031936.00142414</pub-id><pub-id pub-id-type="pmid">25837037</pub-id><pub-id pub-id-type="pmcid">PMC4531307</pub-id></element-citation></ref><ref id="B110-nanomaterials-12-00238"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pearce</surname><given-names>N.</given-names></name><name name-style="western"><surname>A&#239;t-Khaled</surname><given-names>N.</given-names></name><name name-style="western"><surname>Beasley</surname><given-names>R.</given-names></name><name name-style="western"><surname>Mallol</surname><given-names>J.</given-names></name><name name-style="western"><surname>Keil</surname><given-names>U.</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>E.</given-names></name><name name-style="western"><surname>Robertson</surname><given-names>C.</given-names></name><collab>the ISAAC Phase Three Study Group</collab></person-group><article-title>Worldwide trends in the prevalence of asthma symptoms: Phase III of the international study of asthma and allergies in childhood (ISAAC)</article-title><source>Thorax</source><year>2007</year><volume>62</volume><fpage>758</fpage><lpage>766</lpage><pub-id pub-id-type="doi">10.1136/thx.2006.070169</pub-id><pub-id pub-id-type="pmid">17504817</pub-id><pub-id pub-id-type="pmcid">PMC2117323</pub-id></element-citation></ref><ref id="B111-nanomaterials-12-00238"><label>111.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Global asthma network</collab></person-group><source>The Global Asthma Report 2014</source><publisher-name>Global Asthma Network</publisher-name><publisher-loc>Auckland, New Zealand</publisher-loc><year>2014</year><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://globalasthmareport.org/2014/Global_Asthma_Report_2014.pdf" ext-link-type="uri">http://globalasthmareport.org/2014/Global_Asthma_Report_2014.pdf</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2022-01-04">(accessed on 4 January 2022)</date-in-citation></element-citation></ref><ref id="B112-nanomaterials-12-00238"><label>112.</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>World Health Organization (WHO)</collab></person-group><article-title>Up to 650,000 People die of respiratory diseases linked to seasonal Ffu each year</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/news/item/13-12-2017-up-to-650-000-people-die-of-respiratory-diseases-linked-to-seasonal-flu-each-year" ext-link-type="uri">https://www.who.int/news/item/13-12-2017-up-to-650-000-people-die-of-respiratory-diseases-linked-to-seasonal-flu-each-year</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2021-04-02">(accessed on 2 April 2021)</date-in-citation></element-citation></ref><ref id="B113-nanomaterials-12-00238"><label>113.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>WHO</collab></person-group><source>Global Tuberculosis Report 2019</source><publisher-name>WHO</publisher-name><publisher-loc>Geneva, Switzerland</publisher-loc><year>2019</year><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/publications/i/item/9789241565714" ext-link-type="uri">https://www.who.int/publications/i/item/9789241565714</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2022-01-04">(accessed on 4 January 2022)</date-in-citation></element-citation></ref><ref id="B114-nanomaterials-12-00238"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vestbo</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hurd</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Agust&#237;</surname><given-names>A.G.</given-names></name><name name-style="western"><surname>Jones</surname><given-names>P.W.</given-names></name><name name-style="western"><surname>Vogelmeier</surname><given-names>C.</given-names></name><name name-style="western"><surname>Anzueto</surname><given-names>A.</given-names></name><name name-style="western"><surname>Barnes</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Fabbri</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Martinez</surname><given-names>F.J.</given-names></name><name name-style="western"><surname>Nishimura</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease GOLD executive summary</article-title><source>Am. J. Respir. Crit. Care Med.</source><year>2013</year><volume>187</volume><fpage>347</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1164/rccm.201204-0596PP</pub-id><pub-id pub-id-type="pmid">22878278</pub-id></element-citation></ref><ref id="B115-nanomaterials-12-00238"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mei</surname><given-names>D.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>W.S.D.</given-names></name><name name-style="western"><surname>Tay</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Mukhopadhyay</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>W.F.</given-names></name></person-group><article-title>Therapeutic RNA strategies for chronic obstructive pulmonary disease</article-title><source>Trends Pharmacol. Sci.</source><year>2020</year><volume>41</volume><fpage>475</fpage><lpage>486</lpage><pub-id pub-id-type="doi">10.1016/j.tips.2020.04.007</pub-id><pub-id pub-id-type="pmid">32434654</pub-id></element-citation></ref><ref id="B116-nanomaterials-12-00238"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gredic</surname><given-names>M.</given-names></name><name name-style="western"><surname>Blanco</surname><given-names>I.</given-names></name><name name-style="western"><surname>Kovacs</surname><given-names>G.</given-names></name><name name-style="western"><surname>Helyes</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Ferdinandy</surname><given-names>P.</given-names></name><name name-style="western"><surname>Olschewski</surname><given-names>H.</given-names></name><name name-style="western"><surname>Barber&#224;</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Weissmann</surname><given-names>N.</given-names></name></person-group><article-title>Pulmonary hypertension in chronic obstructive pulmonary disease</article-title><source>Br. J. Pharmacol.</source><year>2021</year><volume>178</volume><fpage>132</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1111/bph.14979</pub-id><pub-id pub-id-type="pmid">31976545</pub-id></element-citation></ref><ref id="B117-nanomaterials-12-00238"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lo</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Tsang</surname><given-names>T.H.</given-names></name><name name-style="western"><surname>Leung</surname><given-names>Y.-H.</given-names></name><name name-style="western"><surname>Yeung</surname><given-names>E.Y.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Lim</surname><given-names>W.W.</given-names></name></person-group><article-title>Respiratory infections during SARS outbreak, Hong Kong, 2003</article-title><source>Emerg. Infect. Dis.</source><year>2005</year><volume>11</volume><fpage>1738</fpage><lpage>1741</lpage><pub-id pub-id-type="doi">10.3201/eid1111.050729</pub-id><pub-id pub-id-type="pmid">16318726</pub-id><pub-id pub-id-type="pmcid">PMC3367357</pub-id></element-citation></ref><ref id="B118-nanomaterials-12-00238"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Panagea</surname><given-names>S.</given-names></name><name name-style="western"><surname>Winstanley</surname><given-names>C.</given-names></name><name name-style="western"><surname>Walshaw</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ledson</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hart</surname><given-names>C.</given-names></name></person-group><article-title>Environmental contamination with an epidemic strain of <italic toggle="yes">Pseudomonas aeruginosa</italic> in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces</article-title><source>J. Hosp. Infect.</source><year>2005</year><volume>59</volume><fpage>102</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1016/j.jhin.2004.09.018</pub-id><pub-id pub-id-type="pmid">15620443</pub-id></element-citation></ref><ref id="B119-nanomaterials-12-00238"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Robinson</surname><given-names>P.</given-names></name><name name-style="western"><surname>Carzino</surname><given-names>R.</given-names></name><name name-style="western"><surname>Armstrong</surname><given-names>D.</given-names></name><name name-style="western"><surname>Olinsky</surname><given-names>A.</given-names></name></person-group><article-title><italic toggle="yes">Pseudomonas</italic> cross-infection from cystic fibrosis patients to non-cystic fibrosis patients: Implications for inpatient care of respiratory patients</article-title><source>J. Clin. Microbiol.</source><year>2003</year><volume>41</volume><fpage>5741</fpage><pub-id pub-id-type="doi">10.1128/JCM.41.12.5741.2003</pub-id><pub-id pub-id-type="pmid">14662972</pub-id><pub-id pub-id-type="pmcid">PMC309033</pub-id></element-citation></ref><ref id="B120-nanomaterials-12-00238"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bloemendaal</surname><given-names>A.L.A.</given-names></name><name name-style="western"><surname>Fluit</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Jansen</surname><given-names>W.M.T.</given-names></name><name name-style="western"><surname>Vriens</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Ferry</surname><given-names>T.</given-names></name><name name-style="western"><surname>Argaud</surname><given-names>L.</given-names></name><name name-style="western"><surname>Amorim</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Resende</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Pascual</surname><given-names>A.</given-names></name><name name-style="western"><surname>L&#243;pez-Cerero</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Acquisition and cross-transmission of <italic toggle="yes">Staphylococcus aureus</italic> in European intensive care units</article-title><source>Infect. Control. Hosp. Epidemiol.</source><year>2009</year><volume>30</volume><fpage>117</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1086/593126</pub-id><pub-id pub-id-type="pmid">19133819</pub-id></element-citation></ref><ref id="B121-nanomaterials-12-00238"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boccia</surname><given-names>S.</given-names></name><name name-style="western"><surname>Laurenti</surname><given-names>P.</given-names></name><name name-style="western"><surname>Borella</surname><given-names>P.</given-names></name><name name-style="western"><surname>Moscato</surname><given-names>U.</given-names></name><name name-style="western"><surname>Capalbo</surname><given-names>G.</given-names></name><name name-style="western"><surname>Cambieri</surname><given-names>A.</given-names></name><name name-style="western"><surname>Amore</surname><given-names>R.</given-names></name><name name-style="western"><surname>Quaranta</surname><given-names>G.</given-names></name><name name-style="western"><surname>Boninti</surname><given-names>F.</given-names></name><name name-style="western"><surname>Orsini</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Prospective 3-year surveillance for nosocomial and environmental <italic toggle="yes">Legionella pneumophila</italic>: Implications for infection control</article-title><source>Infect. Control. Hosp. Epidemiol.</source><year>2006</year><volume>27</volume><fpage>459</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1086/503642</pub-id><pub-id pub-id-type="pmid">16671026</pub-id></element-citation></ref><ref id="B122-nanomaterials-12-00238"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sherertz</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Belani</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kramer</surname><given-names>B.S.</given-names></name><name name-style="western"><surname>Elfenbein</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Weiner</surname><given-names>R.S.</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>R.G.</given-names></name><name name-style="western"><surname>Samsa</surname><given-names>G.P.</given-names></name></person-group><article-title>Impact of air filtration on nosocomial <italic toggle="yes">Aspergillus</italic> infections: Unique risk of bone marrow transplant recipients</article-title><source>Am. J. Med.</source><year>1987</year><volume>83</volume><fpage>709</fpage><lpage>718</lpage><pub-id pub-id-type="doi">10.1016/0002-9343(87)90902-8</pub-id><pub-id pub-id-type="pmid">3314494</pub-id></element-citation></ref><ref id="B123-nanomaterials-12-00238"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Passamonte</surname><given-names>P.M.</given-names></name><name name-style="western"><surname>Dix</surname><given-names>J.D.</given-names></name></person-group><article-title>Nosocomial pulmonary mucormycosis with fatal massive hemoptysis</article-title><source>Am. J. Med Sci.</source><year>1985</year><volume>289</volume><fpage>65</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1097/00000441-198502000-00005</pub-id><pub-id pub-id-type="pmid">3976712</pub-id></element-citation></ref><ref id="B124-nanomaterials-12-00238"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Suzuki</surname><given-names>T.</given-names></name><name name-style="western"><surname>Tahara</surname><given-names>H.</given-names></name><name name-style="western"><surname>Narula</surname><given-names>S.</given-names></name><name name-style="western"><surname>Moore</surname><given-names>K.W.</given-names></name><name name-style="western"><surname>Robbins</surname><given-names>P.D.</given-names></name><name name-style="western"><surname>Lotze</surname><given-names>M.T.</given-names></name></person-group><article-title>Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors</article-title><source>J. Exp. Med.</source><year>1995</year><volume>182</volume><fpage>477</fpage><lpage>486</lpage><pub-id pub-id-type="doi">10.1084/jem.182.2.477</pub-id><pub-id pub-id-type="pmid">7629507</pub-id><pub-id pub-id-type="pmcid">PMC2192135</pub-id></element-citation></ref><ref id="B125-nanomaterials-12-00238"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hsueh</surname><given-names>P.</given-names></name><name name-style="western"><surname>Tseng</surname><given-names>S.</given-names></name><name name-style="western"><surname>Teng</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>S.</given-names></name></person-group><article-title>Pan-drug-resistant <italic toggle="yes">Pseudomonas aeruginosa</italic> causing nosocomial infection at a university hospital in Taiwan</article-title><source>Clin. Microbiol. Infect.</source><year>2005</year><volume>11</volume><fpage>670</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.1111/j.1469-0691.2005.01196.x</pub-id><pub-id pub-id-type="pmid">16008621</pub-id></element-citation></ref><ref id="B126-nanomaterials-12-00238"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yew</surname><given-names>W.W.</given-names></name><name name-style="western"><surname>Leung</surname><given-names>C.C.</given-names></name></person-group><article-title>Management of multidrug-resistant tuberculosis: Update 2007</article-title><source>Respirology.</source><year>2007</year><volume>13</volume><fpage>21</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1843.2007.01180.x</pub-id><pub-id pub-id-type="pmid">18197909</pub-id></element-citation></ref><ref id="B127-nanomaterials-12-00238"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kallen</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Brunkard</surname><given-names>J.</given-names></name><name name-style="western"><surname>Moore</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Budge</surname><given-names>P.</given-names></name><name name-style="western"><surname>Arnold</surname><given-names>K.E.</given-names></name><name name-style="western"><surname>Fosheim</surname><given-names>G.</given-names></name><name name-style="western"><surname>Finelli</surname><given-names>L.</given-names></name><name name-style="western"><surname>Beekmann</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Polgreen</surname><given-names>P.</given-names></name><name name-style="western"><surname>Gorwitz</surname><given-names>R.</given-names></name><etal/></person-group><article-title><italic toggle="yes">Staphylococcus aureus</italic> community-acquired pneumonia during the 2006 to 2007 influenza season</article-title><source>Ann. Emerg. Med.</source><year>2009</year><volume>53</volume><fpage>358</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1016/j.annemergmed.2008.04.027</pub-id><pub-id pub-id-type="pmid">18534715</pub-id></element-citation></ref><ref id="B128-nanomaterials-12-00238"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lackenby</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hungnes</surname><given-names>O.</given-names></name><name name-style="western"><surname>Dudman</surname><given-names>S.G.</given-names></name><name name-style="western"><surname>Meijer</surname><given-names>A.</given-names></name><name name-style="western"><surname>Paget</surname><given-names>W.J.</given-names></name><name name-style="western"><surname>Hay</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Zambon</surname><given-names>M.C.</given-names></name></person-group><article-title>Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe</article-title><source>Eurosurveillance</source><year>2008</year><volume>13</volume><fpage>3</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.2807/ese.13.05.08026-en</pub-id><pub-id pub-id-type="pmid">18445375</pub-id></element-citation></ref><ref id="B129-nanomaterials-12-00238"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Lian</surname><given-names>X.</given-names></name><name name-style="western"><surname>Su</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Marraro</surname><given-names>G.A.</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Y.</given-names></name></person-group><article-title>From SARS and MERS to COVID-19: A brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses</article-title><source>Respir. Res.</source><year>2020</year><volume>21</volume><fpage>224</fpage><pub-id pub-id-type="doi">10.1186/s12931-020-01479-w</pub-id><pub-id pub-id-type="pmid">32854739</pub-id><pub-id pub-id-type="pmcid">PMC7450684</pub-id></element-citation></ref><ref id="B130-nanomaterials-12-00238"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomson</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Yew</surname><given-names>W.-W.</given-names></name></person-group><article-title>When and how to treat pulmonary non-tuberculous mycobacterial diseases</article-title><source>Respirology</source><year>2009</year><volume>14</volume><fpage>12</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1843.2008.01408.x</pub-id><pub-id pub-id-type="pmid">19144045</pub-id></element-citation></ref><ref id="B131-nanomaterials-12-00238"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>R.</given-names></name><name name-style="western"><surname>Smitha</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>S.P.</given-names></name></person-group><article-title>The Role of Nanotechnology in combating multi-drug resistant bacteria</article-title><source>J. Nanosci. Nanotechnol.</source><year>2014</year><volume>14</volume><fpage>4745</fpage><lpage>4756</lpage><pub-id pub-id-type="doi">10.1166/jnn.2014.9527</pub-id><pub-id pub-id-type="pmid">24757944</pub-id></element-citation></ref><ref id="B132-nanomaterials-12-00238"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Natan</surname><given-names>M.</given-names></name><name name-style="western"><surname>Banin</surname><given-names>E.</given-names></name></person-group><article-title>From Nano to Micro: Using nanotechnology to combat microorganisms and their multidrug resistance</article-title><source>FEMS Microbiol. Rev.</source><year>2017</year><volume>41</volume><fpage>302</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1093/femsre/fux003</pub-id><pub-id pub-id-type="pmid">28419240</pub-id></element-citation></ref><ref id="B133-nanomaterials-12-00238"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hayat</surname><given-names>S.</given-names></name><name name-style="western"><surname>Muzammil</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fakhar-E-Alam</surname><given-names>M.</given-names></name><name name-style="western"><surname>Aslam</surname><given-names>B.</given-names></name><name name-style="western"><surname>Siddique</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Nisar</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Saqalein</surname><given-names>M.</given-names></name><name name-style="western"><surname>Atif</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sarwar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Khurshid</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Nanoantibiotics future nanotechnologies to combat antibiotic resistance</article-title><source>Front. Biosci.</source><year>2018</year><volume>10</volume><fpage>352</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.2741/e827</pub-id><pub-id pub-id-type="pmid">29293463</pub-id></element-citation></ref><ref id="B134-nanomaterials-12-00238"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Slavin</surname><given-names>Y.N.</given-names></name><name name-style="western"><surname>Asnis</surname><given-names>J.</given-names></name><name name-style="western"><surname>H&#228;feli</surname><given-names>U.O.</given-names></name><name name-style="western"><surname>Bach</surname><given-names>H.</given-names></name></person-group><article-title>Metal nanoparticles: Understanding the mechanisms behind antibacterial activity</article-title><source>J. Nanobiotechnol.</source><year>2017</year><volume>15</volume><fpage>65</fpage><pub-id pub-id-type="doi">10.1186/s12951-017-0308-z</pub-id><pub-id pub-id-type="pmid">28974225</pub-id><pub-id pub-id-type="pmcid">PMC5627441</pub-id></element-citation></ref><ref id="B135-nanomaterials-12-00238"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Borase</surname><given-names>H.P.</given-names></name><name name-style="western"><surname>Salunke</surname><given-names>B.K.</given-names></name><name name-style="western"><surname>Salunkhe</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>Patil</surname><given-names>C.D.</given-names></name><name name-style="western"><surname>Hallsworth</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>B.S.</given-names></name><name name-style="western"><surname>Patil</surname><given-names>S.V.</given-names></name></person-group><article-title>Plant Extract: A Promising biomatrix for ecofriendly, controlled synthesis of silver nanoparticles</article-title><source>Appl. Biochem. Biotechnol.</source><year>2014</year><volume>173</volume><fpage>1</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1007/s12010-014-0831-4</pub-id><pub-id pub-id-type="pmid">24622849</pub-id></element-citation></ref><ref id="B136-nanomaterials-12-00238"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohammadinejad</surname><given-names>R.</given-names></name><name name-style="western"><surname>Shavandi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Raie</surname><given-names>D.S.</given-names></name><name name-style="western"><surname>Sangeetha</surname><given-names>J.</given-names></name><name name-style="western"><surname>Soleimani</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hajibehzad</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Thangadurai</surname><given-names>D.</given-names></name><name name-style="western"><surname>Hospet</surname><given-names>R.</given-names></name><name name-style="western"><surname>Popoola</surname><given-names>J.O.</given-names></name><name name-style="western"><surname>Arzani</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Plant molecular farming: Production of metallic nanoparticles and therapeutic proteins using green factories</article-title><source>Green Chem.</source><year>2019</year><volume>21</volume><fpage>1845</fpage><lpage>1865</lpage><pub-id pub-id-type="doi">10.1039/C9GC00335E</pub-id></element-citation></ref><ref id="B137-nanomaterials-12-00238"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iravani</surname><given-names>S.</given-names></name></person-group><article-title>Green synthesis of metal nanoparticles using plants</article-title><source>Green Chem.</source><year>2011</year><volume>13</volume><fpage>2638</fpage><lpage>2650</lpage><pub-id pub-id-type="doi">10.1039/c1gc15386b</pub-id></element-citation></ref><ref id="B138-nanomaterials-12-00238"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mittal</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Chisti</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Banerjee</surname><given-names>U.C.</given-names></name></person-group><article-title>Synthesis of metallic nanoparticles using plant extracts</article-title><source>Biotechnol. Adv.</source><year>2013</year><volume>31</volume><fpage>346</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1016/j.biotechadv.2013.01.003</pub-id><pub-id pub-id-type="pmid">23318667</pub-id></element-citation></ref><ref id="B139-nanomaterials-12-00238"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>S.Y.</given-names></name><name name-style="western"><surname>Krishnamurthy</surname><given-names>S.</given-names></name><name name-style="western"><surname>Cho</surname><given-names>C.-W.</given-names></name><name name-style="western"><surname>Yun</surname><given-names>Y.-S.</given-names></name></person-group><article-title>Biosynthesis of gold nanoparticles Using <italic toggle="yes">Ocimum sanctum</italic> extracts by solvents with different polarity</article-title><source>ACS Sustain. Chem. Eng.</source><year>2016</year><volume>4</volume><fpage>2651</fpage><lpage>2659</lpage><pub-id pub-id-type="doi">10.1021/acssuschemeng.6b00161</pub-id></element-citation></ref><ref id="B140-nanomaterials-12-00238"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>L&#252;</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H.</given-names></name></person-group><article-title>Silver nanoparticles synthesized using <italic toggle="yes">Eucommia ulmoides</italic> bark and their antibacterial efficacy</article-title><source>Mater. Lett.</source><year>2017</year><volume>196</volume><fpage>217</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1016/j.matlet.2017.03.068</pub-id></element-citation></ref><ref id="B141-nanomaterials-12-00238"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aiad</surname><given-names>I.</given-names></name><name name-style="western"><surname>Marzouk</surname><given-names>M.</given-names></name><name name-style="western"><surname>Shaker</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Ebrahim</surname><given-names>N.E.</given-names></name><name name-style="western"><surname>Abd-Elaal</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tawfik</surname><given-names>S.M.</given-names></name></person-group><article-title>Antipyrine cationic surfactants capping silver nanoparticles as potent antimicrobial agents against pathogenic bacteria and fungi</article-title><source>J. Mol. Liq.</source><year>2017</year><volume>243</volume><fpage>572</fpage><lpage>583</lpage><pub-id pub-id-type="doi">10.1016/j.molliq.2017.08.072</pub-id></element-citation></ref><ref id="B142-nanomaterials-12-00238"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuppusamy</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ichwan</surname><given-names>S.J.A.</given-names></name><name name-style="western"><surname>Parine</surname><given-names>N.R.</given-names></name><name name-style="western"><surname>Yusoff</surname><given-names>M.</given-names></name><name name-style="western"><surname>Maniam</surname><given-names>G.P.</given-names></name><name name-style="western"><surname>Govindan</surname><given-names>N.</given-names></name></person-group><article-title>Intracellular biosynthesis of Au and Ag nanoparticles using ethanolic extract of <italic toggle="yes">Brassica oleracea</italic> L. and studies on their physicochemical and biological properties</article-title><source>J. Environ. Sci.</source><year>2015</year><volume>29</volume><fpage>151</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1016/j.jes.2014.06.050</pub-id><pub-id pub-id-type="pmid">25766024</pub-id></element-citation></ref><ref id="B143-nanomaterials-12-00238"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosa</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Silva</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Sanches</surname><given-names>I.S.</given-names></name><name name-style="western"><surname>Henriques</surname><given-names>C.</given-names></name></person-group><article-title>Simultaneous photo-induced cross-linking and silver nanoparticle formation in a PVP electrospun wound dressing</article-title><source>Mater. Lett.</source><year>2017</year><volume>207</volume><fpage>145</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1016/j.matlet.2017.07.046</pub-id></element-citation></ref><ref id="B144-nanomaterials-12-00238"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huy</surname><given-names>T.Q.</given-names></name><name name-style="western"><surname>Thanh</surname><given-names>N.T.H.</given-names></name><name name-style="western"><surname>Thuy</surname><given-names>N.T.</given-names></name><name name-style="western"><surname>Van Chung</surname><given-names>P.</given-names></name><name name-style="western"><surname>Hung</surname><given-names>P.N.</given-names></name><name name-style="western"><surname>Le</surname><given-names>A.-T.</given-names></name></person-group><article-title>Cytotoxicity and antiviral activity of electrochemical-synthesized silver nanoparticles against poliovirus</article-title><source>J. Virol. Methods</source><year>2017</year><volume>241</volume><fpage>52</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.jviromet.2016.12.015</pub-id><pub-id pub-id-type="pmid">28040515</pub-id></element-citation></ref><ref id="B145-nanomaterials-12-00238"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jannat</surname><given-names>K.</given-names></name><name name-style="western"><surname>Paul</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Bondhon</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Hasan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Nawaz</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jahan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Mahboob</surname><given-names>T.</given-names></name><name name-style="western"><surname>Nissapatorn</surname><given-names>V.</given-names></name><name name-style="western"><surname>Wilairatana</surname><given-names>P.</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>M.D.L.</given-names></name><etal/></person-group><article-title>Nanotechnology applications of flavonoids for viral diseases</article-title><source>Pharmaceutics</source><year>2021</year><volume>13</volume><elocation-id>1895</elocation-id><pub-id pub-id-type="doi">10.3390/pharmaceutics13111895</pub-id><pub-id pub-id-type="pmid">34834309</pub-id><pub-id pub-id-type="pmcid">PMC8625292</pub-id></element-citation></ref><ref id="B146-nanomaterials-12-00238"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sofy</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Hmed</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>El Haliem</surname><given-names>N.F.A.</given-names></name><name name-style="western"><surname>Zein</surname><given-names>M.A.-E.</given-names></name><name name-style="western"><surname>Elshaarawy</surname><given-names>R.F.</given-names></name></person-group><article-title>Polyphosphonium-oligochitosans decorated with nanosilver as new prospective inhibitors for common human enteric viruses</article-title><source>Carbohydr. Polym.</source><year>2019</year><volume>226</volume><fpage>115261</fpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2019.115261</pub-id><pub-id pub-id-type="pmid">31582052</pub-id></element-citation></ref><ref id="B147-nanomaterials-12-00238"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>M.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Deng</surname><given-names>N.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>B.</given-names></name></person-group><article-title>Delivery of VP1 siRNA to inhibit the EV71 virus using functionalized silver nanoparticles through ROS-mediated signaling pathways</article-title><source>RSC Adv.</source><year>2017</year><volume>7</volume><fpage>1453</fpage><lpage>1463</lpage><pub-id pub-id-type="doi">10.1039/C6RA26472G</pub-id></element-citation></ref><ref id="B148-nanomaterials-12-00238"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>X.X.</given-names></name><name name-style="western"><surname>Li</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>C.Z.</given-names></name></person-group><article-title>Curcumin modified silver nanoparticles for highly efficient inhibition of respiratory syncytial virus infection</article-title><source>Nanoscale</source><year>2016</year><volume>8</volume><fpage>3040</fpage><lpage>3048</lpage><pub-id pub-id-type="doi">10.1039/C5NR07918G</pub-id><pub-id pub-id-type="pmid">26781043</pub-id></element-citation></ref><ref id="B149-nanomaterials-12-00238"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>M.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Hua</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>B.</given-names></name></person-group><article-title>Silver Nanoparticle based codelivery of ooeltamivir to inhibit the activity of the H1N1 influenza virus through ROS-mediated signaling pathways</article-title><source>ACS Appl. Mater. Interfaces</source><year>2016</year><volume>8</volume><fpage>24385</fpage><lpage>24393</lpage><pub-id pub-id-type="doi">10.1021/acsami.6b06613</pub-id><pub-id pub-id-type="pmid">27588566</pub-id></element-citation></ref><ref id="B150-nanomaterials-12-00238"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Du</surname><given-names>T.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Dong</surname><given-names>N.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Fang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>S.</given-names></name><name name-style="western"><surname>Han</surname><given-names>H.</given-names></name></person-group><article-title>Glutathione-capped Ag2S nanoclusters inhibit coronavirus proliferation through blockage of viral RNA synthesis and budding</article-title><source>ACS Appl. Mater. Interfaces</source><year>2018</year><volume>10</volume><fpage>4369</fpage><lpage>4378</lpage><pub-id pub-id-type="doi">10.1021/acsami.7b13811</pub-id><pub-id pub-id-type="pmid">29337529</pub-id></element-citation></ref><ref id="B151-nanomaterials-12-00238"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tavakoli</surname><given-names>F.</given-names></name><name name-style="western"><surname>Salavati-Niasari</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ghanbari</surname><given-names>D.</given-names></name><name name-style="western"><surname>Saberyan</surname><given-names>K.</given-names></name><name name-style="western"><surname>Mashkani</surname><given-names>S.M.H.</given-names></name></person-group><article-title>Application of glucose as a green capping agent and reductant to fabricate CuI micro/nanostructures</article-title><source>Mater. Res. Bull.</source><year>2014</year><volume>49</volume><fpage>14</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.materresbull.2013.08.037</pub-id></element-citation></ref><ref id="B152-nanomaterials-12-00238"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gholami</surname><given-names>T.</given-names></name><name name-style="western"><surname>Salavati-Niasari</surname><given-names>M.</given-names></name><name name-style="western"><surname>Varshoy</surname><given-names>S.</given-names></name></person-group><article-title>Investigation of the electrochemical hydrogen storage and photocatalytic properties of CoAl<sub>2</sub>O<sub>4</sub> pigment: Green synthesis and characterization</article-title><source>Int. J. Hydrogen Energy</source><year>2016</year><volume>41</volume><fpage>9418</fpage><lpage>9426</lpage><pub-id pub-id-type="doi">10.1016/j.ijhydene.2016.03.144</pub-id></element-citation></ref><ref id="B153-nanomaterials-12-00238"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verma</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mehata</surname><given-names>M.</given-names></name></person-group><article-title>Controllable synthesis of silver nanoparticles using Neem leaves and their antimicrobial activity</article-title><source>J. Radiat. Res. Appl. Sci.</source><year>2016</year><volume>9</volume><fpage>109</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1016/j.jrras.2015.11.001</pub-id></element-citation></ref><ref id="B154-nanomaterials-12-00238"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Banerjee</surname><given-names>P.</given-names></name><name name-style="western"><surname>Satapathy</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mukhopahayay</surname><given-names>A.</given-names></name><name name-style="western"><surname>Das</surname><given-names>P.</given-names></name></person-group><article-title>Leaf extract mediated green synthesis of silver nanoparticles from widely available Indian plants: Synthesis, characterization, antimicrobial property and toxicity analysis</article-title><source>Bioresour. Bioprocess.</source><year>2014</year><volume>1</volume><fpage>3</fpage><pub-id pub-id-type="doi">10.1186/s40643-014-0003-y</pub-id></element-citation></ref><ref id="B155-nanomaterials-12-00238"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saware</surname><given-names>K.</given-names></name><name name-style="western"><surname>Venkataraman</surname><given-names>A.</given-names></name></person-group><article-title>Biosynthesis and characterization of stable silver nanoparticles Using <italic toggle="yes">Ficus religiosa</italic> leaf extract: A mechanism perspective</article-title><source>J. Clust. Sci.</source><year>2014</year><volume>25</volume><fpage>1157</fpage><lpage>1171</lpage><pub-id pub-id-type="doi">10.1007/s10876-014-0697-1</pub-id></element-citation></ref><ref id="B156-nanomaterials-12-00238"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jha</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Prasad</surname><given-names>K.</given-names></name><name name-style="western"><surname>Prasad</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kulkarni</surname><given-names>A.</given-names></name></person-group><article-title>Plant system: Nature&#8217;s nanofactory</article-title><source>Colloids Surf. B Biointerfaces</source><year>2009</year><volume>73</volume><fpage>219</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1016/j.colsurfb.2009.05.018</pub-id><pub-id pub-id-type="pmid">19539452</pub-id></element-citation></ref><ref id="B157-nanomaterials-12-00238"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bartczak</surname><given-names>D.</given-names></name><name name-style="western"><surname>Muskens</surname><given-names>O.L.</given-names></name><name name-style="western"><surname>Sanchez-Elsner</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kanaras</surname><given-names>A.G.</given-names></name><name name-style="western"><surname>Millar</surname><given-names>T.M.</given-names></name></person-group><article-title>Manipulation of in vitro angiogenesis using peptide-coated gold nanoparticles</article-title><source>ACS Nano</source><year>2013</year><volume>7</volume><fpage>5628</fpage><lpage>5636</lpage><pub-id pub-id-type="doi">10.1021/nn402111z</pub-id><pub-id pub-id-type="pmid">23713973</pub-id></element-citation></ref><ref id="B158-nanomaterials-12-00238"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>El-Gaffary</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bashandy</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>El-Borady</surname><given-names>O.M.</given-names></name></person-group><article-title>Self-assembled gold nanoparticles for in-vitro inhibition of bovine viral diarrhea virus as surrogate model for HCV</article-title><source>Mater. Res. Express</source><year>2019</year><volume>6</volume><fpage>075075</fpage><pub-id pub-id-type="doi">10.1088/2053-1591/ab18b6</pub-id></element-citation></ref><ref id="B159-nanomaterials-12-00238"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sametband</surname><given-names>M.</given-names></name><name name-style="western"><surname>Shukla</surname><given-names>S.</given-names></name><name name-style="western"><surname>Meningher</surname><given-names>T.</given-names></name><name name-style="western"><surname>Hirsh</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mendelson</surname><given-names>E.</given-names></name><name name-style="western"><surname>Sarid</surname><given-names>R.</given-names></name><name name-style="western"><surname>Gedanken</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mandelboim</surname><given-names>M.</given-names></name></person-group><article-title>Effective multi-strain inhibition of influenza virus by anionic gold nanoparticles</article-title><source>Med. Chem. Comm.</source><year>2011</year><volume>2</volume><fpage>421</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1039/c0md00229a</pub-id></element-citation></ref><ref id="B160-nanomaterials-12-00238"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Botteon</surname><given-names>C.E.A.</given-names></name><name name-style="western"><surname>Silva</surname><given-names>L.B.</given-names></name><name name-style="western"><surname>Ccana-Ccapatinta</surname><given-names>G.V.</given-names></name><name name-style="western"><surname>Silva</surname><given-names>T.S.</given-names></name><name name-style="western"><surname>Ambrosio</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>Veneziani</surname><given-names>R.C.S.</given-names></name><name name-style="western"><surname>Bastos</surname><given-names>J.K.</given-names></name><name name-style="western"><surname>Marcato</surname><given-names>P.D.</given-names></name></person-group><article-title>Biosynthesis and characterization of gold nanoparticles using Brazilian red propolis and evaluation of its antimicrobial and anticancer activities</article-title><source>Sci. Rep.</source><year>2021</year><volume>11</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1038/s41598-021-81281-w</pub-id><pub-id pub-id-type="pmid">33479338</pub-id><pub-id pub-id-type="pmcid">PMC7820602</pub-id></element-citation></ref><ref id="B161-nanomaterials-12-00238"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haimov</surname><given-names>E.</given-names></name><name name-style="western"><surname>Weitman</surname><given-names>H.</given-names></name><name name-style="western"><surname>Polani</surname><given-names>S.</given-names></name><name name-style="western"><surname>Schori</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zitoun</surname><given-names>D.</given-names></name><name name-style="western"><surname>Shefi</surname><given-names>O.</given-names></name></person-group><article-title>Meso-tetrahydroxyphenylchlorin-conjugated gold nanoparticles as a tool To improve photodynamic therapy</article-title><source>ACS Appl. Mater. Interfaces</source><year>2018</year><volume>10</volume><fpage>2319</fpage><lpage>2327</lpage><pub-id pub-id-type="doi">10.1021/acsami.7b16455</pub-id><pub-id pub-id-type="pmid">29298037</pub-id></element-citation></ref><ref id="B162-nanomaterials-12-00238"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>E.C.</given-names></name><name name-style="western"><surname>Davis-Poynter</surname><given-names>N.</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>C.T.H.</given-names></name><name name-style="western"><surname>Peters</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Monteith</surname><given-names>G.R.</given-names></name><name name-style="western"><surname>Strounina</surname><given-names>E.</given-names></name><name name-style="western"><surname>Popat</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ross</surname><given-names>B.P.</given-names></name></person-group><article-title>GAG mimetic functionalised solid and mesoporous silica nanoparticles as viral entry inhibitors of herpes simplex type 1 and type 2 viruses</article-title><source>Nanoscale</source><year>2016</year><volume>8</volume><fpage>16192</fpage><lpage>16196</lpage><pub-id pub-id-type="doi">10.1039/C6NR03878F</pub-id><pub-id pub-id-type="pmid">27604476</pub-id></element-citation></ref><ref id="B163-nanomaterials-12-00238"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fahmi</surname><given-names>M.Z.</given-names></name><name name-style="western"><surname>Sukmayani</surname><given-names>W.</given-names></name><name name-style="western"><surname>Khairunisa</surname><given-names>S.Q.</given-names></name><name name-style="western"><surname>Witaningrum</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Indriati</surname><given-names>D.W.</given-names></name><name name-style="western"><surname>Matondang</surname><given-names>M.Q.Y.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>J.-Y.</given-names></name><name name-style="western"><surname>Kotaki</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kameoka</surname><given-names>M.</given-names></name></person-group><article-title>Design of boronic acid-attributed carbon dots on inhibits HIV-1 entry</article-title><source>RSC Adv.</source><year>2016</year><volume>6</volume><fpage>92996</fpage><lpage>93002</lpage><pub-id pub-id-type="doi">10.1039/C6RA21062G</pub-id></element-citation></ref><ref id="B164-nanomaterials-12-00238"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tong</surname><given-names>T.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>J.</given-names></name><name name-style="western"><surname>Deng</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Fang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>S.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>J.</given-names></name></person-group><article-title>Glycyrrhizic-acid-based carbon dots with high antiviral activity by multisite inhibition mechanisms</article-title><source>Small</source><year>2020</year><volume>16</volume><fpage>e1906206</fpage><pub-id pub-id-type="doi">10.1002/smll.201906206</pub-id><pub-id pub-id-type="pmid">32077621</pub-id><pub-id pub-id-type="pmcid">PMC7169479</pub-id></element-citation></ref><ref id="B165-nanomaterials-12-00238"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Du</surname><given-names>X.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>R.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Yin</surname><given-names>L.</given-names></name><name name-style="western"><surname>He</surname><given-names>C.</given-names></name><name name-style="western"><surname>Li</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>J.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Hypericin-loaded graphene oxide protects ducks against a novel duck reovirus</article-title><source>Mater. Sci. Eng. C</source><year>2019</year><volume>105</volume><fpage>110052</fpage><pub-id pub-id-type="doi">10.1016/j.msec.2019.110052</pub-id><pub-id pub-id-type="pmid">31546360</pub-id></element-citation></ref><ref id="B166-nanomaterials-12-00238"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Donskyi</surname><given-names>I.S.</given-names></name><name name-style="western"><surname>Azab</surname><given-names>W.</given-names></name><name name-style="western"><surname>Cuellar-Camacho</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Guday</surname><given-names>G.</given-names></name><name name-style="western"><surname>Lippitz</surname><given-names>A.</given-names></name><name name-style="western"><surname>Unger</surname><given-names>W.E.S.</given-names></name><name name-style="western"><surname>Osterrieder</surname><given-names>K.</given-names></name><name name-style="western"><surname>Adeli</surname><given-names>M.</given-names></name><name name-style="western"><surname>Haag</surname><given-names>R.</given-names></name></person-group><article-title>Functionalized nanographene sheets with high antiviral activity through synergistic electrostatic and hydrophobic interactions</article-title><source>Nanoscale</source><year>2019</year><volume>11</volume><fpage>15804</fpage><lpage>15809</lpage><pub-id pub-id-type="doi">10.1039/C9NR05273A</pub-id><pub-id pub-id-type="pmid">31433428</pub-id></element-citation></ref><ref id="B167-nanomaterials-12-00238"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ocsoy</surname><given-names>I.</given-names></name><name name-style="western"><surname>Temiz</surname><given-names>M.</given-names></name><name name-style="western"><surname>Celik</surname><given-names>C.</given-names></name><name name-style="western"><surname>Altinsoy</surname><given-names>B.</given-names></name><name name-style="western"><surname>Yilmaz</surname><given-names>V.</given-names></name><name name-style="western"><surname>Duman</surname><given-names>F.</given-names></name></person-group><article-title>A green approach for formation of silver nanoparticles on magnetic graphene oxide and highly effective antimicrobial activity and reusability</article-title><source>J. Mol. Liq.</source><year>2017</year><volume>227</volume><fpage>147</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1016/j.molliq.2016.12.015</pub-id></element-citation></ref><ref id="B168-nanomaterials-12-00238"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Gong</surname><given-names>G.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hua</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>J.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Restriction of H1N1 influenza virus infection by selenium nanoparticles loaded with ribavirin via resisting caspase-3 apoptotic pathway</article-title><source>Int. J. Nanomed.</source><year>2018</year><volume>13</volume><fpage>5787</fpage><lpage>5797</lpage><pub-id pub-id-type="doi">10.2147/IJN.S177658</pub-id><pub-id pub-id-type="pmcid">PMC6165773</pub-id><pub-id pub-id-type="pmid">30310281</pub-id></element-citation></ref><ref id="B169-nanomaterials-12-00238"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Agelidis</surname><given-names>A.</given-names></name><name name-style="western"><surname>Koujah</surname><given-names>L.</given-names></name><name name-style="western"><surname>Suryawanshi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Yadavalli</surname><given-names>T.</given-names></name><name name-style="western"><surname>Mishra</surname><given-names>Y.K.</given-names></name><name name-style="western"><surname>Adelung</surname><given-names>R.</given-names></name><name name-style="western"><surname>Shukla</surname><given-names>D.</given-names></name></person-group><article-title>An intra-vaginal zinc oxide tetrapod nanoparticles (ZOTEN) and genital herpesvirus cocktail can provide a novel platform for live virus vaccine</article-title><source>Front. Immunol.</source><year>2019</year><volume>10</volume><fpage>500</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2019.00500</pub-id><pub-id pub-id-type="pmid">30949169</pub-id><pub-id pub-id-type="pmcid">PMC6435576</pub-id></element-citation></ref><ref id="B170-nanomaterials-12-00238"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ashraf</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Farideh</surname><given-names>N.</given-names></name><name name-style="western"><surname>Hamidreza</surname><given-names>M.</given-names></name><name name-style="western"><surname>Parichehre</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Mahboobeh</surname><given-names>N.M.</given-names></name></person-group><article-title>Assessment of antioxidant and antibacterial activities of zinc oxide nanoparticles, graphene and graphene decorated by zinc oxide nanoparticles</article-title><source>Int. J. Nano Dimens.</source><year>2019</year><volume>10</volume><fpage>350</fpage><lpage>358</lpage></element-citation></ref><ref id="B171-nanomaterials-12-00238"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Veisi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Kavian</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hekmati</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hemmati</surname><given-names>S.</given-names></name></person-group><article-title>Biosynthesis of the silver nanoparticles on the graphene oxide&#8217;s surface using <italic toggle="yes">Pistacia atlantica</italic> leaves extract and its antibacterial activity against some human pathogens</article-title><source>Polyhedron</source><year>2019</year><volume>161</volume><fpage>338</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1016/j.poly.2019.01.034</pub-id></element-citation></ref><ref id="B172-nanomaterials-12-00238"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zilker</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kozlova</surname><given-names>D.</given-names></name><name name-style="western"><surname>Sokolova</surname><given-names>V.</given-names></name><name name-style="western"><surname>Yan</surname><given-names>H.</given-names></name><name name-style="western"><surname>Epple</surname><given-names>M.</given-names></name><name name-style="western"><surname>&#220;berla</surname><given-names>K.</given-names></name><name name-style="western"><surname>Temchura</surname><given-names>V.</given-names></name></person-group><article-title>Nanoparticle-based B-cell targeting vaccines: Tailoring of humoral immune responses by functionalization with different TLR-ligands</article-title><source>Nanomed. Nanotechnol. Biol. Med.</source><year>2017</year><volume>13</volume><fpage>173</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1016/j.nano.2016.08.028</pub-id><pub-id pub-id-type="pmid">27593489</pub-id></element-citation></ref><ref id="B173-nanomaterials-12-00238"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rezaei</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hosseini</surname><given-names>S.N.</given-names></name><name name-style="western"><surname>Khavari-Nejad</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Najafi</surname><given-names>F.</given-names></name><name name-style="western"><surname>Mahdavi</surname><given-names>M.</given-names></name></person-group><article-title>HBs antigen and mannose loading on the surface of iron oxide nanoparticles in order to immuno-targeting: Fabrication, characterization, cellular and humoral immunoassay</article-title><source>Artif. Cells Nanomed. Biotechnol.</source><year>2019</year><volume>47</volume><fpage>1543</fpage><lpage>1558</lpage><pub-id pub-id-type="doi">10.1080/21691401.2019.1577888</pub-id><pub-id pub-id-type="pmid">31007088</pub-id></element-citation></ref><ref id="B174-nanomaterials-12-00238"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pimentel</surname><given-names>T.A.P.F.</given-names></name><name name-style="western"><surname>Yan</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Jeffers</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Holmes</surname><given-names>K.V.</given-names></name><name name-style="western"><surname>Hodges</surname><given-names>R.S.</given-names></name><name name-style="western"><surname>Burkhard</surname><given-names>P.</given-names></name></person-group><article-title>Peptide nanoparticles as novel immunogens: Design and analysis of a Ppototypic severe acute respiratory syndrome vaccine</article-title><source>Chem. Biol. Drug Des.</source><year>2009</year><volume>73</volume><fpage>53</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1111/j.1747-0285.2008.00746.x</pub-id><pub-id pub-id-type="pmid">19152635</pub-id><pub-id pub-id-type="pmcid">PMC2756483</pub-id></element-citation></ref><ref id="B175-nanomaterials-12-00238"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Geng</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Tai</surname><given-names>W.</given-names></name><name name-style="western"><surname>Baxter</surname><given-names>V.K.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wan</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Montgomery</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Taft-Benz</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Knight</surname><given-names>A.C.</given-names></name><etal/></person-group><article-title>Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection</article-title><source>PLoS Pathog.</source><year>2021</year><volume>17</volume><elocation-id>e1009897</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1009897</pub-id><pub-id pub-id-type="pmid">34492082</pub-id><pub-id pub-id-type="pmcid">PMC8448314</pub-id></element-citation></ref><ref id="B176-nanomaterials-12-00238"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coleman</surname><given-names>C.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.V.</given-names></name><name name-style="western"><surname>Mu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>J.K.</given-names></name><name name-style="western"><surname>Massare</surname><given-names>M.</given-names></name><name name-style="western"><surname>Flyer</surname><given-names>D.C.</given-names></name><name name-style="western"><surname>Glenn</surname><given-names>G.M.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>G.E.</given-names></name><name name-style="western"><surname>Frieman</surname><given-names>M.B.</given-names></name></person-group><article-title>Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice</article-title><source>Vaccine</source><year>2014</year><volume>32</volume><fpage>3169</fpage><lpage>3174</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2014.04.016</pub-id><pub-id pub-id-type="pmid">24736006</pub-id><pub-id pub-id-type="pmcid">PMC4058772</pub-id></element-citation></ref><ref id="B177-nanomaterials-12-00238"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barlow</surname><given-names>P.G.</given-names></name><name name-style="western"><surname>Clouter-Baker</surname><given-names>A.</given-names></name><name name-style="western"><surname>Donaldson</surname><given-names>K.</given-names></name><name name-style="western"><surname>MacCallum</surname><given-names>J.</given-names></name><name name-style="western"><surname>Stone</surname><given-names>V.</given-names></name></person-group><article-title>Carbon black nanoparticles induce type II epithelial cells to release chemotaxins for alveolar macrophages</article-title><source>Part. Fibre Toxicol.</source><year>2005</year><volume>2</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1186/1743-8977-2-11</pub-id><pub-id pub-id-type="pmid">16332254</pub-id><pub-id pub-id-type="pmcid">PMC1325251</pub-id></element-citation></ref><ref id="B178-nanomaterials-12-00238"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gurr</surname><given-names>J.-R.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C.-H.</given-names></name><name name-style="western"><surname>Jan</surname><given-names>K.-Y.</given-names></name></person-group><article-title>Ultrafine titanium dioxide particles in the absence of photoactivation can induce oxidative damage to human bronchial epithelial cells</article-title><source>Toxicology</source><year>2005</year><volume>213</volume><fpage>66</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1016/j.tox.2005.05.007</pub-id><pub-id pub-id-type="pmid">15970370</pub-id></element-citation></ref><ref id="B179-nanomaterials-12-00238"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Cai</surname><given-names>X.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>R.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>W.</given-names></name></person-group><article-title>Comparative study on the acute pulmonary toxicity induced by 3 and 20 nm TiO<sub>2</sub> primary particles in mice</article-title><source>Environ. Toxicol. Pharmacol.</source><year>2007</year><volume>24</volume><fpage>239</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1016/j.etap.2007.06.004</pub-id><pub-id pub-id-type="pmid">21783817</pub-id></element-citation></ref><ref id="B180-nanomaterials-12-00238"><label>180.</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name name-style="western"><surname>Cummins</surname><given-names>G.</given-names></name><name name-style="western"><surname>Lay</surname><given-names>H.</given-names></name><name name-style="western"><surname>Cox</surname><given-names>B.</given-names></name><name name-style="western"><surname>Seetohul</surname><given-names>V.</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Stewart</surname><given-names>F.</given-names></name><name name-style="western"><surname>Faerber</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mitrakos</surname><given-names>V.</given-names></name><name name-style="western"><surname>Al Rawhani</surname><given-names>M.</given-names></name><name name-style="western"><surname>Beeley</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Sonopill: A platform for gastrointestinal disease diagnosis and therapeutics</article-title><source>Proceedings of the 6th Joint Workshop on New Technologies for Computer/Robot Assisted Surgery</source><conf-loc>Pisa, Italy</conf-loc><conf-date>12&#8211;14 September 2016</conf-date></element-citation></ref><ref id="B181-nanomaterials-12-00238"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scaldaferri</surname><given-names>F.</given-names></name><name name-style="western"><surname>Pizzoferratom</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gerardim</surname><given-names>V.</given-names></name><name name-style="western"><surname>Lopetuso</surname><given-names>L.</given-names></name><name name-style="western"><surname>Gasbarrini</surname><given-names>A.</given-names></name></person-group><article-title>The gut barrier</article-title><source>J. Clin. Gastroenterol.</source><year>2012</year><volume>46</volume><fpage>S12</fpage><lpage>S17</lpage><pub-id pub-id-type="doi">10.1097/MCG.0b013e31826ae849</pub-id><pub-id pub-id-type="pmid">22955350</pub-id></element-citation></ref><ref id="B182-nanomaterials-12-00238"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lopetuso</surname><given-names>L.R.</given-names></name><name name-style="western"><surname>Petito</surname><given-names>V.</given-names></name><name name-style="western"><surname>Graziani</surname><given-names>C.</given-names></name><name name-style="western"><surname>Schiavoni</surname><given-names>E.</given-names></name><name name-style="western"><surname>Sterbini</surname><given-names>F.P.</given-names></name><name name-style="western"><surname>Poscia</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gaetani</surname><given-names>E.</given-names></name><name name-style="western"><surname>Franceschi</surname><given-names>F.</given-names></name><name name-style="western"><surname>Cammarota</surname><given-names>G.</given-names></name><name name-style="western"><surname>Sanguinetti</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Gut microbiota in health, diverticular disease, irritable bowel syndrome, and inflammatory bowel diseases: Time for microbial marker of gastrointestinal disorders</article-title><source>Dig. Dis.</source><year>2017</year><volume>36</volume><fpage>56</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1159/000477205</pub-id><pub-id pub-id-type="pmid">28683448</pub-id></element-citation></ref><ref id="B183-nanomaterials-12-00238"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Daniels</surname><given-names>L.</given-names></name><name name-style="western"><surname>Philipszoon</surname><given-names>L.E.</given-names></name><name name-style="western"><surname>Boermeester</surname><given-names>M.A.</given-names></name></person-group><article-title>A Hypothesis</article-title><source>Dis. Colon Rectum</source><year>2014</year><volume>57</volume><fpage>539</fpage><lpage>543</lpage><pub-id pub-id-type="doi">10.1097/DCR.0000000000000078</pub-id><pub-id pub-id-type="pmid">24608313</pub-id></element-citation></ref><ref id="B184-nanomaterials-12-00238"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paul</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Paul</surname><given-names>A.</given-names></name><name name-style="western"><surname>Jahan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Jannat</surname><given-names>K.</given-names></name><name name-style="western"><surname>Bondhon</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Hasan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Nissapatorn</surname><given-names>V.</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Wilairatana</surname><given-names>P.</given-names></name><name name-style="western"><surname>Rahmatullah</surname><given-names>M.</given-names></name></person-group><article-title>Probiotics and amelioration of rheumatoid arthritis: Significant roles of <italic toggle="yes">Lactobacillus casei</italic> and <italic toggle="yes">Lactobacillus acidophilus</italic></article-title><source>Microorganisms</source><year>2021</year><volume>9</volume><elocation-id>1070</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms9051070</pub-id><pub-id pub-id-type="pmid">34065638</pub-id><pub-id pub-id-type="pmcid">PMC8157104</pub-id></element-citation></ref><ref id="B185-nanomaterials-12-00238"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>H.</given-names></name></person-group><article-title>Dysbiosis in gastrointestinal disorders</article-title><source>Best Pract. Res. Clin. Gastroenterol.</source><year>2016</year><volume>30</volume><fpage>3</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.bpg.2016.02.001</pub-id><pub-id pub-id-type="pmid">27048892</pub-id></element-citation></ref><ref id="B186-nanomaterials-12-00238"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mayer</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Savidge</surname><given-names>T.</given-names></name><name name-style="western"><surname>Shulman</surname><given-names>R.J.</given-names></name></person-group><article-title>Brain&#8211;gut microbiome interactions and functional bowel disorders</article-title><source>Gastroenterology</source><year>2014</year><volume>146</volume><fpage>1500</fpage><lpage>1512</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2014.02.037</pub-id><pub-id pub-id-type="pmid">24583088</pub-id><pub-id pub-id-type="pmcid">PMC4114504</pub-id></element-citation></ref><ref id="B187-nanomaterials-12-00238"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heya</surname><given-names>M.</given-names></name><name name-style="western"><surname>David Torres-Hern&#225;ndez</surname><given-names>&#193;.</given-names></name><name name-style="western"><surname>Heya</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Torres Hern&#225;ndez</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Cordero D&#237;az</surname><given-names>A.</given-names></name><name name-style="western"><surname>Garc&#237;a Coronado</surname><given-names>P.L.</given-names></name></person-group><article-title>Biomedical apllication of nanoformulated plant Diagn&#243;stico de las dermatofitosis View project Biomedical apllication of nanoformulated plant View project Biomedical apllication of nanoformulated plant</article-title><source>Artic. Int. J. Pharm. Sci. Res.</source><year>2022</year><volume>13</volume><fpage>1000</fpage><pub-id pub-id-type="doi">10.13040/IJPSR.0975-8232.13</pub-id></element-citation></ref><ref id="B188-nanomaterials-12-00238"><label>188.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Ryan</surname><given-names>E.T.</given-names></name><name name-style="western"><surname>Hill</surname><given-names>D.R.</given-names></name><name name-style="western"><surname>Solomon</surname><given-names>T.</given-names></name><name name-style="western"><surname>Aronson</surname><given-names>N.</given-names></name><name name-style="western"><surname>Endy</surname><given-names>T.P.</given-names></name></person-group><source>Hunter&#8217;s Tropical Medicine and Emerging Infectious Diseases E-Book</source><edition>10th ed.</edition><publisher-name>Elsevier</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2020</year><isbn>9780323555128</isbn></element-citation></ref><ref id="B189-nanomaterials-12-00238"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Madureira</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>A.</given-names></name><name name-style="western"><surname>Pintado</surname><given-names>M.</given-names></name></person-group><article-title>Current state on the development of nanoparticles for use against bacterial gastrointestinal pathogens. Focus on chitosan nanoparticles loaded with phenolic compounds</article-title><source>Carbohydr. Polym.</source><year>2015</year><volume>130</volume><fpage>429</fpage><lpage>439</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2015.05.030</pub-id><pub-id pub-id-type="pmid">26076644</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="nanomaterials-12-00238-f001" orientation="portrait"><label>Figure 1</label><caption><p>Representation of delivery of phytopharmaceuticals using nanotechnology. The figure was made with <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="www.biorender.com">www.biorender.com</uri> (access date: 17 December 2021).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nanomaterials-12-00238-g001.jpg"/></fig><fig position="float" id="nanomaterials-12-00238-f002" orientation="portrait"><label>Figure 2</label><caption><p>Encapsulation of bioactive compounds from herbal extracts of <italic toggle="yes">Curcuma longa</italic> and <italic toggle="yes">Panax ginseng</italic> into various nanoparticle platforms facilitates delivery to targeted areas in the brain from the blood, improves solubility, and enhances retention rates. The figure was made with <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="www.biorender.com">www.biorender.com</uri> (access date: 12 January 2022). Abbreviations: BBB, blood-brain barrier; PLGA, poly (<sc>d,l</sc>-lactic acid-co-glycolic acid).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nanomaterials-12-00238-g002.jpg"/></fig><fig position="float" id="nanomaterials-12-00238-f003" orientation="portrait"><label>Figure 3</label><caption><p>Encapsulation of bioactive compounds with nanoparticles from various herbal extracts to prevent cardiovascular disorders. Abbreviation: PLGA, poly (<sc>d,l</sc>-lactic acid-co-glycolic acid). The figure was made with <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="www.biorender.com">www.biorender.com</uri> (access date: 12 January 2022).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nanomaterials-12-00238-g003.jpg"/></fig><fig position="float" id="nanomaterials-12-00238-f004" orientation="portrait"><label>Figure 4</label><caption><p>Encapsulation of bio-active compounds from various herbal extracts with silver, silicon, or gold nanoparticles to improve delivery in lungs and to prevent pulmonary disorders. The figure was made with <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="www.biorender.com">www.biorender.com</uri> (access date: 12 January 2022).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nanomaterials-12-00238-g004.jpg"/></fig><fig position="float" id="nanomaterials-12-00238-f005" orientation="portrait"><label>Figure 5</label><caption><p>Encapsulation of bioactive compounds from various herbal extracts with silver, gold, cellulose, and polymeric nanoparticles to improve delivery in the gastrointestinal tract, and to prevent or cure various diseases. The figure was made with <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="www.biorender.com">www.biorender.com</uri> (access date: 12 January 2022).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nanomaterials-12-00238-g005.jpg"/></fig><table-wrap position="float" id="nanomaterials-12-00238-t001" orientation="portrait"><object-id pub-id-type="pii">nanomaterials-12-00238-t001_Table 1</object-id><label>Table 1</label><caption><p>Nano-formulations of active compounds or extracts from curcumin and ginseng for neurological disorders.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Nanoformulation</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Phyto-Pharmaceutical</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Effect</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Liposomal carriers</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Curcumin (LipoCur)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced proliferation and reactivity of human microglia and astrocytes; reduced glial scarring</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B34-nanomaterials-12-00238" ref-type="bibr">34</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ginsenoside Rg3 in combination with paclitaxel (Rg3-PTX-LPs)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-proliferative effect on C6 glioma cells; triggered expansion of CD8 + T-cell populations in C6-bearing mice/rats</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B66-nanomaterials-12-00238" ref-type="bibr">66</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tween 80-coated nanoparticles</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Curcumin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Higher accumulation of curcumin in Wistar rats; improved solubilisation and plasma distribution to vital organs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B37-nanomaterials-12-00238" ref-type="bibr">37</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dextran-coated cerium oxide nanoparticles</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Curcumin (CNP-Cur)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enhanced cell death in neuroblastoma cells through caspase-dependent apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B38-nanomaterials-12-00238" ref-type="bibr">38</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Silk fibroin nanoparticles</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Curcumin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enhanced tumour-specific toxicity in neuroblastoma cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B39-nanomaterials-12-00238" ref-type="bibr">39</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zein&#8211;chitosan nanoparticles</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Curcumin-piperine combination (CPZChN)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced SH-SY5Y neuroblastoma cell viability by half</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B40-nanomaterials-12-00238" ref-type="bibr">40</xref>]</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Solid lipid nanoparticles (SLNs);Nanostructured lipid carriers (NLCs)</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Curcumin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Highest bioaccumulation of curcumin in rat brains compared to free compound and SLNs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B43-nanomaterials-12-00238" ref-type="bibr">43</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced LPS-induced neuroinflammation in BV-2 microglial cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B68-nanomaterials-12-00238" ref-type="bibr">68</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Downregulation of pyknotic neurons and anti-inflammatory effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B47-nanomaterials-12-00238" ref-type="bibr">47</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lipid-core nanocapsules (LNC)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Curcumin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reversal of degeneration and reduced inflammatory cytokine levels in AD mice model</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B44-nanomaterials-12-00238" ref-type="bibr">44</xref>]</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Poly (D,L-lactic acid-co-glycolic acid, PLGA) polymer nanoparticles</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Curcumin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced neuroinflammation in 5xFAD mice</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B48-nanomaterials-12-00238" ref-type="bibr">48</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Curcumin co-administered with phytol and selenium</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibited &#946; amyloid aggregation in AD models</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B50-nanomaterials-12-00238" ref-type="bibr">50</xref>,<xref rid="B51-nanomaterials-12-00238" ref-type="bibr">51</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ginsenoside Rg3 combined with Thioflavin T</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Effective penetration of an in vitro blood-brain barrier</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B58-nanomaterials-12-00238" ref-type="bibr">58</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Novel PLGA nanoparticles added with a BBB-penetrating (cyclic CRTIGPSVC) peptide</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Curcumin with A&#946; generation inhibitor</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Transgenic Alzheimer&#8217;s disease mice had improved spatial memory scores and enhanced &#8217;new-object&#8217; recognition</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B9-nanomaterials-12-00238" ref-type="bibr">9</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chitosan-coated poly (lactic-co-glycolic acid) nanoparticles (CUR-CS-PLGA-NPs);<break/>Hydroxypropyl-&#946;-cyclodextrin-encapsulated CUR (CUR/HP-&#946;-CD inclusion) complex</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Curcumin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory effect in BV-2 cells and higher bioavailability in vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B52-nanomaterials-12-00238" ref-type="bibr">52</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Curcumin-conjugated superparamagnetic iron oxide (SPIO) particles; magnetic nanoparticles</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Curcumin (Cur-MNPs)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Co-localisation of particles with amyloid plaques, enabling less invasive (MRI-based) AD diagnosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B53-nanomaterials-12-00238" ref-type="bibr">53</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Gold and silver nanoparticles</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Red ginseng water extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytoprotective effect on neuron-like PC-12 cells due to decreased intracellular oxidative stress; promotion of synaptic impulse transmission</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B59-nanomaterials-12-00238" ref-type="bibr">59</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fresh ginseng leaf extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antioxidant, anticancer and anti-inflammatory activities in HaCaT cells, 3T3-L1 pre-adipocyte cells, A549 lung cancer and B16BL6 skin melanoma cancer cell lines and RAW 264.7 cell lines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B64-nanomaterials-12-00238" ref-type="bibr">64</xref>]</td></tr></tbody></table></table-wrap><table-wrap position="float" id="nanomaterials-12-00238-t002" orientation="portrait"><object-id pub-id-type="pii">nanomaterials-12-00238-t002_Table 2</object-id><label>Table 2</label><caption><p>Nano-phytopharmaceuticals for therapeutic applications in CVDs.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Nanoformulation</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Phyto-Pharmaceutical</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Effects</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Liposomes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Curcumin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-hypercholesterolemic, anti-atherosclerotic and protective against cardiac ischemia and reperfusion.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B102-nanomaterials-12-00238" ref-type="bibr">102</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PLGA nanoparticle</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quercetin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-hypercholesterolemia, better cell rescue by lowering oxidized thiols and sustaining superior ATP production, improved therapeutics for ROS-based cardiac diseases.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B89-nanomaterials-12-00238" ref-type="bibr">89</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Solid lipid Nanoparticle</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Resveratrol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protective action of vascular walls towards oxidation, inflammation, platelet oxidation and thrombus formation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B103-nanomaterials-12-00238" ref-type="bibr">103</xref>,<xref rid="B104-nanomaterials-12-00238" ref-type="bibr">104</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1,2-diacyl-Sn-glycero-3-phosphocholine [EPC] and 1,2-dipalmitoyl-Sn-glycero-3-phosphocholine (DPPC) liposomes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Magnolol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enhanced inhibitory effect on migration and hyperplasia of vascular smooth-muscle cells; Anti-platelet, anti-thrombotic, and anti-hypertensive via inhibiting MAPK family activation, Akt/ERK1/2/GSK3 &#946;-catenin pathway, and angiotensin-converting enzyme (ACE)/angiotensin II (Ang II)/Ang II type 1 receptor (AT-1R) cascade and upregulating PPAR-&#946;/&#947; and NO/guanosine 3&#8242;,5&#8242;-cyclic phosphate/PKG.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B85-nanomaterials-12-00238" ref-type="bibr">85</xref>,<xref rid="B105-nanomaterials-12-00238" ref-type="bibr">105</xref>,<xref rid="B106-nanomaterials-12-00238" ref-type="bibr">106</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nano-micelles</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tilianin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protective effects of cardiomyocytes by inhibiting inflammation and oxidative stress during myocardial ischemia-reperfusion injury</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B99-nanomaterials-12-00238" ref-type="bibr">99</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PEGylated nanostructured lipid carriers</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Baicalin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Improved myocardial ischemia; beneficial roles against the initiation and progression of CVDs such as atherosclerosis, hypertension, myocardial infarction, reperfusion and heart failure</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B100-nanomaterials-12-00238" ref-type="bibr">100</xref>,<xref rid="B101-nanomaterials-12-00238" ref-type="bibr">101</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Liposomes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Berberine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Effect of protecting heart failure, hypertension, hyperlipidemia, insulin resistance, arrhythmias, and platelet aggregation.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B96-nanomaterials-12-00238" ref-type="bibr">96</xref>,<xref rid="B107-nanomaterials-12-00238" ref-type="bibr">107</xref>]</td></tr></tbody></table></table-wrap><table-wrap position="float" id="nanomaterials-12-00238-t003" orientation="portrait"><object-id pub-id-type="pii">nanomaterials-12-00238-t003_Table 3</object-id><label>Table 3</label><caption><p>Nano-phytopharmaceuticals for therapeutic applications in GI disorders.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Nanoformulation</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Phyto-Pharmaceutical</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Enteropathogen/GI Cell Lines; IC<sub>50</sub>/MIC</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Polymeric (EPO)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Berberis vulgaris</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Entamoeba histolytica</italic>; 26 ppm</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B187-nanomaterials-12-00238" ref-type="bibr">187</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Polymeric (EPO)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Curcuma longa</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Entamoeba histolytica</italic>; 19 ppm</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B187-nanomaterials-12-00238" ref-type="bibr">187</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Polymeric (Cerium oxide)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Nelumbo nucifera</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Human colon cancer (HCT 116); 4.16 &#181;g/mL</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B187-nanomaterials-12-00238" ref-type="bibr">187</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cellulose (Ethyl)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Garcinia mangostana</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Helicobacter pylori</italic>; 62.5 &#181;g/mL</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B187-nanomaterials-12-00238" ref-type="bibr">187</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Metallic (Silver)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Toxicodendron vernicifluum</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Helicobacter pylori</italic>; 18.14 &#181;g/mL</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B187-nanomaterials-12-00238" ref-type="bibr">187</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Metallic (Silver)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Toxicodendron vernicifluum</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">E.coli</italic>; 8.12 &#181;g/mL</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B187-nanomaterials-12-00238" ref-type="bibr">187</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Metallic (Gold)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Tribulus terrestris</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Helicobacter pylori</italic>; 16.75 &#181;g/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B187-nanomaterials-12-00238" ref-type="bibr">187</xref>]</td></tr></tbody></table></table-wrap></floats-group></article></pmc-articleset>